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Acanthamoeba is a small free-living amoeba found in tap water and 
soil with two life stages: the trophozoite and cyst. Acanthamoeba 
species are opportunistic pathogens of humans that cause two main 
diseases including a potentially blinding infection of the cornea called 
Acanthamoeba keratitis (AK) in immunocompetent individuals, and a 
fatal granulomatous encephalitis in the immunocompromised.  
In this study, an ex vivo model of AK was developed to better 
understand the pathophysiological processes that occur in this 
disease. The model has several applications such as studying the 
interaction of Acanthamoeba with cells of innate immunity, 
investigating the efficacy of different pharmaceutical products in 
stopping the progression of the disease beside using the model to 
correlate between in vivo and ex vivo confocal microscopy findings of 
various morphologies of Acanthamoeba cysts and trophozoites. 
Furthermore, the study evaluated the phenotypic similarities between 
Acanthamoeba and cells of the innate immune system mainly 
macrophages using flow cytometry analysis to enhance the 




Porcine corneas were used to establish a reproducible ex vivo model 
which was maintained for four weeks and optimised by the supplement 
of CO2 and the use of air – liquid interface rocking system that mimics 
natural eye blinking. Once the model was established, Acanthamoeba 
trophozoites and cysts were added to the corneal model to evaluate 
the pathogenesis of Acanthamoeba keratitis, and the study 
successfully demonstrated the development of the infection in the 
model. This study was also able to demonstrate that the addition of 
macrophages and neutrophils to the AK model did not limit the process 
of the infection as these cells were phagocytosed by Acanthamoeba. 
 
The model was also used to investigate the efficacy of doxycycline and 
polyhexamethylene biguanide (PHMB) in stopping the disease 
progression and the results demonstrated the ability of PHMB to 
inactivate Acanthamoeba trophozoites with minimal toxicity to the 
corneal epithelium. Doxycycline was not found to have any major 
antimicrobial effect on the viability of Acanthamoeba. 
 
The model was also utilized to study the ex vivo confocal microscopy 
(EVCM) features of various forms of Acanthamoeba and correlate these 
findings to in vivo confocal microscopy (IVCM) images from culture 
positive AK cases. The study demonstrated similarity in the 
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morphological features of Acanthamoeba in both ex vivo and in vivo 
confocal microscopy images, which makes EVCM images a reliable 
reference to validate IVCM findings. 
 
Finally, this study evaluated the phenotypic similarities between 
Acanthamoeba and macrophages using flow cytometry analysis which 
identified various degrees of positive reactivity of amoebic cell surface 
to a limited number of anti-human monoclonal antibodies. This suggests 
some structural and functional similarities in protein surfaces between 
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Chapter 1: General Introduction 
1.1 Brief History 
Cells are divided into two main categories: prokaryotic and eukaryotic (Whittaker, 
1969). The unicellular organisms of bacteria and archaea domains are classified as 
prokaryotes (Murat et al.,2010). Animal cells, plant cells, fungi, and protists are 
eukaryotes (Youngson ,2006). Eukaryotic cells have four components in common: 
a plasma membrane which separates the internal structures of the cell from the 
outside environment, cytoplasm within which other cellular organelles are located, 
deoxyribonucleic acid (DNA) which is the genetic material of the cell, and ribosomes 
which are the particles that synthesize proteins (Whittaker, 1969). Prokaryotes are 
structurally different from eukaryotic cells as they are single-cell organisms with no 
nucleus or other membrane-bound organelles (Charles et al.,2012). 
The invention of the microscope in the 1600s was a revolutionary step in enabling 
scientists to study objects that cannot be observed by the naked eye. In 1676, the 
Dutch scientist Antonie Van Leeuwenhoek was the first to identify microorganisms 
when he was studying a drop of water under the microscope and noticed some 
microorganisms, and he was the first to identify free-living protozoa (Lane, 2015)  
Protozoa are unicellular eukaryotes that have complicated internal structure and 
perform complex metabolic functions like feeding in which they ingest food by a 
process called pinocytosis to engulf liquids or small particles, and another process 
called phagocytosis for larger food particles (Flannagan et al., 2009).  
Living organisms are subtyped into two super kingdoms: prokaryotes and 
eukaryotes; The eukaryotes are divided into five kingdoms: animalia, plantae, fungi, 
chromista and protista (Ruggiero et al., 2015). Amoebozoa is classified as a phylum 
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in the Protozoa subkingdom within the Protista kingdom, it has a characteristic ability 
to change its shape by forming projections called pseudopodia, and all amoebae 
share a common amoeboid motion (Singleton and Sainsbury 2006).  
 
1.2 Amoebic Discovery History 
In 1875, Lösch described the relationship between Entamoeba 
and chronic dysentery in a young farmer (Lesh,1875). In 1899, Schadinger 
correlated the clinical symptoms of a patient with dysentery with a flagellate amoeba 
he isolated from the patient’s stool and named it Amoeba gruberi (Martinez and 
Visvesvara 1997). In 1903, Schaudinn stated that the underlying cause of chronic 
dysentery is the parasite Entamoeba histolytica (Martinez and Visvesvara 1997). 
In 1909, Kurt Naegler reported that Amoeba gruberi is a harmless amoeba and 
renamed it Naegleria gruberi (Martinez and Visvesvara 1997). In 1930, 
Acanthamoeba was discovered as a contamination of a yeast culture of 
Cryptococcus pararoseus by the British/Italian scientist Sir Aldo Castellani who 
classified the organism in genus Hartmannella and named it Hartmannella 
castellanii (Castellani 1930; Douglas 1930; Volkonsky 1931), however the new 
classification has classified Hartmannella and Acanthamoeba as separate genera 
(Martinez and Visvesvara 1997).  
During the development of the polio vaccine Clyde Culbertson reported the 
pathogenic effect of Acanthamoeba on monkey kidney cells at the Eli Lily Laboratory 
in Indianapolis, USA. This contamination was the first time that the free-living 
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amoeba Acanthamoeba was reported to exhibit a pathogenic effect (Culbertson et 
al.,1958) and Singh named it Acanthamoeba culbertsoni (Singh and Das 1970).  
In 1972, the first case of Granulomatous Amoebic encephalitis (GAE) in humans 
was discovered by Jager and Stamm. In 1974, Naginton reported the first published 
case of Acanthamoeba keratitis in a healthy schoolteacher who had been 
complaining of blurred vision with no prior eye trauma, his symptoms worsened over 
a period of six weeks and a ring infiltrate formed around the cornea which ended up 
with ulceration resistant to conventional treatment. The second case was a farmer 
with a history of eye trauma who started to complain from pain in his eye then 
developed a painful ring abscess surrounding the cornea which was refractory to 
treatment. The histology sections for the cornea of both patients showed heavy 
infiltration of Acanthamoeba cysts (Naginton et al., 1974).   
The pathogenic types of free-living amoeba are the most significant to study 
because of their relevance and implications on human health. Acanthamoeba 
species cause keratitis and GAE, Naegleria fowleri causes primary amoebic 
meningoencephalitis (PAM) in children and adults, Sappinia diploidea is known to 
cause brain infection (Visvesvara et al.,1990, Visvesvara  et al.,2007),  Balamuthia 
mandrillaris causes skin and lung infections and lethal encephalitis in young patients 
and it was first isolated from a mandrill baboon that died at the San Diego Zoo 
Park in California in 1986 with the first human infection reported in 1990, and the 
name Balamuthia was given by Visvesvara after his mentor, parasitologist William 
Balamuth in recognition of his contribution to the field of studying amoeba 




1.3 Acanthamoeba: Trophozoite Stage 
Acanthamoeba is a virtually ubiquitous free-living amoeba with a life cycle 
characterized by a phenotypic switch between the trophozoite (active) stage and the 
cyst (dormant) stage. The trophozoite stage is the active, feeding and replicating 
stage where the organism moves by contraction of protoplasmic tooth-like 
projections called acanthopodia which are 1-2 µm in diameter that extend several 
microns from the amoeba and are formed of hyaline cytoplasm (Bowers and Korn, 
1968) giving the trophozoite its characteristic ‘thorny’ appearance (acanthus is Latin 








Figure 1.1:Trophozoite stage of Acanthamoeba castellanii (ATCC 50370) 
demonstrating contractile vacuoles and acanthopodia at 200X. 
 
The average size of trophozoites ranges from 25 µm to 40 µm (Marciano-Cabral 
and Cabral 2003). It is composed of a plasma membrane formed of two layers of 





that include mitochondria, a network of rough endoplasmic reticulum, contractile 
vacuoles which control the concentration of water inside the cell by their contractile 
ability that expels extra water out of cell, food vacuoles scattered throughout the 
cytoplasm which form after ingestion of food material , and a central nucleus that 
contains a large nucleolus (Marciano-Cabral and Cabral 2003). 
The plasma membrane consists of proteins, phospholipids, sterols and 
lipophysphoglycan (Dearborn and Kornl 1974). The lipophosphoglycan component 
forms 31% of the cell membrane of Acanthamoeba and 14% of the 
lipophosphonoglycan of the Acanthamoeba plasma membrane is formed of classes 
of long chain fatty acids as saturated, unsaturated and branched (Korn et al.,1974). 
Acanthamoeba grows and replicates by mitosis (Neelam and Niederkorn 2017), and 
feeds on organic matter such as algae, yeast and bacteria (Marciano-Cabral and 
Cabral 2003). When feeding on bacteria in monoxenic culture, Acanthamoeba 
trophozoites feed on both gram-negative bacilli (including Escherichia coli, 
Enterobacter aerogenes) and gram-positive bacteria like Staphylococcus epidermis 
(Marciano-Cabral and Cabral 2003). It can also be grown axenically in Peptone 
Yeast Glucose extract (PYG) medium consisting of 2% proteose peptone, 0.2% 
yeast extract and 0.1% M glucose (Marciano-Cabral and Cabral, 2003) which was 
first described by Neff (Neff, 1957). Acanthamoeba castellanii can grow and 
replicate in media containing amino acids, vitamins and any carbon sources or salts 






1.4 Acanthamoeba: Cyst Stage 
The cyst is smaller than the trophozoite and is approximately 12-20 µm in diameter 
depending on the species. In this stage, Acanthamoeba is mitotically inactive 
securing itself within a tough cyst wall to survive difficult environmental conditions 
(Figure 1.2). The alterations to ribonucleic acid (RNA), proteins, lipids and glycogen 
during the encystment process lead to a decline in cellular volume and weight 
(Weisman 1976) as the encystment process completes.  Acanthamoeba castellanii 
has a specific amount of cAMP that increases two- to threefold before starting to 
decline when cyst formation starts, cAMP helps in glycogen breakdown by activating 
glycogen phosphorylase and changing glycogen synthase to the less-active glucose 
6-phosphate-dependent form, a mechanism that may account for glycogen 
degradation in the encystment stage (Weisman 1976).  
Cellulose is mainly detected in the cyst stage; it is fibrous in nature and its rigidity 
and high tensile strength explains its presence in many rigid cell walls like the cyst 
stage (Weisman,1976). The dormant cyst stage is responsible of the ubiquity of 
Acanthamoeba due to its ability to respond to adverse environmental conditions 
such as extremes of temperature, change in pH, starvation and change in osmolarity 
(Page 1988). Acanthamoeba castellanii trophozoite has a surface receptor called 
‘Encystment Stimulating Protein’ (ESP) that initiates the encystment process after 
binding to its natural ligand in the environment which could be an antibody on the 
target cell and the trophozoite remains encysted as long as this binding is present 
(Yang and Villemez,1994). ESP is an osmolarity receptor which increases its binding 
affinity as the osmolarity increases (Cordingley et al.,1996). 
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The cysts are resistant to chemicals, repeated cycles of freeze-thawing (Neelam 
and Niederkorn 2017) and chlorinated water (Dawson and Brown 1987). 
Acanthamoeba culbertsoni survives after 3 hours of exposure to concentrations 
more than 40 µg/mL chlorine in swimming pools (De Jonckheere,1991), however 
the cyst is killed by moist heat, 3 minutes of microwave irradiation, and 15 minutes 
cycle of ultraviolet irradiation (De Jonckheere,1991).  
The cyst has a double wall structure, the outer layer (ectocyst) contains 
polysaccharides, and the inner layer (endocyst) is made of cellulose (Weisman 
1976, Neff et al., 1964a). At periodic intervals, the endocyst and ectocyst come in 
contact together forming points called ostioles and the cytoplasm bulges at these 
points to be closer to the outside of the cyst (Bowers and Korn, 1968). The centre 
of this specific area is called the operculum (Bowers and Korn, 1968), and 
Acanthamoeba excysts through this pore leaving behind an empty cyst (Stratford 
and Griffiths, 1978). 
In laboratory, encystation process is initiated by using  a medium composed of many 
compounds like NaCl, KCl, MgSO4 ,NaHCO3, CaCl2, and Neff`s constant- pH 
encystment medium containing magnesium, chloride and amine buffer at pH 8.9-9 
(Hughes et al.,2001; Khunkitti et al.,1998; Neff et al.,1964) or  through starvation 
and depletion of bacterial food source by culturing trophozoites on non-nutrient agar 
(NNA) seeded with Escherichia Coli, or in axenic medium for 6 weeks or more 
(Hughes et al.,2001; Buck and Rosenthal 1996; Page 1988). 
Acanthamoeba encystment can also be stimulated by taurine or catecholamines 
including epinephrine and norepinephrine (Srivastava et al.,1983, Verma et 
al.,1974). Activation of the encystment process using epinephrine is facilitated by a 
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receptor that induces cAMP synthesis (Murti,1984) which has the capability of 








Figure 1.2: Mature cysts of Acanthamoeba castellanii demonstrating endocyst and 
ectosyst at 400X. 
 
1.5 Acanthamoeba Feeding 
Acanthamoeba feeds through a range of engulfment methods such as pinocytosis 
and phagocytosis (Allen and Dawidowicz 1990, Alsam 2005). The pinocytosis 
process is nonspecific and depends on membrane invagination to engulf large 
amounts of liquid and small particles (Bowers and Olszewski 1972) while 
phagocytosis is a direct ingestion of large food particles by enveloping them in 
vacuoles using a receptor dependent process (Khan 2006). Acanthamoeba has the 
ability to distinguish between digestible and nondigestible content by digesting the 
former and expelling the latter out of the cell (Bowers and Olszewski 1972). Feeding 





Acanthamoeba (Page ,1967). The food cup (Figure 1.3) is part of the cell wall that 









Figure 1.3: Scanning electron microscope of Acanthamoeba trophozoites showing 
the food cup (Banjo, 2018). 
 
1.6 Acanthamoeba Distribution 
Acanthamoeba is distributed worldwide, as it is considered one of the most 
prevalent protozoa in the environment which can be found in natural and artificial 
areas, such as soil, drinking water, water wash bottles, deep ocean bottom, cooling 
water of nuclear power plants, swimming pools (Carnt et al.,2020, Lorenzo-Morales 
et al.,2015, Taravaud,2017), air conditioning units, dental treatments units, dialysis 
units, contact lenses, lens care products, contamination in tissue culture (Marciano-
Cabral and Cabral 2000) hot tubs, ventilation ducts and eye wash stations 
(Niederkorn et al.,1999).  Acanthamoeba are also frequently isolated from tap water 
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in houses with a variation between seasons ranging from 27.9% during the winter 
period to 29.6% over summer (Carnt et al.,2020). It is thus obvious that human 
beings regularly encounter and interact with this organism. 
1.7 Acanthamoeba Classification 
Acanthamoeba is a eukaryote organism of the Protozoa Subkingdom within the 
Protista kingdom (Martinez and Visvesvara, 1997). It is a member of the Rhizopodia 
Superclass that contains Genera Entamoeba, Hartmannella, Naegleria, 
Vahlkampfia, and Balamuthia (Martinez and Visvesvara,1997).  Extensive research 
has been conducted to study Acanthamoeba since its discovery by Castellani in 
1930 in a culture of the yeast Cryptococcus pararoseus (Castellani 1930) which was 
initially classified under genus Hartmannella and called Hartmannella Castellanii 
(Castellani 1930, Douglas 1930), and this classification was modified one year later 
when Volkonsky found that the genus Hartmannella was in fact a different group of 
amoebae that has its distinctive features. 
In 1931, Volkonsky divided Hartmannella into 3 groups: Group 1 was named 
Hartmannella which is characterized by a rounded smooth cyst wall and cylindrical 
spindle, group 2 named Glaeseria characterized by nuclear division in the cyst, and 
group 3 named Acanthamoeba and has double walled cyst with irregular outer layer 
and pointed spindles during mitosis.  
In 1952, Singh stated that it was unreliable to classify amoeba based on morphology 
and mitotic spindle shape so the genus Acanthamoeba was dropped. In 1966, 
Pussard endorsed the fact that the mitotic spindle shape was not helpful, however 
he disagreed with the futility of using cyst morphology to differentiate between 
35 
 
various species at the level of genera and thus renowned the genus Acanthamoeba 
which was acknowledged again by Page in 1967 (Pussard and Pons 1977). 
In 1976, Page differentiated between Acanthamoeba castellanii and Acanthamoeba 
polyphaga based on the degree of contact between the layers of the cyst wall and 
how smooth or wrinkled the cyst wall is (Stratford and Griffiths 1978). Pussard and 
Pons divided Acanthamoeba into three groups depending on cyst morphology 
(Table 1.1) identifying 18 different species of Acanthamoeba. Group 1 includes: 
Acanthamoeba Astronyx, Acanthamoeba Comandori, Acanthamoeba Echinulata 
and Acanthamoeba Tubiashi. This group has a cyst diameter of 18-25 µm and both 
ectocyst and endocyst are wildly separated with a smooth stellate inner layer 
(Pussard and Pons 1977, Marciani-Cabral and Cabral 2003). Group 2 constitutes 
the most widespread Acanthamoeba and includes: Acanthamoeba Castellanii, 
Acanthamoeba Polyphaga and Acanthamoeba Rhysodes. The cyst diameter is less 
than 18 µm and endocyst and ectocyst can either be separated or in close proximity 
to each other. Group 3 includes: Acanthamoeba culbertsoni and Acanthamoeba 
Pustulosa, with a cyst diameter of almost 18 µm and a thin ectocyst. Groups 2 and 
3 are pathogenic, while group 1 is nonpathogenic (Pussard and Pons 1977; Gast et 
al.,1996; Walochnik et al.,2000b; Walochnik et al.,2003).  
Sawyer discovered that the ionic strength of the growth medium can change the 
morphology of cyst walls, which rendered the previous classification uncertain 
(Stothard et al.,1998). In 1978, Stratford and Griffenns stated that cyst morphology 
is not a reliable classification criterion as it can change depending to the surrounding 






A. astronyxis A. comantioni  
A. tubiashi A. echinulata  
Group II 
A. castellanii A. mauritaniensis 
A. polyphaga A. lug-dunensis 
A. quina A. rhysodes 
A. divionensis A. paradivionensis 
A.griffini   A. triangularis 
A. hatchetti  
Group III 
A. palestinensis A. culbertsoni 
A. lenticulata A. pustulosa 
A. royreba  
 
Table 1.1: Classification of Acanthamoeba based on morphology (Xuguang Sun et 
al., 2018) 
 
1.7.1 Genetic Grouping  
The genome size of Acanthamoeba is around 1X108 base pairs (Byers et al.,1990) 
and it has 24 copies of 18s ribosomal RNA (Yang et al.,1994), and the ploidy is 
between 9 and 25 depending on the stage of the cell cycle and the strain 
(Matsunaga et al.,1998, Rimm et al.,1988). This difference may be attributed to the 
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destruction of part of the DNA during the encystment (Byers et al.,1991). In 1996, 
T-typing classification of Acanthamoeba was introduced by Gast et al. based on 18s 
ribosomal RNA sequence, to overcome the restrictions of cyst morphological 
characteristic classification. Four genotypes were identified based on sequences of 
nuclear small ribosomal subunits RNA genes and were named T1, T2, T3, T4 (Gast 
et al.,1996). Acanthamoeba genotypes vary by less than 5% depending on 18s 
ribosomal RNA sequence (Stothard et al.,1998).  
Acanthamoeba is currently classified into 20 different genotypes T1-T20 (Table 1.2) 
based on ribosomal RNA sequence (Schuster and Visvesvara 2004; Corsaro and 
Venditti 2010; Horn et al.,1999; Magnet et al.,2014). A research in 2005 suggested 
to further subdivide T2 into T2a, T2b to help recognizing and differentiating 
pathogenic from non-pathogenic genus (Maghsood et al.,2005). Groups T3, T4, T6 
comprise the majority of pathogenic strains (Stothaed et al.,1998; Walochnik et 
al.,2000) as T4 genotype is responsible for 90% of keratitis, granulomatous 
Acanthamoeba encephalitis and cutaneous infection (Maghsood et al.,2005).  
 
Morphology groups Genotypes 
Group I T7, T8, T9, T17 
Group II, III T1-T6, T10-T16 
 
Table 1.2: Morphology groups and genotypes of Acanthamoeba based on 18s 





1.8 Acanthamoeba as a Reservoir for Other Microorganisms 
Some bacteria, viruses and fungi can grow and survive inside the free-living amoeba 
(Greub and Raoult, 2004). Endosymbiont is a term used when two non-related 
microorganisms co-exist where one of them lives inside the other (Figure 1.4). 
Acanthamoeba is shown to act as a reservoir for bacteria (Drozanski, 1956) and 
pathogenic facultative mycobacteria such as Mycobacterium avium, Mycobacterium 
marinum, Mycobacterium simiae, Mycobacterium phlei, Mycobacterium smegmatis 
and Mycobacterium fortuitum (Krishna-Prasad and Gupta, 1978). Burkholderia 
cepacia was seen in different in vitro strains of Acanthamoeba (Marolda et al.,1999), 
Legionella was detected in vesicles of trophozoites and within the cysts of 
Acanthamoeba astronyxis cultured in vitro (Marciano-Cabral and Cabral 2000) and 
it was demonstrated that Mimivirus uses Acanthamoeba polyphaga as a natural  








Figure 1.4: Transmission electron microscopy image of Acanthamoeba cyst 
containing Legionella (arrow) (Miller et al.,2012). 
39 
 
1.9 Pathogenicity of Acanthamoeba 
The pathogenicity of Acanthamoeba is initiated by the adhesion step where the 
mannose binding proteins on the plasma membrane of the Acanthamoeba interact 
with the carbohydrate mannose residues in the host cell membrane to firmly attach 
the Acanthamoeba to the infected tissue and avoid being cleared during the disease 
onset (Huth et al.,2017). This binding initiates the release of metallo and cysteine 
proteases that digest extracellular targets (Cao et al.,1998) and also stimulates 
Acanthamoeba to secrete a mannose-induced 133 kDa protease (MIP-133) that 
interacts with the plasma membrane of the target cells leading to activation of 
cytosolic phospholipase A2 leading to cell damage (Tripathi et al., 2012). 
Acanthamoeba binds to target cells by using acanthopodia after the formation of a 
structure called an amoebastome, then invades the membrane of the target cell, 
with many studies reporting that Acanthamoeba cannot attach to the tissue without 
acanthopodia demonstrating the critical role of these structures in the pathogenicity 
of Acanthamoeba (Khan et al.,2001). The target cells are engulfed by the 
phagocytosis process which facilitates infection and cause further invasion and 
damage of the tissue by the proteolytic enzymes leading to apoptosis and necrosis 




1.9.1 Granulomatous Amoebic Encephalitis (GAE)  
GAE is a chronic slowly progressive disease of the central nervous system (CNS) 
mostly caused by Acanthamoeba genotype T4 (Walochnik ,2014) which was first 
identified by Jager and Stamm in 1972 (Willaert et al.,1978). It is characterized by 
granulomatous encephalitis mostly affecting immunocompromised individuals such 
as patients with malignancies, systemic lupus erythematosus, diabetes mellitus, 
liver cirrhosis and acquired immunodeficiency syndrome. Granulomatous response 
is seen in several tissues including skin, liver, kidney, adrenal, pancreas, prostate, 
lymph nodes and bone marrow (Khan 2006), and may also involve the lungs 
(Marciano-Cabral and Cabral 2003).  
There are many risk factors for GAE such as alcohol dependence, drug abuse, 
chemotherapy and organ transplant, all of which suppress immunity (Marciano-
Cabral and Cabral 2003). GAE is different from amoebic meningeo-encephalitis 
which is a fast-progressing disease that affects healthy and debleated patients and 
is caused by the free-living amoeba Naegleria fowleri that enters the central nervous 
system via olfactory neuroepithelium causing hemorrhagic meninigo-encephalitis 
(Butt, 1966; Valenzela et al.,1984). 
The entry of Acanthamoeba to the human body is by inhalation or via skin lesions 
then by hematogenous spread (Martinez & Visvesvara, 1997) as shown in Figure 
1.5. The disease progresses within weeks or months to exhibit clinical signs and 
symptoms of headache, nausea, vomiting, fever, neck stiffness, increased 
intracranial pressure, Seizure, diplopia and coma (Martinez et al.,1980). 
Postmortem examination reveals many pathological findings including necrosis, 
thrombus formation and inflammation with the majority of lesions found in the basal 
ganglia, mid-brain, brainstem and cerebral hemispheres (Khan, 2006). 
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The diagnosis is difficult to establish as it requires ruling out other pathogens like 
viruses, bacteria and fungi which are more common to cause CNS infections. 
Cerebrospinal fluid findings include lymphocytosis, increase protein concentration 
and decrease glucose concentration (Marciano-Cabral and Cabral 2000). 
Treatment is difficult due to Acanthamoeba resistance and the inability of the drug 
to pass through the blood brain barrier into the CNS. This fatal disease has a 
mortality rate of more than 90% despite aggressive treatment with different 
combinations of drugs such as amphotericin B, rifampicin, pentamidine, 
pyrimethamine, ketoconazole, voriconazole or clotrimazole (Taravaud et al.,2017; 
Siddiqui et al.,2016; Ong et al.,2017), with amphotericin B being the most widely 
used medication for treatment of GAE (Siddiqui et al.,2016; Ong et al.,2017).  
Figure 1.5: Life cycle of Acanthamoeba in environment and human body, credit: 
modification of work by Centers for Disease Control and Prevention. 
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1.9.2 Acanthamoeba Keratitis (AK)  
Acanthamoeba keratitis is a progressive infection caused by pathogenic 
Acanthamoeba strains mostly T4 genotype (Maghsood et al.,2005; Walochnik et 
al.,2014) and affects healthy immunocompetent individuals with higher prevalence 
in males (Niederkorn et al.,1999). The first eye infection caused by Acanthamoeba 
was reported in United Kingdom in a healthy young teacher in 1974 (Nagington et 
al.,1974).  
Despite being a rare infection, Acanthamoeba keratitis carries serious clinical 
implications as it causes ulceration of the corneal epithelium, swelling of the stroma 
and scarring that can result in permanent blindness (Figure 1.6) (Khan, 2006). The 
infection is usually unilateral but can affect both eyes and the clinical symptoms are 
similar to herpes simplex keratitis and include eye pain, photophobia and blurred 
vision (Robaei et al., 2014), and the common signs are ptosis and conjunctival 
redness without eye discharge (Niederkorn et al.,1999). The infection rarely extends 
beyond the cornea and poor prognosis is anticipated if sclero-keratitis develops or 





Figure 1.6: (a) Normal eye compared to (b) Acanthamoeba-infected eye (Siddiqui 




1.9.2.1 Pathogenesis of Acanthamoeba Keratitis 
The first step in the pathogenesis of Acanthamoeba keratitis is the attachment of 
trophozoites to specific mannosylated glycoprotein receptors at the corneal 
epithelium inducing the release of MIP133 and initiating a cascade of cytolytic 
processes including the production of proteases leading to destruction to Bowman’s 
membrane and deep penetration and dissolution of corneal structures but rarely 
beyond the stroma as shown in Figure 1.7 (Clarke and Niederkorn, 2006). 








Figure 1.7: The pathogenesis of Acanthamoeba keratitis (Clarke, Niederkorn,2006). 
Step (1): trophozoites attach to mannosylated glycoproteins at corneal epithelium 
following abrasion. Step (2): trophozoites induce the release of MIP133 following 
mannose exposure. Step (3): destruction of Bowman's membrane and trophozoites 
penetrate stroma. Step (4): trophozoites produce proteases that dissolute corneal 
stroma. Step (5): trophozoites aggregate around corneal nerves, causing radial 
keratoneuritis. Step (6): AK rarely progresses beyond the corneal endothelium. 
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1.9.2.2 Risk Factors 
The most common risk factors for developing Acanthamoeba keratitis are the use 
of contact lenses and poor lens hygiene (Carnt et al.,2020),the use of Oxipol 
disinfection which is an agonist combination of cleaning, disinfecting and lubricating 
agents, poor hand hygiene and the use of contact lenses while swimming or bathing 
(Pinna et al.,2017; Carnt and Stapelton 2016; Page and Mathers 2013, Carnt et 
al.,2018). Acanthamoeba is the most common agent of contact lens-related keratitis 
in addition to Pseudomonads and Staphylococci (Walochnik et al.,2004). The 
frequent use of contact lenses causes abrasion and microtrauma to the corneal 
epithelium which is noted more in soft contact lenses as they have more adherent 
surfaces than hard lenses increasing the probability of the attachment of 
trophozoites to the corneal epithelium (Maycock and Jayaswal 2016) increasing the 
incidence of the disease over the past 3 decades as a result of the climbing use of 
contact lenses.  
 
1.9.2.3 Incidence 
The incidence of Acanthamoeba keratitis in developed countries is 1 to 33 
cases/1,000,000 contact lens wearer per year, in the United Kingdom it is reported 
as 1.4 cases/1,000,000 persons per year (Pinna et al.,2017). The current surge in 
cases of Acanthamoeba keratitis started in 2010–2011 with a threefold increase 
compared to the years 2004–2009 (Carnt et al.,2018). A recent study conducted 
over 12 years took place in a tertiary UK hospital covering 1500 keratitis cases 
reported an incidence rate for Acanthamoeba keratitis of around 2.3% (Tan et 
al.,2017). Acanthamoeba keratitis should be considered as a possible cause of 
keratitis in all contact lens wearers and any case of corneal trauma (Cohen al. 1985), 
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and effective disinfection of contact lenses is crucial to eliminate the risk of 
Acanthamoeba keratitis (Radford et al.,1995). 
Since the cyst stage of Acanthamoeba can resist unfavourable conditions and 
drugs, this might lead to a delay in diagnosis and difficulty in treating the illness 
leading to further complications including severe extra-corneal inflammation 
(Robaei et al.,2014) along with recurrence of infection. In the first stages of the 
infection, AK can be missed and confused with Herpes simplex keratitis and as the 
disease advances the infection attains a similar clinical picture of  fungal keratitis 
(Carnt et al.,2018) which further delays correct diagnosis and treatment which 
profoundly impacts the prognosis with poorer visual outcome in these patients and 
prolonged duration of treatment, increased incidence of corneal perforation and 
increase in the number of cases requiring penetrating keratoplasty (Carnt et 
al.,2018). Early and accurate diagnosis is fundamental to initiate the most effective 
therapy, ideally introduced within 3 weeks for a better prognosis (Kovacevic et 
al.,2008; Claerhout et al.,2004). 
 
1.9.2.4 Contact Lens Disinfection 
Most cases of AK occur in wearers of soft contact lenses, so a good lens hygiene is 
crucial to prevent the infection (Carnt et al.,2020). There are two main groups of 
lens disinfectants: one group contains hydrogen peroxide and the other group 
contains polyhexamethylene biguanide (PHMB) or myristamidopropyl 
dimethylamine (MAPD), however there are no agreed standards of evaluating the 
efficacy of contact lens solutions (Buck et al., 1998, Hughes et al., 2003b). 
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1.9.2.5 Diagnosis of Acanthamoeba Keratitis 
Acanthamoeba keratitis should be suspected in patients with a history of contact 
lens use with exposure to contaminated water, symptoms of severe pain in the 
affected eye and negative laboratory cultures for bacterial, viral and fungal 
especially if there is no clinical improvement following antimicrobial therapy 
(Moshirfar et al., 2006). There are many laboratory techniques used to diagnose AK 
such as culture of corneal scraping where samples are obtained by scraping the 
corneal surface then the sample is cultured in appropriate culture media and 
examined for growth of Acanthamoeba. Another method for diagnosing AK is 
corneal biopsy which is reliable but invasive (Page and Mathers 2013) and must 
involve the active edge and base of the corneal ulcer.  
After either scraping the cornea or taking a biopsy, the sample is inoculated on E. 
coli on non-nutrient agar or buffered charcoal-yeast extract agar (Hau et al.,2010) 
and the Acanthamoeba cyst can be visualized using Gram’s and Giemsa stains or 
Calcofluor white stain with fluorescent microscope. Corneal culture takes 21 days 
and has low sensitivity of 50% misdiagnosed cases (Rusciano et al., 2013) as the 
positive culture rate ranges between 31 to 55% (Goh ,2018, Tu, 2008). 
In vivo confocal microscopy (IVCM) is used to detect cysts and trophozoites in 
corneal tissue and the diagnostic criteria of Acanthamoeba keratitis include the 
recognition of specific cystic and trophozoite-like structures with single file 
presentation and clustering of cystic objects as a reliable predictor of poor visual 
outcome (De Craene 2018, Chopra 2020). Confocal microscopy examination is 
effective in detecting organisms deeply located within the cornea that are difficult to 
be sampled by scraping and also provides a tool for prognostication based on the 
confocal microscopy findings as the presence of clusters or chains of cysts is 
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associated with poor prognosis (Garg et al.,2017). Nevertheless, the accuracy of 
this method is highly dependent on the experience of the observer (Hau et al.,2010). 
Impression cytology is a non-invasive technique used to diagnose superficial ocular 
surface infection by applying a cellulose acetate filter to the corneal surface to 
remove the superficial layers of the epithelium, then performing histological immune-
histochemical stains and molecular analysis (Singh et al.,2005). Polymerase chain 
reaction (PCR) is another method used to detect Acanthamoeba DNA in corneal 
scrapping and tears (Mathers et al.,2000). PCR is quick, sensitive, and specific 
compared to corneal culture (Pasricha et al.,2003; Zamfir et al.,2006; Thompson et 
al.,2008; Niyyati et al.,2009), can detect as few as five cells (Khan et al.,2001) and 
can be used without prior culture (Gast ,2001).  
 
 
1.9.2.6 Treatment of Acanthamoeba Keratitis 
There is no licensed pharmacological treatment for Acanthamoeba keratitis, and the 
current unlicensed therapy is based on individual cases which is a topical therapy 
of either polyhexamethylene biguanide (PHMB) 0.02% (v/v) or chlorhexidine 
digluconate 0.02% (v/v) as a single therapy or in combination with propamidine 
isetionate (Brolene™) 0.1% (w/v) or hexamidine diisethionate (Desomedine®) 0.1% 
(w/v) (Papa et al.,2020). 
PHMB is a sterilizing agent for contact lenses that reacts with the cytoplasmic 
membrane leading to cellular leakage (Ikeda et al.,1984) and depression of 
respiratory enzymes essential for Acanthamoeba survival (Broxton et al.,1984; 
Larkin et al.1991). It is widely used as a disinfectant and antiseptic agent due to its 
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effectiveness against multiple pathogens including Pseudomonas aeruginosa 
(Hübner et al., 2010), Enterococcus faecalis, Staphylococcus epidermidis and 
Candida albicans (Medvedec et al., 2018) 
Corticosteroids comprise another pharmacological therapy for stromal infiltration at 
the site of infection (Azuara -Blanco et al.,1997) or if there is limbitis, scleritis or 
uveitis (Bacon et al.,1993), However the use of topical steroid as a monotherapy 
without combination with amoebicidal therapy will lead to proliferation of 
Acanthamoeba trophozoites. This is clinically significant especially when steroids 
are used as a monotherapy in patients not correctly diagnosed with AK where 
steroids were prescribed to alleviate corneal inflammation and uveitis which leads 




1.9.2.7 Surgical Treatment 
A delay in the diagnosis and treatment of Acanthamoeba keratitis leads to corneal 
destruction and progression of the infection which may ultimately require surgical 
interventions such as penetrating keratoplasty (Figure 1.8) which is a full-thickness 
removal of the patient's cornea, followed by placement of a full-thickness donor 







Figure 1.8: Penetrating keratoplasty: full thickness donor graft placed using 
interrupted sutures in radial distribution (Donaghy et al.,2015) 
 
Penetrating keratoplasty is used in special circumstances such as severe scarring, 
increase in the size of the corneal abscess, severe eye pain, corneal perforation 
(Zhong et al.,2017) and failure of medical treatment (Robaei et al.,2014). This 
procedure includes the excision of all infected tissue to decrease the chance of graft 
reinfection and the need for subsequent re-grafting of the cornea and should be 
deferred to a minimum of 6 months from complete healing to reduce any risk of 
rejection (Donaghy et al.,2015). 
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1.10 Overview of the Immune System 
The immune system plays a significant role in protecting the body against 
endogenous and exogenous toxins and microorganisms including bacteria, viruses 
and parasites (Foligne et al.,2007). The immune system has two response systems: 
innate and adaptive. 
The innate system recognizes pathogens such as bacteria, fungi, viruses and 
parasites by pattern recognition receptors (PRRs), and this recognition step is vital 
for the innate system to provide protection against pathogens by recruitment and 
proliferation of immune cells, secretion of proinflammatory cytokines, and 
phagocytosis of pathogens (Schroecksnadel et al.,2011). The phagocyte system is 
composed of three major cell types: monocytes, macrophages and dendritic cells. 
Monocytes and macrophages have a crucial role in innate immunity and response 
to pathogens by phagocytosis, secretion of reactive oxygen species, cytokines and 
chemokines while dendritic cells present antigens to the cells of the adaptive 
immune system (Gordon and Tylor, 2005).  
The adaptive system is more specific and has the capacity to recognize prior non 
self-antigens by creating memory cells for faster immune response in subsequent 
infections (Cousins et al., 2003, Rogers et al. ,2003). The adaptive system has two 
major cell lineages: B cells which produce antibodies that bind to antigens and 
neutralize them or cause lysis, and T cells that interact with the pathogen and 
differentiate into cytotoxic T cells that ultimately lead to destruction or lysis of the 
pathogen (Mangan and Wahl, 1991).  
The Complement system is one component of the immune system that is made of 
a large number of proteins and enzymes that react with each other to regulate the 
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production of enzymes and chemotaxins to help fighting infection (Law Ska 1995).  
There are three pathways to activate the complement system: the classical pathway 
which is directly activated by antibody or by direct binding between the pathogen 
surface and complement component C1q, the mannan-binding lectin that binds 
some encapsulated bacteria and the alternative pathway that is triggered directly on 




1.11 The Human Eye 
The human eye is a unique and well protected organ containing many distinguished 
structures with specialized physiological functions (Figure 1.9). It is divided into an 
anterior segment that contains the cornea, limbus, conjunctiva, iris, ciliary body, 
aqueous humor and lens and a posterior segment composed of sclera, choroid, 
retina, optic nerve and vitreous humor (Patel et al.,2013). The cornea is the outer 
part of the anterior segment covering 15% of the anterior surface area of the eye 
(Willoughby et al.,2010), and it maintains the structural integrity of the eye globe, 
protects the eye component from injury and focuses the light into the retina without 








Figure 1.9: Schematic diagram of the human eye (Kolb, 2012). 
 
The limbus is a transitional zone between the cornea and the sclera, and the 
epithelium of this area bridges the conjunctiva to the corneal epithelium (Snell and 
Lemp,1998). The limbus is the site where the stem cell niches of the corneal 
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epithelium are located. The conjunctiva is a translucent mucous membrane divided 
into palpebral, fornical and bulbar conjunctiva and plays an important function in 
ocular surface protection and lubrication due to its goblet cells, melanocytes and 
immune cells (Snell and Lemp,1998, Knop and Knop, 2007). 
The cornea is composed of five layers (Figure 1.10) with the stroma being the 
thickest layer forming 90% of the thickness of the cornea and gives it its 
transparency and strength. The other layers are the epithelium, Bowmen’s layer, 








Figure 1.10: Schematic diagram of corneal layers (www.AllAboutVision.com). 
 
1.11.1 Defense Mechanisms  
The eye globe is surrounded by strong bony structures that provide external 
protection from injury (Snell and Lemp,1998), and the cornea is well protected from 
the external environment and pathogens by several mechanical, chemical and 
cellular defence mechanisms including blinking, lacrimation, tears enzymes, 
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epithelium, keratocytes, antimicrobial peptides, antigens, cytokines and 
inflammatory mediators (Zhou et al.,2000, Ruan et al.,2002, Choy et al.,2009). 
Corneal nerves transport the sensory stimulation which leads to reflux movement 
and secretion of neuropeptides that stimulate neutrophils chemotaxis following 
irritation of ocular surface (Muller et al.,1996; Tran et al.,2000). 
Epithelial cells secrete cytokines such as Interleukin-1 (IL-1) that protect against 
bacteria, fungi, and enveloped viruses that may invade the cornea from ocular 
trauma, dust exposure or contact lens use (Mcdermott, 2004). 
 
1.11.1.1 Tear Film 
The tear film has a vital role in preventing dryness of cornea while deterring the 
entrance of antigens by flushing pathogens and foreign bodies from the surface 
through lid wiping of the tear fluid that contains immunoglobulin A (IgA) and 
immunoglobulin G beside other antimicrobial proteins such as lactoferrin and 
lysozymes (Knop and Knop 2007). IgA antibodies prevent the adhesion of 
Acanthamoeba trophozoites to the epithelial layer, however they have limited effect 
if trophozoites have already penetrated the cornea (Clarke and Niederkorn, 2006). 
The binding of Acanthamoeba to IgA will activate the complement system via the 
alternative pathway (Ferrante ,1991) which stimulates opsonization and lysis of 







 1.11.1.2 Immunological Factors 
The cornea has immune privilege as it tolerates the introduction of antigens without 
generating an inflammatory immune response that would potentially damage its own 
structure and affect its function (Hong and Kaer, 1999). The cornea has no centrally 
located antigen presenting cells, however Langerhans cells that are peripherally 
located can migrate to the centre of cornea upon invasion by non-self antigens and 
act as antigen presenting cells (Klink et al., 1997). 
Acanthamoeba trophozoites are identified by Toll-like receptor-4 (TLR4), activating 
nuclear factor kappa B (NF-kB) and MAPK/ERK (Mitogen Activated Protein Kinases/ 
Extracellular Signal-Regulated Kinases) pathway which leads to the production of 
pro-inflammatory and chemotactic mediators such as interferon- β (IFN-β), 
interleukin 8 (IL-8) and tumour necrosis factor alpha (TNF-α) attracting 
macrophages and neutrophils to the site of injury (Ren et al.,2009). 
 
The role of cells of innate immunity in protecting the ocular surface from pathogens 
cannot be overemphasized; Neutrophils are the main acute inflammatory cells that 
phagocyte pathogens (Trocme and Aldave,1994) and macrophages secrete 
inflammatory cytokines and have phagocytic ability to kill microbes (Underhill and 
Ozinsky,2002). Both cell types induce phagocytosis and lysis of Acanthamoeba by 
different mechanisms where macrophages initiate an inflammatory response by 
secreting macrophage inflammatory protein 2 (MIP-2) (Marciano-Cabral and Toney, 
1998), and neutrophils release myeloperoxidase enzymes contained within 




1.12 Aims and Objectives 
In this study, we will develop an ex vivo model of Acanthamoeba keratitis (AK) to 
better understand the pathophysiological processes that occur throughout the 
disease and to study the pathogenesis of Acanthamoeba and the role of cells of 
innate immunity in fighting the infection. The study will also evaluate the phenotypic 
similarities between Acanthamoeba and cells of the innate immune system mainly 
macrophages. The aims of this study are:  
1. Establish an ex vivo model for Acanthamoeba keratitis (AK) using porcine   
corneas.  
2. Utilise the model to investigate the pathogenesis, drug treatment and 
diagnosis of AK.  
3. Correlate ex vivo confocal microscopy (EVCM) findings with in vivo confocal 
microscopy (IVCM) images from culture positive AK cases.  
4. Investigate the phenotypic and functional similarities between Acanthamoeba 
and human macrophages.  
 
 
1.12.1 Objectives for Aim 1: Developing ex vivo model 
• Optimisation of methods for maintenance of corneal tissue in the lab.  
• Developing different systems of corneal culture models to optimise the model 
integrity at gross and microscopic levels. 




1.12.2 Objectives for Aim 2: Using the model to study Acanthamoeba           
           keratitis (AK) 
• Applying Acanthamoeba trophozoites and cysts to the corneal model to study 
the pathogenesis of AK. 
• Evaluating the effect of macrophages and neutrophils on the progress of AK. 
• Studying in vitro and ex vivo activity of a number of therapeutic compounds 
including doxycycline and polyhexamethylene biguanide (PHMB).  
 
1.12.3 Objectives for Aim 3: Correlation between ex vivo (EVCM) and in vivo        
            confocal microscopy (IVCM) findings 
• Preparation of various forms of Acanthamoeba live and dead trophozoites 
and live, dead and empty cysts.  
• Inoculation of the model with various forms of Acanthamoeba.  
• Studying the model using confocal microscopy. 
• Comparing EVCM findings with IVCM images of patients with AK.  
 
1.12.4 Objectives for Aim 4: Investigating similarities between Acanthamoeba  
           and human macrophages 
• Differentiation of human leukemic cell line  (THP-1) cell line into 
macrophages. 
• Running a flow cytometry analysis to assess the expression of various 



























Chapter 2: Materials and Methods 
2.1 Chemicals 
All chemicals, materials and media used in this study were obtained from the Sigma 
Chemical Company Ltd and VWR International and Scientific Laboratory Supplies 
Ltd (UK) unless otherwise stated.  
 
2.2 Test Organisms  
The table illustrates the organisms and cell lines used in this study.  
Human cell line  Strain  
Human epithelial cell type 2 (HEp-2) ECACC #86030501 
THP-1 Cell ATCC TIB-202 
HL-60 ATCC CCL-240 
Amoebae  Strain  
Acanthamoeba polyphaga  ATCC 30461  
Acanthamoeba castellanii  ATCC 50370 
Acanthamoeba culbertsoni ATCC 30171 
Gram –ve bacteria   Strain 
Escherichia coli (E. coli) ATCC 8739  
   




Acanthamoeba castellanii (ATCC 50370), A. polyphaga (ATCC 30461) and 
Acanthamoeba culbertsoni (ATCC 30171) were obtained from the American Type 
Culture Collection (ATCC) (LGC Standards, Teddington, U.K.). The human cell line 
was obtained from the European Collection of Cell Cultures (PHE, Salisbury, U.K). 
 
2.3 Acanthamoeba Cell Culture 
The ingredients for Acanthamoeba trophozoites medium (Ac#6 growth medium) 
were based on a study by Hughes and Kilvington (2001) which is formed of 5g 
glucose, 0.3g potassium dihydrogen orthophosphate (KH2PO4), 15mg L-
methionine, 10mg vitamin B12 and 20g biosate peptone, all in 900 mL of distilled 
water. The pH of the medium was modified to pH 6.5-6.6 with 1M Sodium hydroxide 
(NaOH) and the volume adjusted to 1000ml.The solution was then divided into four 
bottles with 250 mL in each and autoclaved for 15 minutes at 121°C. 
Penicillin-Streptomycin was added to the medium to give a final concentration of 
100 U/mL and 0.1 mg/mL respectively. The medium was kept at 25◦C to be used 
within one month. The trophozoites were grown in tissue culture flask at 32◦C. 
 
2.4 Cryopreservation of Acanthamoeba 
The cells were assessed using inverted microscope to confirm the absence of any 
contamination, then the cells were centrifuged at 500 x g for 5 minutes. The pellet 
was suspended in foetal bovine serum containing 5 % (v/v) dimethyl sulphoxide 
(DMSO) as freezing media. 1mL was aliquoted in each cryoprotective ampule then 
placed inside a passive freezer Naglene Mr Frosty filled with Propan-2-ol and placed 
in a -80◦C freezer for 48 hours. The propan-2-ol reduces cell damage by slowing the 
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rate of temperature drop to 1◦C/min. The frozen ampules were taken out from Mr 
Frosty and kept in the freezer at -80◦C. 
Recovery of the cryopreserved cells was achieved by taking cells from deep freezer 
and thawing them quickly in a 37◦C water bath, then the aliquots were added to a 
fresh prewarmed Ac#6 growth medium incubated in small 25 cm2 culture flasks at a 
temperature of 32◦C. After 6 hours, a fresh media replaced the original one to 
remove any remnants of DMSO that might cause toxicity. The cells were examined 
after 24 hours using inverted microscope to detect any contamination and confirm 
cell growth. 
 
2.5 Preparation of Acanthamoeba Food E. coli Stock 
A tryptic soy agar (TSA) agar plate was prepared for E.coli culture and incubated 
for 24 hours at 37◦C to facilitate colony formation. One colony of E. coli was placed 
in 100 mL of tryptic soy broth (TSB) in a 182.5 cm2 tissue culture flask and incubated 
overnight at 37°C. at 120 revolutions per minute (rpm) in an orbital shaking incubator. 
The suspension was transferred to two 50 mL polypropylene tubes and centrifuged 
at 3000 x g for 30 minutes to pellet the E. coli. The pellet was washed by ¼ strength 
Ringer’s solution twice to prevent further multiplication of the bacteria, then the E. 
coli pellet was suspended in 10mL of ¼ strength Ringer’s solution and stored at 4°C 




2.6 Preparation of Acanthamoeba Mature Cysts in Neff’s Medium 
The production of cysts was successfully achieved using Neff’s encystment medium 
(NEM) by the method described by Neff in 1964 (Kilvington and Lam,2013, Hughes 
et al.,2003). The trophozoites were cultured in 182.5 cm2 tissue culture flask (1 x 105 
cells/mL) of Ac#6 growth medium then were incubated at 32◦C for 48 hours. 
Trophozoites were centrifuged (500 x g) for 5 minutes, then washed three times 
using ¼ strength Ringer’s solution. The resulting pellet was suspended again in       
50 mL NEM (5 x 105 cells/mL) using 75 cm2 tissue culture flask. The flask was 
incubated in an orbital shaking incubator at 32◦C at 120 rpm for 7 days. On day 8, 
the cysts were examined using the inverted light microscope which confirmed cysts 
maturation. The cysts were finally harvested from the flask and the inner side was 
swabbed to collect any adherent cysts. the resultant cysts were washed three times 
with a ¼ strength Ringer’s solution (1000 x g for 10 minutes). Using a modified 
Fuchs Rosenthal haemocytometer, the final pellet was adjusted to 5 x 106 cells/mL 
and stored at 4-8◦C to be used within two weeks. 
 
2.7 The Preparation of Acanthamoeba Mature Cysts in NNA Medium  
A different approach was used for the preparation of a smaller number of cysts as 
the non-nutrient agar (NNA) method was prepared by adding 2.5% (w/v) agar (non-
nutrient) and 1 tablet of ¼ strength Ringer’s solution in 500 mL of deionized water 
then autoclaved at 121°C for 15 minutes. The plates were poured and allowed to dry 
overnight at 37°C. The prepared E. coli stock were added to each plate by dropping 
2-3 drops, then they were spread out and left to dry overnight. Acanthamoeba 
trophozoites were centrifuged (1000 x g for 10 minutes), then 2-3 drops of E. coli 
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stock were added to the trophozoites pellet and this suspension was spotted on the 
prepared plates which were incubated at 32°C for 7-10 days to complete the 
encystment process. The plates were checked periodically for any contamination 
and also to assess the replication of Acanthamoeba. 
In order to harvest the cysts, 20mL of ¼ strength Ringer’s solution were first added 
to the agar surface, then firm pressure was applied in a circular motion using a 
sterilised rubber teat and the resulting suspension was centrifuged (1000 x g for 10 
minutes) and the pellet was washed twice in ¼ strength Ringer’s solution to remove 
any traces of E.coli. Following this step, the pellet was suspended by ¼ strength 
Ringer’s solution and the cell density was assessed under the microscope using a 
modified Fuchs Rosenthal haemocytometer and the cell count was adjusted to 2 × 
104 cysts/mL and the resultant pellet was stored at 2-8°C for up to 14 days. 
 
2.8 Human Epithelial Cell Line Culture (HEp-2) 
The medium of HEp-2 cells contains Dulbecco’s minimum essential medium 
(DMEM) with 10% (v/v) foetal bovine serum, 2 mM L-glutamine, 15 mM HEPES 
buffer. Penicillin/Streptomycin were added to the medium of 100 U/mL and 0.1 
mg/mL, respectively. Cells were grown in 75cm2 tissue culture flask at 37°C and 5 




2.9 HEp-2 Cells Sub-culture 
The culture medium was removed and discarded, and the cells were rinsed with     
10 mL of pre-warmed Dulbecco’s phosphate buffered saline (DPBS) to remove all 
traces of serum that might contain any residual buffer, then 3mL of 0.25 % w/v 
trypsin solution were added to the flask and gently rocked so that the solution 
covered the whole surface. The flask was incubated at 37°C,  5% CO2 for 5 minutes. 
0.3-0.5mL of the trypsinized cell solution was added to the new sterile flask 
containing 20 mL of complete growth medium and the cell count was kept around 1 
x 105 cells/flask (75 cm2) and was sub-cultured every 3-4 days. The culture vessel 
was kept in 5% CO2, 37°C incubator. 
2.10 Cryopreservation of HEp-2 Cells 
The cells were checked using inverted microscope confirming the absence of any 
contamination and the adherent cells were brought into suspension using 
trypsin/EDTA then were suspended in a fresh medium with the same volume as that 
of trypsin then centrifuged at 500 x g for 5 minutes. The pellet was then suspended 
in foetal bovine serum containing 5% (v/v) Dimethyl Sulphoxide (DMSO) as a 
freezing media. 1mL was aliquoted in each cryoprotective ampule then placed inside 
a passive freezer Naglene Mr Frosty which was filled with Propan-2-ol and placed 
in a -80°C freezer for 48 hours. The propan-2-ol reduces cell damage by slowing the 
rate of temperature drop to 1°C/min. The frozen ampules were taken out from Mr 
Frosty and kept at -80°C. Recovery of the cryopreserved cells was achieved by 
taking the cells from the deep freezer and thawing them quickly in a 37°C water bath, 




2.11 THP-1 and HL-60 Cell Culture 
The cell line used for THP-1 is the human monocytic leukaemia cell line (ATCC TIB-
202), and the cell line used for HL-60 is the human acute promyelocytic leukaemia 
cell line (ATCC CCL-240) which predominantly shows neutrophilic  morphology, 
and both cell lines were obtained from the European Collection of Cell Cultures 
(Centre for Applied Microbiology and Research, Salisbury, UK). The cells were 
grown in tissue culture flask at 37°C. incubator, 5% CO2 in RPMI 1640 growth 
medium with 2mμ L-glutamine.10% foetal bovine serum and Penicillin/Streptomycin 
were added to the medium of 100U/mL and 0.1mg/mL respectively. The density of 
the cells was kept between 1×105 cells/mL to 1×106 cells/mL because if they got 
denser, they would stop dividing or even clump. The cells were sub-cultured every 
2-3 days by centrifugation and changing the media. 
 
2.12 Cryopreservation of THP-1 and HL-60 Cell 
The cells were assessed using inverted microscope which confirmed the absence 
of any contamination, then were centrifuged at 500 x g for 5 minutes. The pellet was 
then suspended in foetal bovine serum containing 5% (v/v) Dimethyl Sulphoxide 
(DMSO) as a freezing media. 1mL was aliquoted in each cryoprotective ampule then 
placed inside passive freezer Naglene Mr Frosty- filled with Propan-2-ol and placed 
in a -80°C freezer for 48 hours which controls the rate of freezing to 1 degrre C / min. 
The frozen ampules were taken out from Mr Frosty and kept at -80°C freezer and 
thawing them quickly in a 37°C water bath, then the growth medium was added to 




2.13 THP-1 Differentiation to Macrophages 
The cells were centrifuged at 500 x g and suspended in fresh RPMI 1640 media to 
a concentration of 1×106 cells/mL. The PMA (phorbol 12-myristate 13-acetate) was 
diluted to 100ng/L and added to 1 mL of cell suspension in 24 well plate and allowed 
to differentiate for 2-3 days at 37°C. incubator, 5% CO2. 
 
2.14 Excision of Cornea from Porcine Ocular Globe 
Porcine eye globes were obtained from freshly slaughtered pigs (Gill 
slaughterhouse, Wolverhampton, UK). They were collected 10 globes at a time. 
Excess tissue muscle and fat were removed from the eyes and the corneas were 
harvested in a Class 2 safety cabinet following these steps adapted from (Parekh et 
al., 2012): 
The corneas were visually inspected for defects such as pigmentation or scratches 
on the epithelium; those with defects were discarded. The eye globes were 
immersed in sterile povidone-iodine (I-PVP) 0.5% (w/v) for 2 minutes to 
decontaminate the ocular globes (Figure 2.1b), then transferred using sterile forceps 
in sodium thiosulphate 0.1% (w/v) for 1 minute which acts as a reducing agent for 
the I-PVP, then further transferred to 0.1% (w/v) gentamicin phosphate buffered 
saline (PBS) solution for 15 minutes to prevent bacterial infection and finally to a 
bottle containing sterile saline solution (PBS) at room temperature where corneas 
are kept until processed.  
The eye globes were taken out of the bottle within 10 minutes using forceps and 
hand-held using sterile gloves and sterile gauze maintaining adequate pressure, 
then forceps and scissors were used to remove the remaining conjunctiva. Following 
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this step, a scalpel blade was used to perform a scleral incision of 3-4mm from the 














Figure 2.1: Corneal harvesting. a. Eye globes. b. Initial stage of the sterilization 
process: eye globes immersed in sterile I-PVP 0.5% for 2 minutes to decontaminate 
the ocular globes. c. Scalpel blade was used to perform a scleral incision of 3-4 mm 







2.15 Culture of Corneal Tissue 
The corneas were cultured in a previously prepared storage medium which is 
Dulbecco’s minimum essential medium (DMEM) (Sigma Aldrich, UK), Ham's F12 
medium  in a 1:1 ratio plus 10 % (v/v) foetal bovine serum, 2μm L-glutamine and 2 
mL pluronic-F68 for deswelling of corneal stroma (Zhao et al., 2008). The above 
medium was further supplemented with 200μg of gentamicin, 
Penicillin/Streptomycin of 100U/mL and 0.1mg/mL respectively and 2.5μg/mL 
amphotericin B and 10ng/mL epidermal growth factor (EGF), 5μg/mL insulin, 
2.5μg/mL as the use of EGF and insulin in corneal medium results in a better safety 
and efficacy profile compared to media without them (Lass et al., 1994) The corneas 
were cultured at 37°C in 5% CO2 environment. The culture techniques were adapted 
from (Deshpande et al., 2015).  
 
2.16 Histological Techniques 
For histological processing of the cornea, the following steps were undertaken: 
• Corneas were harvested from the porcine eyes (steps described above). 
• Fixation of the cornea in 10% (v/v) formaldehyde for 24-48 hours inside paraffin 















Figure 2.2: Histology processing - fixation process. a. Paraffin block. b. Fixation of 
cornea in 10% formaldehyde. 
 
• Dehydration:  this is a vital step to remove the water from the tissue. Isopropyl 
alcohol (IPA) is a favoured reagent because it is miscible in paraffin. The tissue 
must not be dehydrated rapidly because this will cause distortion of the tissue.  
Dehydration is carried out in a slow, stepwise approach (Table 2.2) by passing 
the tissue block through a series of solutions of increasing IPA concentration to 
ensure the water is fully replaced by IPA (Figure 2.3 a ,b). 
Step Incubation period 
70% (v/v) IPA 1 hour 
70% (v/v) IPA 1 hour 
85% (v/v) IPA 1 hour 
95% (v/v) IPA 1 hour 
100% (v/v) IPA 1 hour 
100% (v/v) IPA 1 hour 










Figure 2.3: Dehydration processor (Leica EM TP, Milton Keynes, UK) 
 
• Clearing: the alcohol was then replaced by a clearing agent (xylene) which is an 
intermediate step before embedding the tissue in paraffin wax which does not mix 
with alcohol hence the need for the clearing process (Table 2.3). 
 
Step Incubation period 
Xylene 20 minutes 
Xylene 20 minutes 
Xylene 45 minutes 
 




• Infiltration and embedding: prior to sectioning, the tissue block must be infiltrated 
with a material that acts as a support during the sectioning process. For the 
method described here, paraffin serves this purpose. During infiltration, the 
paraffin will eventually equilibrate within the tissue block occupying all the space 
in the tissue that was originally held by the clearing agent. To achieve this, the 
blocks were kept in a vial filled with melted paraffin, then the tissue was allowed 
to equilibrate in an incubator at 58°C (Table 2.4), then the paraffin was poured 
into the container labelled for paraffin disposal. The newly fresh melted paraffin 
was used for embedding, and the tissue was left to solidify in a mould, embedded 















Step Incubation period 
Wax 30 minutes 
Wax 30 minutes 





















Figure 2.4: Histology processing - embedding process. a. Block moulds. b. Paraffin 






• Sectioning: this step was performed by using a cutting device called microtome 
(Anglia Scientific 0325, UK) to obtain thin sections of very precise thickness 








Figure 2.5: Histology processing - sectioning process. a. The microtome. b. Ribbon 
of thin sections. 
 
• Mounting of sections on adhesive microscope slides: in this step, the sections 
were permanently attached to microscope slides by following these steps: 
- The sections were carefully transferred to a 45°C water bath (Figure 2.6 a). 
Within a few seconds, the sections were flattened, and the wrinkles 
disappeared (Figure 2.6 b).  
- A clean microscope slide was dipped in the water bath, and was slowly pulled 
upward, out of the water, allowing the sections to adhere to the surface 
(Figure 2.6 c).  


















Figure 2.6: Histology processing - mounting process. a. The water bath. b, c. Slide 
dipped in water bath, pulled out of water with sections adhering to its surface d. The 




• Rehydration: before a section can be stained, the paraffin must be removed by 
a clearing rehydration process (Table 2.5). After clearing, only the tissue remains 
adherent to the slide. Rehydration was done by passing the mounted sections 
through the solvent clearance that dissolved the paraffin (Figure 2.7). 
 
Step Incubation period 
Clearing agent 1    3 minutes 
Clearing agent 2    2 minutes 
Clearing agent 3   1 minutes 
100% (v/v) IPA 30 seconds 
95% (v/v) IPA 30 seconds 
70% (v/v) IPA 30 seconds 
Tap water 30 seconds 
 
       Table 2.5: Histology processing - clearing and rehydration process. 
 
 
• Staining: this step helps recognizing non distinguishable features under the 
microscope (Table 2.6), (Figure 2.7). For routine histological stain, two dyes are 
usually used, one that stains certain components with a bright colour and the 
other -called the counterstain- stains other cellular structures with a contrasting 
colour. The two stains are usually haematoxylin and eosin. Haematoxylin stains 
negatively charged structures such as DNA with a blue colour. Eosin stains most 
of the other cell components by red colour. 
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Step Incubation period 
Haematoxylin 2 minutes 
Tap water                30 seconds 
Scott’s solution       1 minute 
Tap water                30 seconds 
Buffer 1 minute 
Tap water         30 seconds 
70% (v/v) IPA              1 minute 
95%  (v/v) IPA                1 minute 
Eosin 1 minute 
95% (v/v) IPA               2-3 minutes 
100% (v/v)  IPA             2-3 minutes 
Clearing Agent      1 minute 
Clearing Agent      1 minute 
Clearing Agent      1 minute 
 
















Figure 2.7: Histology processing - rehydration and staining process.  
 
• Preparing permanently mounted sections: the final step in this procedure is to 













• The slides were permanently mounted ready for examination under the light 
microscope and were stored in storage boxes for subsequent examinations 









Figure 2.9: Storage of slides and examination a. Slides stored in storage boxes b. 
Slides examined under the light microscope. 
 
2.17 Capturing Microscopic Slides 
All images of microscopic slides were captured on a Canon EOS M50 digital camera 




























Chapter 3: Establishing Ex Vivo Corneal Model 
3.1 Introduction 
The human eye is a protected organ consisting of many specialized structures with 
unique physiological functions (Figure 3.1). It is formed of many structures including 
the cornea, limbus, conjunctiva, iris, ciliary body, aqueous humor, lens, sclera, 












The cornea is the outer part of the eye globe and comprises 15% of the anterior 
surface area of the eye (Willoughby et al.,2010) with the conjunctiva covering the 
anterior, non-corneal areas of the globe (Shumway et al.,2020). The cornea 
continues posteriorly with the white oblique sclera and plays a vital role in 
maintaining the structural integrity of the eye globe, protecting the eye components  
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from injury and focusing the light into the retina which is made possible by the 
transparent and avascular nature of the cornea (Willoughby et al.,2010)  
The cornea is composed of 5 layers (Figure 3.2 & 3.3). The stroma is the layer where 
collagenous lamellae intersect and run parallel to cover the whole of the cornea 
which gives the cornea its transparency and strength and forms 90% of the corneal 
surface. The other four layers form the remaining 10% include the epithelium, 
Bowmen’s layer, Descement’s membrane and the endothelium (Knop and 























Figure 3.3: Histology section from cornea of pig eye showing parts of the epithelium 
(E) with five to six layers of squamous cells, stroma (S) with regular parallel collagen 
fibres and Descemet’s membrane (D). (The cornea was harvested and processed 
in University of Wolverhampton laboratories, UK)  
 
3.1.1.1 The Epithelium 
The epithelium (Figure 3.2) is a non-keratinized stratified squamous layer of about 
50-90 µm thickness composed of five to six layers of nucleated cells (Knop and 
Knop,2007). The layers are self-regenerating with high turnover rate and maintain 
the same thickness overtime (Reinstein et al.,2008). The number of epithelial cells 
is balanced by division at limbus and basal layers and cell sloughing at the surface 
(Zhou et al.,2000). When the old cells slough off into the tear film, the newly formed 
cells take their place and get exposed to the surface (Zhou et al.,2000). The renewal 
rate takes around a week in normal cornea (Bantseev et al.,2007), and this high 
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turnover rate protects the cornea from adherent pathogens and mechanical stress 
at the surface (Ladage et al.,2003). 
The basal layer of the epithelium forms the germinative layer which is the 
innermost layer from which new cells arise. (Figure 3.2). It is generated by the 
corneal epithelial stem cells at the limbus (Wolff et al.,1997). The horizontal 
migration from the limbus to the centre of the cornea can take as long as a year 
(Kaye 1980). The basal lamina is formed of collagen, glycoproteins, and filamentary 
materials secreted by the deep basal cells (Wolff et al.,1997, Snell and Lemp,1998).  
 
3.1.1.2 Bowman’s Layer 
The Bowman’s layer is the acellular part of the anterior stroma and is regarded as 
a visible indicator of ongoing stromal-epithelial interactions in the human eye 
(Wilson et al.,2000). It is 8-12 µm in thickness and is composed of randomly oriented 
collagen fibers contributing to its structural strength, however the destruction of this 
layer can lead to fibrous tissue formation as it is unable to regenerate or divide (Snell 
and Lemp,1998, Bron et al.,1997).  
 
3.1.1.3 The Stroma 
The stroma (substantia propria) is 500 µm thick layer that is composed of regularly 
spaced sheets of collagen bundles produced by keratocytes and lie in proteoglycan 
ground substance parallel to each other and to the corneal surface (Figure 3.2 & 
3.3). The stroma forms 90% of the corneal thickness and has no blood or lymphatic 
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vessels so that it can maintain corneal transparency to maximize transmission of 
light to the photoreceptors (Knop and Knop, 2007).   
3.1.1.4 Descemet’s Membrane and Endothelium 
The Descemet’s membrane (Figure 3.2 & 3.3) is a true basal lamina produced by 
underlying endothelial cells and it is formed of type IV collagen and laminin (Bron et 
al.,1997). The endothelium (Figure 3.2) is formed of a single layer of cuboidal flat 
cells that do not regenerate, it demonstrates an important role in maintaining corneal 
transparency and regulating the transportation of glucose, amino acids and oxygen 
to other corneal layers (Bron et al.,1997). The endothelium layer keeps the cornea 
dehydrated and transparent by acting as a pump (Snell and Lemp 1998).  
 
3.1.2 Previous Models 
3.1.2.1 In Vivo Animal Models 
The expansion in research on products that are potentially harmful to the human 
eye led to an increasing demand on animal models used to evaluate these products. 
The use of live animals had been established since the early 18th century and 
continued since (Wilhelmus, 2001). Many models of animal corneas have been 
established from live animals including rabbits, rats, and hamsters. In vivo Models 
of rabbit corneas are widely used compared to corneas from other animals such as 
pigs, monkeys, dogs, and cats given the reasonable size of rabbits compared to 
large animals which facilitates its handling in a laboratory setting while at the same 
time having the appropriate size of the eye globe compared to smaller animals 
(Hornof et al.,2005).  
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The animal rights movement which started in the 1950s focused on the ethical 
aspect of using animals in experimental studies (Stephens and Mak, 2013). One 
study classified some of these experiments as inhumane based on many factors 
including degrees of pain and the lasting harm inflicted on the animals being tested 
(Russell et al.,1959). This was the core research upon which the 3R’s concept 
emerged: Replacement, Reduction and Refinement of animals in research (Russell 
et al.,1959). The principle focuses on avoiding or replacing animals as test objects 
by using technology to design tools and models that can be used for the experiments 
instead of live animals, appropriately designing and analysing animal experiments 
to reduce the number of animals used and the amount and duration of the 
experiments, and finally refining the used methods to minimise the suffering of 
animals and improve welfare. 
The 3R’s principle highlights the need to find alternatives to in vivo animal testing 
and to use available resources to establish in vitro and ex vivo alternatives to the 
conventional in vivo animal studies. 
 
3.1.2.2 In Vitro Models 
In vitro epithelial models were first developed in the 1960s to be used as an 
alternative to in vivo models using primary and immortalized cell lines of both animal 
and human origins (Postnikoff et al.,2014). The models can be used in the 
evaluation of different combinations of parameters not easily achievable using in 
vivo animal models (Elliott et al.,2011). In vitro cell based models are simple, easily 
constructible, inexpensive and reproducible and offer a clear deterministic 
explanation of the results (Barar et al.,2009). 
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Rabbit corneal epithelial cells are widely used in research to build cell culture cornea 
models due to the similarity with the layers and barriers of human cornea (Hornof et 
al.,2005).A publication from 1998 established a rabbit corneal epithelial cells model 
and tested the potential appropriateness of the model to study drug permeation and 
metabolism. Rabbit corneal epithelial cells were cultured in DMEM-F12 seeded on 
Transwell-COL inserts coated with fibronectin to promote cell attachment and 
spreading, and the integrity of the epithelial layers was evaluated using scanning 
and transmission electron microscopy 8 days after the seeding step, with the 
measurement of the permeability of beta-adrenergic antagonist as an indication of 
transcellular permeability. Upon ultrastructural analysis, the model was shown to be 
multi-layered containing many cytoplasmic organelles and desmosomes (junctions 
between the epithelial layers and underlying basement membrane) resembling an 
intact cornea in structure and permeability (Kawazu et al., 1998). 
One of the successes in establishing in vitro human cell-based cornea models is the 
development of 3-dimensional tissue engineering models (Germain et al.,2000) as 
EpiOcular™ (MatTek), SkinEthic™, and Clonetics™ (Lonza). EpiOcular™ is a 
stratified, squamous epithelial model in which a permeable polycarbonate 
membrane is used to culture human epidermal cells from neonatal skin (Jung et 
al.,2011) (Figure 3.4). SkinEthic™ model is developed from human epithelium 
mucosa cells cultured at air–liquid interface that exhibit similar growth and 
morphological features to in vivo environment. (Van Goethem et al.,2006). 
EpiOcular™ and SkinEthic™ are used for eye irritation tests in product development 
which is a mandatory test for new cosmetic and pharmaceutical agents before 
licensing them for human use (Mohan et al.,2003). This application of the model 
replaces the conventional Draize test previously adapted as an international 
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standard assay for acute ocular toxicity (Draize et al.,1944). Another application of 
the model is the assessment of corneal penetration of pharmaceutical ophthalmic 
preparations and permeability studies (Jung et al.,2011). 
 
Figure 3.4: Haematoxylin-eosin-stained histological cross-section of the 
EpiOcular™ tissue model (Kolle et al.,2018) 
 
In vitro cell based models from both primary and immortalized cell lines have their 
own limitations as the primary cells have limited cell division and tend to lose the 
cell characteristics after few passages, while the immortalized cell lines change their 
growth behaviour and become aggressive by secreting cell surface markers in 
abnormal levels and expressing several chromosomal anomalies (Toropainen et 
al.,2007) making in vitro based models less reflective of in vivo environment. The 
human cell-based model has similar limitation being developed from noncorneal and 
immortalized cell lines (Wilson et al.,2015) and requires great care when handling 




3.1.2.3 Ex Vivo Animal Model 
To comply with the 3R’s principle of animal research, there is an ever growing need 
to move away from the heavy dependence on in vivo animal models by establishing 
an ex vivo corneal model that minimises animal suffering and improves its welfare 
while at the same time overcoming the limitations of in vitro models.  
The use of ocular organotypic models started in 1981 (Burton et al.,1981) with the 
introduction of isolated rabbit eyes from animals already processed for the food 
industry (ICCVAM, 2010). Slaughterhouse waste was explored as a potential tissue 
source for isolated eyes for bovine and porcine corneas (Prinsen,1996, Reichl and 
Muller-Goymann,2001). 
Researchers use different species including pig, rabbit, cow and chicken tissues to 
study a variety of ocular diseases, eye irritants, and permeability assays. The 
isolated rabbit eye test was initially developed to evaluate the damage caused by 
severe ocular irritants (Brantom et al.,1997, Xiang et al.,2012) and it was accredited 
by many regulatory bodies (Wilson et al.,2015). The isolated chicken eye test 
method was developed to mitigate the limitations of the isolated rabbit eye test 
(Prinsen and Koëter,1993). The model was used to evaluate the toxic responses by 
measuring surface tissue changes, retention of fluorescein, opacity changes and 
the effect of swelling on tissue thickness (OECD, 2009). In 1992, bovine cornea 
opacity and permeability (BCOP) assay was developed (Gautheron et al.,1992) and 
as advised by the scientific advisory committee of the European Centre for the 
Validation of Alternative Methods (ECVAM), both corneal opacity permeability assay 
and isolated chicken eye test are scientifically validated to detect severe ocular 
irritants (Zuang et al., 2015). 
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The development of porcine cornea opacity permeability (PCOP) assay has several 
advantages over bovine based assays because it shares similar structure and 
thickness to the human cornea (Lynch and Ahearne, 2013), there are fewer 
concerns about bovine spongiform encephalopathy (Van den Berghe et al.,2005) 
and the developed models had already been successful in producing favourable 
results at lower costs and fewer ethical concerns over animal welfare. Nevertheless, 
there will always be interspecies anatomical and physiological differences that 
cannot be overcome, and the models can only be used to investigate the corneal 
rather than the systemic effects of substances (Shafaie et al.,2016). 
 
3.1.2.4 Ex Vivo Human Model 
Other potential sources for human tissue are expired donor corneas from eye banks, 
excised corneas from keratoconus patients in addition to corneal remnants following 
corneal procedures and corneal rim tissues which are corneoscleral rims from 
human cadaveric eyes not suitable for transplantation. However, the supply is 
mainly dependant on hospitals and collection after surgery and this uncertainty of 










This study adapts the ex vivo model that provides the benefit of studying the full 
corneal structure with its various layers without having to run the experiments on 
live animals which is more compliant with the 3R’s principle for animal welfare by 
reducing the number of animals used and their suffering. Porcine cornea is used to 
establish the model given its close resemblance to native human cornea and its 
availability as slaughterhouse waste compared to bovine which reduces costs and 
contributes further to minimising the implications on animals. 
The establishment of ex vivo model will have many applications including the 
development of Acanthamoeba keratitis and studying the progression of infection in 
the model without the effect of human immune response in the in vivo setting and 
can also be used to evaluate drug efficacy against this infection which will be further 
discussed in the subsequent chapters. 
 
3.1.4 Aim and Objectives 
The aim of this chapter is to establish an ex vivo model of porcine cornea. The 
objective is to investigate different culture techniques to optimize the survival of 
cornea and maintain its normal structure with preservation of the transparency of 
the cornea. The culture techniques are: 
• Immersion system 
• Air/liquid interface system 
• Cornea culture in Petri dish, static with CO2 





3.2.1 Excision of Cornea from Porcine Ocular Globe 
Porcine eye globes were obtained from freshly slaughtered pigs (FA Gill Ltd, 
Wolverhampton, UK). The eye globes were collected 10 at a time (Figure 3.5a). 
Excess tissue muscle and fat were removed from the eyes and the corneas were 
harvested in a Class 2 safety cabinet (BioMAT 2) following the same steps 
described in chapter 2 section 2.14. 
 
3.2.2 Culture of Corneal Tissue 
The corneas were cultured in a previously prepared storage medium (DMEM), 
Ham's F12 medium in a 1:1 ratio plus 10 % ( v/v) foetal bovine serum, 2μM L-
glutamine and 2 mL pluronic-F68 (x100 stock).The above medium was further 
supplemented with 200 μg/mL of gentamicin, 100 IU/mL penicillin, 100 μg/mL 
streptomycin, 2.5 μg/mL amphotericin B, 10 ng/mL, Epidermal growth factor (EGF) 
and 5 μg/mL insulin. The corneas were cultured at 37◦C in 5% CO2 environment. 
The culture techniques were adapted from (Deshpande et al.,2015) as previously 
described in chapter 2 section 2.15. The systems studied were immersion system 




3.2.2.1 Immersion System 
In this system, corneas were cultured by complete immersion in the above-
mentioned medium in a sterile 50 mL tissue culture flat tubes (Figure 3.5) which 
were kept at 37°C in 5% carbon dioxide (CO2) environment and the medium was 







Figure 3.5: Immersion method. Corneas cultured in storage medium in 50 mL tissue 
culture flat tubes.  
 
3.2.2.2 Air/Liquid Interface System 
Cornea culture in Petri dish, static with CO2: 
The endothelial corneal concavity was filled with 500 μl DMEM containing 1% 
agarose. The gel form of the mixture helps supporting the structure of the cornea. 
Each cornea was cultured in 13 mL of the above-mentioned medium in 90 mm Petri 
dish in air–liquid interface (Figure 3.6). The corneas were kept in an incubator at 
37°C in 5% CO2 environment. The medium was changed every 48hrs and the 
corneas were kept moist by adding 2 drops of the medium on the anterior surface 
93 
 
every day. This static model was simple to set up but did not mimic the in vivo 
conditions in which the corneas are kept intermittently wet through the blinking 








Figure 3.6: Culture in Petri dish, static with CO2. Corneas cultured in storage 
medium in 90 mm Petri dish. 
 
Cornea culture in Petri dish, rocking with and without CO2: 
The endothelial corneal concavity is filled with 500 μl DMEM containing 1% agarose. 
The corneas were cultured in 13 mL of the previously described medium in 90 mm 
Petri dish then placed in an egg incubator (Rcom King Suro Max-20 Incubator, 
























Figure 3.7: Cornea culture in Petri dish, rocking system. a. Cultured corneas in Petri 
dish. b.  Cultured corneas inside an egg incubator placed on a rocker. c. The 
incubator was placed inside a sealed system box. d. Sealed system box supplied 
with 5% CO2 by a tube connected to a 5% CO2 cylinder. 
 
We developed a sealed system using a fully sealed box (Hespapa ,50L Box with Lid 
and Latching Handles) (Figure 3.7,3.8), by drilling four openings in the sides: two 
for entry and exit of CO2, an opening for the power cord for the incubator and one 
opening for the CO2 sensor. The openings were secured with airtight glands to 
prevent any CO2 leakage. The incubator was placed inside this sealed system box 
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Figure 3.8: Schematic diagram of the box – containing the egg incubator- placed on 
a platform rocker supplied with 5% CO2 added through a hole in the sealed box by 
a tube connected to a 5% CO2 cylinder. The CO2 levels were monitored through a 
CO2 sensor attached to the system. 
 
A CO2 sensor (The ExplorIR®-M) was connected to the box to regularly monitor the 
CO2 level (Figure 3.9). The sealed system was placed on a platform rocker (Platform 
Rocker STR6; Stuart, VWR, UK) (Figure 3.9) set at a speed of 10 rpm to keep the 
medium flowing over the corneal surface mimicking the normal blinking of the eye 
which would intermittently bath the anterior section of the eye.  Up to 16 corneas 


































Figure 3.9: Cornea culture in Petri dish, rocking system with 5% CO2. a. The box – 
containing the egg incubator- placed on a platform rocker. b. 5% CO2 cylinder.           
c. CO2 added through a hole in the sealed box by a tube connected to the CO2 
cylinder. d. CO2 exit. e. CO2 sensor attached to the box. f. CO2 levels monitoring 
using a computer software analysing the data from the CO2 sensor. The graph 
demonstrates a steady 5% CO2 concentration within the sealed box. 
 
We studied the rocking model with and without CO2 administration to compare the 
effect of CO2 on the corneal model. For all the above-described systems, the 
corneas were evaluated daily for gross evidence of contamination and were 
evaluated histologically at the following intervals: one week, two weeks, and four 
weeks. The selected corneas were placed in 10% formaldehyde (v/v) for tissue 
fixation prior to sectioning into histology slides using the method described in 
chapter 2 section 2.16.  
 
3.2.3 Assessment Methodology 
There were two main outcomes assessed for each model: the transparency of the 
cornea and the maintenance of the integrity of the model through following the 
preservation of the epithelium and the development of stromal oedema seen under 
the microscope as mild disruption of the collagen fibres arrangement and swelling 
of the connective tissue. These outcomes were observed and recorded at the end 




The transparency of the cornea cultured by different techniques was assessed till 
the point it became opaque. The transparency was observed by placing the cornea 
over a letter ‘X’ and reading the letter through the cornea. If the letter ‘X’ was easily 
visible, the cornea was described as ‘transparent’. If the letter ‘X’ was not visible 
through the cornea, it was described as ‘opaque’.  
The integrity of the model was assessed depending on two main features: how long 
the model maintained its epithelial lining, and how early stromal oedema emerged. 
The following grading system was developed to facilitate the comparison between 
culture techniques and determine the best ex vivo corneal model: 
• Grade 0: Healthy cornea. 
• Grade 1: Superficial loss of the outermost layers of the corneal epithelium, 
normal stroma. 
• Grade 2: Loss of < 50% of the epithelium layers, mild oedema of the stroma. 
• Grade 3: Loss of >50% of the epithelium layers, mild oedema of the stroma. 












In this study, corneas were cultured by both full immersion and air-liquid interface 
techniques with the latter performed through both a static and rocking approach. 
The rocking function was used to mimic the blinking action of the eyelids that kept 
the cornea wet. The CO2 effect was investigated in the rocking technique by running 
the experiment with and without CO2. The two main outcomes assessed were 
corneal transparency and the preservation of epithelial layers with the development 
of any stromal oedema. 
 
3.3.1 Immersion system 
Corneal transparency: 
At day 0 (control), the cornea was placed against the letter ‘X’ and it was easily 
readable through it. The cornea was described as ‘transparent’ (Figure 3.10a). 
At week 1, the cornea was further assessed for transparency. The ‘X’ letter was not 
read through it and the cornea was described as ‘opaque’ (Figure 3.10b). No further 
















Figure 3.10: Corneal transparency, immersion system. a. Day 0 (control): 
transparent cornea.  b. Week 1: opaque cornea. 
  
Model integrity: 
At day 0 (control), the cornea was examined under the light microscope (Figure 
3.11a). It showed normal epithelial lining of healthy five to six non-keratinized, 
stratified squamous epithelium and normal stroma forming 90% of the thickness of 
cornea which contained regularly spaced collagen fibres oriented in a uniform 
parallel direction that maintained transparency. The cornea was labelled as grade 
0. 
At week 1, the model was examined under the light microscope. There was a total 
loss of the epithelium with no epithelial layers seen in the section and there was also 
a mild disruption of the collagen fibres not running parallel to each other which 
indicated a mild degree of stromal oedema (Figure 3.11b). The cornea was labelled 











Figure 3.11: Histology sections, immersion system. a. Day 0 (control), grade 0: 
healthy cornea with five to six layers of squamous epithelium (E), normal underlying 
stroma (S) and regular parallel collagen fibres. b. Week 1, grade 4: total loss of the 
epithelium with mild disruption of the collagen fibres arrangement not running 
parallel to each other indicating mild degree of stroma oedema.  
 
3.3.2 Air/Liquid Interface System 
3.3.2.1 Cornea Culture in Petri Dish, Static with CO2 
Corneal transparency: 
At day 0 (control), the cornea was placed against the letter ‘X’ which was easily 
visible through it (Figure 3.12a). The cornea at this stage was described as 
‘transparent’.  
At week 1, the cornea was further assessed for transparency and the letter ‘X’ was 








At week 2, The ‘X’ letter was not visible through the cornea which was described as 
opaque (Figure 3.12c). No further assessment regarding transparency was 













Figure 3.12: Corneal transparency, static with CO2. a.  Day 0 (control): transparent 









At day 0 (control), the cornea was examined under the light microscope (Figure 
3.13a) and it showed normal epithelial lining of healthy five to six non-keratinized, 
stratified squamous epithelium and normal stroma which contained regularly spaced 
collagen fibres oriented in a uniform parallel direction. The cornea was labelled as 
grade 0. 
At week 1, the model was examined under the light microscope. There was loss of 
the epithelium layers less than 50% of the full thickness where the number of 
epithelial layers was around 2-3 layers. There was a mild disruption of the collagen 
fibres indicating mild degree of stromal oedema (Figure 3.13b). The cornea was 
labelled as grade 2. 
At week 2, the model was examined under the light microscope. There was further 
loss of the epithelium layers of more than 50% of the full thickness with mild 
disruption of the arrangement of collagen fibres indicating mild degree of stromal 
oedema (Figure 3.13c). The cornea was labelled as grade 3. 
At week 4, the model was examined under the light microscope. There was a 
complete loss of the epithelium with mild disruption of the arrangement of collagen 
fibres indicating mild degree of stromal oedema (Figure 3.13d). The cornea was 




















Figure 3.13: Histology sections, static with CO2. a. Day 0 (control), grade 0: normal 
cornea with five to six layers squamous epithelium (E), normal underlying stroma 
(S) and regular parallel collagen fibres. b. Week 1, grade 2: there is loss of less than 
50% of the epithelia thickness, mild disruption of the collagen fibres c. Week 2, 
grade 3: further loss of the epithelium layers of more than 50% of the full thickness 
with mild disruption of the arrangement of collagen fibres d. Week 4, grade 4: 

















3.3.2.2 Cornea Culture in Petri Dish, Rocking without CO2 
Corneal transparency: 
At day 0 (control), the cornea was placed against the letter ‘X’ which was easily 
visible (Figure 3.14a). The cornea was described as ‘transparent’. 
At week 1, the cornea was further assessed for transparency and the letter ‘X’ was 
still visible (Figure3.14b). The cornea was described as ‘transparent’. 
At week 2, The ‘X’ letter was not visible through the cornea which was described as 
‘opaque’. (Figure 3.14c). No further assessment regarding transparency was 











Figure 3.14: Corneal transparency, rocking without CO2. a.  Day 0 (control): 






At day 0 (control), the cornea was examined under the light microscope. It showed 
normal epithelial lining of healthy five to six non-keratinized, stratified squamous 
epithelium and normal stroma which contains regularly spaced collagen fibres 
oriented in a uniform parallel direction that maintained transparency. The cornea 
was labelled as grade 0. (Figure 3.15a) 
At week 1, the model was examined under the light microscope. There was a 
superficial loss of the outermost epithelium layers and the number of epithelial layers 
was 4-5 layers, with normal underlying stroma (Figure 3.15b). The cornea was 
labelled as grade 1. 
At week 2, the model was examined under the light microscope. There was a loss 
of the epithelium layers less than 50% of the full thickness as the number of epithelial 
layers was around 2-3 layers in this cornea. There was mild disruption of the 
arrangement of collagen fibres indicating mild degree of stromal oedema (Figure 
3.15c). The cornea was labelled as grade 2. 
At week 4, the model was examined under the light microscope. There was further 
loss of the epithelium layers of more than 50% of the full thickness and the number 
of epithelial layers is around 1-2 layers. There was mild disruption of the collagen 
fibres indicating mild degree of stromal oedema. The cornea was labelled as grade 


















Figure 3.15: Histology sections, rocking without CO2. a. Day 0 (control), grade 0: 
normal epithelial layers (E) and parallel collagen fibres within the stroma (S). b. 
Week 1, grade 1: superficial loss of the outermost epithelium layers, with normal 
underlying stroma. c. Week 2, grade 2: loss of < 50% of the epithelium layers, with 
mild disruption of the alignment of collagen fibres. d. Week 4, grade 3: loss of >50% 




















3.3.2.3 Cornea Culture in Petri Dish, Rocking with CO2 
Corneal transparency: 
At day 0 (control), the cornea was placed against the letter ‘X’ which was easily 
visible (Figure 3.16a). The cornea was described as ‘transparent’.  
At week 1, the cornea was further assessed for transparency and the letter ‘X’ was 
visible through it (Figure 3.16b). The cornea was described as ‘transparent’. 
At week 2, The ‘X’ letter was not visible through the cornea which was described as 
opaque (Figure 3.16c). No further assessment regarding transparency was 











Figure 3.16: Corneal transparency, rocking with CO2. a.  Day 0 (control): transparent 






At day 0 (control), the cornea was examined under the light microscope. The cornea 
demonstrated normal epithelial lining of healthy five to six non-keratinized, stratified 
squamous epithelium and normal stroma with regularly spaced collagen fibres 
oriented in a uniform parallel direction that maintained transparency (Figure 3.17a). 
The cornea was labelled as grade 0 . 
At week 1, the cornea was examined under the light microscope. The cornea 
showed normal epithelial lining and normal underlying stroma (Figure 3.17b). The 
cornea was labelled as grade 0. 
At week 2, the cornea was examined under the light microscope. It showed normal 
epithelial lining and normal stroma (Figure 3.17c). The cornea was labelled as  
grade 0. 
At week 4, the model was examined under the light microscope. There was a 
superficial loss of the outermost epithelium layers as the number of layers is around 






















Figure 3.17: Histology sections, rocking with CO2. a. Day 0 (control), grade 0: normal 
cornea with five to six layers squamous epithelium (E) with normal underlying 
stroma (S)with regular parallel collagen fibres. b. Week 1, grade 0: healthy cornea 
with normal underlying stroma. c. Week 2, grade 0: healthy cornea with normal 
underlying stroma. d. Week 4, grade 1: superficial loss of the outermost epithelium 
layers and the number of epithelial layers is 4-5 layers, the stroma was normal with 




















The ex vivo model demonstrated that air-liquid interface model culture system 
generated better results regarding corneal transparency and the preservation of 
epithelium for longer period s in comparison to the immersion system. It was also 
shown that the air-liquid rocking system gave better results from the air-liquid static 
model. In the air liquid rocking system, the supplement of CO2 gave superior results 
to a system without CO2. 
Corneal transparency was maintained for one week only in the immersion system 
before becoming opaque. The air-liquid interface system preserved corneal 
transparency one week longer than the immersion system (2 weeks in total) with no 
difference between the air-liquid static and rocking techniques. This illustrates the 
significance of attempting to mimic the exact in vivo environment when making an 
ex vivo model because the air-liquid interface shares more similarities with the 
normal eye.  
Using the immersion system, the corneal model showed complete loss of all 
epithelial layers by the end of week 1 with stromal oedema (grade 4). The use of the 
air-liquid interface system yielded better results compared to the immersion system 
with a notable difference between the air-liquid static and rocking approaches and 
even better outcome with the administration of CO2 in the rocking system .The 
microscopic examination by the end of week 4 for the air-liquid static model revealed 
total loss of all epithelial layers and stromal oedema (grade 4), while the air-liquid 
rocking model without CO2 showed loss of >50% of the epithelium layers with mild 
oedema of the stroma (grade 3), and the air-liquid rocking model with CO2 showed 
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superficial loss of the outermost layers of the corneal epithelium with normal stroma 
(grade 1).  
The results illustrate the advantages of the air-liquid rocking system and the 
supplement of CO2 on the model integrity. In the normal eye, the corneal cells are 
nourished by the tear film that is continuously provided by the blinking of the eyelid. 
This is the rationale behind the rocking system which aims to mimic the blinking of 
the eyelid by ensuring a constant spread of the nutrient rich medium over the cornea 
at a desired rate resembling the frequent blinking which constantly provides 
adequate nutrition to the corneal epithelium.  The addition of CO2 helps preserving 
the model due to its fundamental role in cell growth by keeping the pH around 6.9-
7.8 (Ceccarini and Eagle,1971). Carbon dioxide dissolves into culture medium and 
reacts with water to form carbonic acid that interacts with its conjugate base (the 
dissolved bicarbonate ions in the medium) and this tightly controlled buffering 
system ensures a stable physiological pH environment (Bernhardt et al.,1988). 
When pH deviates from neutral, this will negatively affect cell growth and viability, 
therefore maintaining a tight control of pH around neutral value keeps the 
equilibrium in the tissue culture medium and prevents the increase in the pH to over 
8.5 which is toxic to cells (Zetterberg et al.,1981). In a publication from 1974, CO2 
was found to serve as a vital nutrient utilized by cells for growth as the paper 
reported failure of cell growth using HEPES buffered medium without CO2 
supplement, however the growth drastically improved when CO2 was added to the 




3.4.1 Previous Studies 
This current study is adapted from a published research in 2015 that investigated 
the effect of rocking versus static conditions on the integrity of the corneal epithelium 
by developing an ex vivo model from New Zealand white rabbits (leporine). In the 
study, the authors investigated the effect of cytokines on wound healing by inducing 
injury to the epithelial surface. This was achieved by wounding the central area of 
the cornea using 20% methanol within an 8 mm diameter trephine, then scraping 
the epithelium using a sclerotome knife. Subsequently, the corneas were placed in 
a medium that contained interleukins (IL-17A, IL-22) and were cultured using a 
similar technique compared to our study where corneas were kept in Petri dishes 
and were placed on an egg incubator at 37°C which was in turn placed on a rocker 
system at a speed of 10 rpm (Platform Rocker STR6) for 4 weeks and were finally 
compared with the same model in static condition. They also studied the effect of 
CO2 supplement to the rocking system by culturing the model with and without CO2 
administered using a 5% CO2 cylinder connected to a tube entering the incubator 
from a hole on the top and documenting their observations at week 2 and week 4 
by evaluating corneas using the light microscope (Deshpande et al.,2015). 
 
The outcome of their study supported the results of this current study as authors 
concluded that culturing corneas under static conditions with CO2 over 2 or 4 weeks 
resulted in an epithelium only one or two cell layers thick while the rocking system 
with or without CO2 resulted in an epithelium five cell layers thick over the same 
period. Under rocking conditions, there was poor organisation of epithelium in 
corneas cultured without CO2 compared to corneas cultured with CO2 after 2 weeks. 
At 4 weeks, the epithelium was completely lost in corneas cultured without CO2 
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compared to corneas cultured with CO2 that maintained its organisation showing 
only loss of superficial cells. They also concluded that wound healing process 
generated a single layer of epithelium using the static model while approximately 5 
layers of new epithelium developed using the rocking system.  
 
In the work presented in this chapter, porcine (pig) corneas were used which share 
more anatomical similarities to the human eye having similar size, appearance and 
having no tapetum lucidum layer as rabbit eyes do. Pig eyes are thus a more 
suitable choice to develop an ex vivo model to study Acanthamoeba keratitis and 
possible treatment modalities. We studied the immersion system in addition to 
comparing the effect of rocking over static conditions and the effect of CO2. The 
outcome was measured at both gross (corneal opacity) and microscopic level 
(integrity of epithelium and stromal oedema). In this current study, we did not study 
wound healing or the effect of cytokines. 
 
One major addition in our work was the filling of the corneal concavity with a gel 
formed of DMEM containing 1% agarose to maintain the convex shape of the cornea 
and further support the structure of the model during the rocking process. The gel 
also provides nutrition to the overlying endothelium. 
The Petri dishes were placed in an egg incubator at 37°C contained within an air-
tight sealed box with the whole system placed on a rocker platform. This is another 
major modification in our research as we established a fully sealed box supplied 
with 5% CO2 and continuously monitored by a CO2 sensor attached to the box as 
previously described (section 3.2.2.2). The use of the sealed box has many benefits: 
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it provides a contamination-free environment to culture corneas in tightly controlled 
conditions regarding temperature and CO2 levels, it provides a physical space for a 
CO2 sensor to be attached to the apparatus to continuously monitor CO2 level and 
finally the consumption of the gas will be significantly minimized compared to 
‘Deshpande et al.’ study as the closed system we use conserves the gas within the 
system. 
Regarding the assessment methodology for both studies, ‘Deshpande et al.’ study 
evaluated the microscopic changes under the light microscope regarding the 
thickness of the epithelium and its cell organization, but no grading system was 
implemented  and no description of the stromal architecture was reported while we 
developed a grading system to describe the microscopic features of corneal 
epithelial layer and the stroma and we used this system for the comparisons made 
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Table 3.1: Outcome of current study and ‘Deshpande et al.’ study 
 
As shown in the table above both studies illustrated the beneficial role of CO2 in the 
maintenance and preservation of the epithelium over longer periods of time as the 
microscopic examination at the end of the 4-week period for both studies 
demonstrated complete loss of the epithelial layers for corneas cultured without CO2 
and the preservation of the layers with CO2 administration in rocking conditions with 
loss of superficial cells only. Both studies demonstrated that when using the air-
liquid interface system, the rocking system was better than the static system in 
preserving epithelial layers. This current study further demonstrated that the air-
liquid interface system can better preserve corneal transparency and number of 
epithelial layers compared to the immersion system and this comparison was not 




A recent study in 2016 evaluated the differences between immersion and air-liquid 
interface systems over one week and the outcome was similar to this study 
demonstrating that air-fluid interface model preserves corneal transparency by the 
end of the experiment and maintains corneal architecture by preserving the corneal 
epithelia layers with lesser degrees of stromal oedema. They used horse corneas 
randomly placed in either immersion condition or air/liquid interface condition for 7 
days. The immersion system was developed by completely submerging the cornea 
in the culture medium while in the air-liquid interface system, the endothelium was 
totally bathed in the medium leaving only a small area of the cornea exposed to air. 
All corneas were cultured in tissue culture plates filled with minimum essential 
medium (MEM) supplemented with 10% (v/v) foetal bovine serum, essential amino 
acids, penicillin, streptomycin, and MEM vitamins at 37°C in 5% CO2 for 7 days. The 
corneas were evaluated daily by gross photography, and on day 7 they performed 
histological examination, real-time polymerase chain reaction (PCR) and terminal 
deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) assay (Marlo et 
al.,2016).   
The outcome of ‘Marlo et al.’ study supported this current study as they evaluated 
the corneas both grossly and under the light microscope at day 7 and noticed that 
corneal transparency was completely lost for corneas cultured under the immersion 
system in contrast to those cultured under air-liquid interface system that maintained 
their natural transparency. They generated a grading system for microscopic 
features where healthy control corneas were classified as grade 0, while corneas 
with complete loss of the corneal epithelium in addition to breaks in Descemet's 
membrane and severe corneal oedema were classified as grade 3. They reported 
that corneas cultured using the immersion system had complete loss of the corneal 
120 
 
architecture with complete loss of epithelium and severe corneal oedema (grade 3), 
while the corneas cultured using air-liquid interface system had better preservation 
of architecture as some corneas demonstrates features of healthy corneas (grade 
0) and others developed minimal disruption of the corneal epithelium and mild 
corneal oedema (grade 1).  
They also performed real-time (PCR) to evaluate for alpha smooth muscle actin (α-
SMA) which is a cellular cytokine that indicates the transformation of corneal 
fibroblasts to myofibroblasts compared to a control (Fini and Stramer,2005) as an 
increased detection α-SMA reflects an increase in wound healing processes caused 
by an increased loss of epithelium. They found a significantly increased α-SMA 
levels in corneas cultured with immersion system compared to corneas cultured with 
air-liquid interface system. They also found that α-SMA was seven times higher in 
corneas cultured using the immersion system compared to healthy control corneas 
while corneas cultured using air-liquid interface system also had higher levels than 
control corneas however the latter was not statistically significant. 
They also used  TUNEL assay which is a well-established method to detect DNA 
fragments as a reflection of the level of cellular apoptosis. They noticed higher levels 
of cellular apoptosis in corneas cultured using immersion system compared to 
control corneas, while there was minimal apoptosis in corneas cultured using air-






In our study, we ran a longer experiment over 4 weeks, and we used pig (porcine) 
corneas instead of horse (equine) corneas and the medium used in culture 
contained other components: DMEM, Ham's F12 medium in a 1:1 ratio 
supplemented with penicillin, streptomycin, gentamicin, amphotericin B, EGF and 
insulin. Similar to ‘Marlo et al.’ study, this current study evaluated both immersion 
and air-liquid interface systems and we further supported the cornea in the latter 
system by filling the corneal concavity with a gel formed of DMEM containing 1% 
(w/v) agarose. Both static and rocking settings were evaluated in the air-liquid 
interface system using an egg incubator and a rocker platform placed inside a 
sealed box system.  The corneas were cultured at 37°C with and without CO2 and 
for an extended period for 4 weeks. The model was evaluated by studying corneal 
transparency, number of epithelial layers and the development of any stromal 
oedema.  
The following table illustrates the outcome of both studies: 
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Our study continued for four weeks and we were able to maintain corneal 
transparency for one week with corneas cultured in the immersion system and two 
weeks for corneas cultured in the air-liquid interface system. At week 1, corneas 
cultured by the immersion system were examined under the light microscope and 
demonstrated similar results to ‘Marlo et al.’ study with complete loss of epithelial 
layers however the corneas showed only mild stromal oedema compared to severe 
oedema in their model and this might be attributed to the difference in the 
components of the medium used in both studies as stated earlier. In our model, 
corneas cultured with air-liquid interface system under static conditions 
demonstrated the presence of epithelial layers with loss of less than 50% of 
epithelial thickness and mild disruption of the collagen fibres indicating mild oedema 
while their study reported the presence of epithelial layers without commenting on 
the thickness and they reported mild to moderate corneal oedema. 
Our study demonstrated a notable difference between the static and rocking 
approaches for corneas cultured in air-liquid interface system and better 
preservation of the epithelial layer for four weeks with the administration of CO2 in 
the rocking system.  
 
3.4.2 Eye Banks- Corneal Storage Techniques 
There are several approaches adapted by eye banks for the storage and 
preservation of corneas and the three main modalities are organ culture 
(immersion), hypothermia and cryopreservation (Armitage, 2011). Most eye banks 
in Europe store corneas using organ culture technique due to the prolonged storage 
time it offers. The media widely used is Eagle's minimum essential medium (MEM) 
with different banks using up to 8% foetal bovine serum with the addition of penicillin, 
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streptomycin and amphotericin B (Claerhout et al.2010). This prolongs storage 
times up to 4 weeks (Pels et al.,1983) with some banks reporting storage times up 
to 7 weeks with successful subsequent transplantation (Ehlers et al.,1999). Corneas 
stored using organ culture technique are reported to maintain endothelial and outer 
epithelial cell layers up to four weeks with cell loss via apoptosis affecting epithelial 
cell layers more than the endothelial cells (Crewe and Armitage,2001). 
Compared to our study, it is noticed that the immersion technique used by eye banks 
preserves corneal integrity for an extended period of four weeks while we managed 
to preserve the cornea for one week only using the immersion system, and up to 
four weeks using the air-liquid interface. There are many factors that might possibly 
explain this discrepancy as eye banks use human corneas while we use animal 
corneas which are obviously not identical to human tissue and have more tendency 
to rapidly swell and lose transparency  (Crouzet et al., 2016), and also their handling 
of corneas takes place in controlled clinical settings at all levels starting from the 
harvesting step, transport and storage by experts in corneal tissue transplant in a 
strictly sterile environment compared to laboratory setting. Nevertheless, human 
corneas are not a reliable source to establish corneal model due to its scarcity 
therefore the widely available porcine corneas are considered a suitable alternative 




3.5 Conclusion and Future Work 
In developing ex vivo corneal model, better preservation of corneal transparency 
and model integrity was observed under the following conditions: 
- Air liquid interface compared to immersion. 
- Rocking system compared to static system. 
- The supplement of CO2. 
 
It is thus clear that when establishing an ex vivo model, corneal gross and 
microscopic architecture are better maintained when developing a rocking system 
that mimics the blinking action of the eyelid and even better results are reported with 
the supplement of 5% CO2 that provides vital nutrition to the cells and keeps the pH 
close to neutral, all of which lead to more resemblance to in vivo environment.  
 
Future studies can use corneal rim tissue left over from a transplant and human 
donor corneas which are not suitable for human transplant (past transplant window 
or those taken from keratoconus patients) and this can provide a closer similarity to 
the human in vivo model. This requires collaboration between the research team 



























Chapter 4: Establishing Ex Vivo Acanthamoeba Keratitis Model 
 
4.1 Introduction 
4.1.1 Acanthamoeba  
Acanthamoeba is a small free-living amoeba found in tap water and garden soil 
(Carnt et al.,2020). The organism has a life cycle of a feeding and replicating 
trophozoite which, in response to adverse conditions including drug treatment can 
form a dormant highly resistant cyst stage (Kovacs et al.,2015). Acanthamoeba 
species are opportunistic pathogens of humans that can cause a fatal 
granulomatous encephalitis in the immunocompromised patients and a potentially 
blinding infection of the cornea called Acanthamoeba keratitis (AK) (Carnt et 
al.,2016) in both contact lens wearers and non-contact lens wearers (Lorenzo-
Morales et al., 2015).  
 
4.1.2 Acanthamoeba Keratitis 
In the United Kingdom, it is estimated that there are approximately 4.1 million people 
who wear contact lenses (Carnt et al.,2020). There are established independent risk 
factors attributed to the development of Acanthamoeba keratitis in wearers of 
contact lenses which include: bathing or swimming while wearing the contact lenses 
(Carnt et al.,2020), exposure to house tap water (Carnt et al., 2020) and poor lens 
hygiene (Stehr-Green et al.,1987, Radford et al.,2002, Cope et al.,2016). 
According to one study in the UK, free-living amoeba was isolated from 76% of water 
samples from bathroom cold taps in houses of patients who developed 
Acanthamoeba keratitis as water storage tanks increase the level of water 
colonization by free living amoeba including Acanthamoeba (Kilvington et al.,2004). 
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Efficacy issues with certain contact lenses disinfection systems are also linked to 
previous outbreaks of the disease in the United States and the United Kingdom (Tu 
et al.,2010).  
A recent study conducted over a period of 12 years covering 1500 keratitis cases 
took place in Manchester Royal Eye Hospital and reported an incidence rate for 
Acanthamoeba keratitis of around 2.3% (Tan et al.,2017). Having such a low 
incidence of AK cases, the disease can be initially misdiagnosed and treated as 
bacterial, fungal or herpes simplex keratitis (Carnt et al.,2018) before a proper yet 
delayed diagnosis of AK is established. This delay in diagnosis profoundly impacts 
the prognosis with poorer visual outcome, prolonged duration of treatment, increase 
incidence of corneal perforation and an increased number of patients requiring 
penetrating keratoplasty (Carnt et al.,2018).  
 
4.1.3 Pathogenesis 
The process of keratitis starts by adhesion of trophozoites to the corneal epithelium 
by specific receptors inducing cytolytic effect to the epithelium that is followed by 
degradation and penetration to deeper layers however rarely to progress beyond 
the cornea. Patients are likely to have a poor prognosis if they develop sclero-
keratitis or a persistent infection despite the treatment (Perez-Santonja et al.,2003).   
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Acanthamoeba keratitis has three phases: phase 1 infects the corneal epithelium 
only and has the best prognosis, phase 2 causes one or more corneal epithelial 
defects, invades the underlying stroma and damages the collagen with severe 
inflammation leading to stromal or perineural infiltrates which can be demonstrated 
in up to 63% of cases  of AK, while phase 3 forms corneal ring infiltrate highly 
suggestive of AK and seen in about 50% of the cases , beside one or more features 
of the second phase (Niederkorn et al.,1999; Robaei et al.,2014). The late stages of 
AK are characterized by focal loss of keratocytes and stromal tissue (Awwad et 
al.,2005).  
 
Figure 4.1: The pathogenic cascade of Acanthamoeba keratitis. 1. Acanthamoeba 
trophozoites adhere to the corneal epithelium. 2. Acanthamoeba trophozoites cause 
damage to corneal epithelial cells. 3. Trophozoites breach Bowman’s membrane 
and enter the collagenous stroma leading to destruction of the corneal stroma. 4. 
Trophozoites often cluster around corneal nerves producing radial keratoneuritis 
(Lorenzo- Morales et al.,2015). 
130 
 
The disease affects the corneal epithelium of humans and can cause experimental 
infection in pigs and hamsters (Neelam and Niederkorn,2017, Clarke and 
Niederkorn,2006). It is caused by several Acanthamoeba species including 
Acanthamoeba castellanii, A. culbertsoni, A. polyphaga, A. hatchetti, A. rhysodes, 
A. lugdunesis, and A. griffini (Lorenzo-Morales et al.,2015). 
 
4.1.4 Pharmacological Treatment 
There is no licensed treatment for AK and the current unlicensed therapy is topical 
preparation of a biguanide which is 0.02% (v/v) polyhexamethylene biguanide 
(PHMB) or 0.02% (v/v) chlorhexidine used alone or in combination with 0.1% (w/v) 
hexamidine or 0.1% (w/v) propamidine (Papa et al., 2020). 
 
4.1.5 Previous Models 
There is some success in developing an animal model of Acanthamoeba keratitis. 
Rabbits treated with immunosuppressive drugs were used for the development of 
Acanthamoeba keratitis models where researchers successfully demonstrated AK 
by intrastromal injection of Acanthamoeba cysts without corticosteroid treatment 
(Font et al.,1982). Another group of researchers developed a model of AK in rabbit 
eyes that had a better demonstration of the actual process of infection and immune 
response against Acanthamoeba corneal infection in humans (Feng et al., 2015). 
Developing a porcine model of AK was achieved by using contact lenses already 
contaminated with Acanthamoeba and applying them onto the corneas of pigs, and 
the induced infection was similar clinically and histologically to human 
Acanthamoeba keratitis (He et al.,1992). 
One study compared different methods of developing animal models of AK, and it 
showed that corneal scratching followed by applying Acanthamoeba laden contact 
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lenses has higher rate of infection than corneal scratching alone, but intrastromal 
injection yielded the highest rate and most severe form of AK (Ren et al.,2009). 
Other researchers developed AK model using infected contact lenses on rabbit eyes 
after debridement of corneal epithelium (Ortillés et al.,2017). 
 
4.1.6 Rationale 
Patients with Acanthamoeba keratitis characteristically develop a stromal “haze” 
caused by infiltration of host macrophages. The infiltrates are responsible for loss 
of visual acuity of patients which makes it difficult to follow the progression of the 
infection in an in vivo cornea. Therefore, an ex vivo model would offer a unique 
opportunity to monitor the progression of infection in the absence of host immune 
response by observing the spread of infection from initial attachment to corneal 
epithelial cells until invasion of the corneal stroma. 
The establishment of an ex vivo Acanthamoeba keratitis model may enable it to be 
used for many applications such as comparing different diagnostic methods for this 
particular infection (Costa et al.,2017), testing different pharmacologic agents and 
drug resistance (Vasseneix et al.,2006), studying the underlying molecular 
pathways that enhance adhesion of Acanthamoeba to corneal epithelium (Panjwani 
et al.,1997) and studying the role of the risk factors associated with AK like the use 
of contact lenses and trauma (Huth et al. 2017). 
A substantial consideration in the establishment of this model is the adherence to 
the 3R principle for animal research (replacement, reduction, and refinement) which 
minimises the number of animals used per experiment, reducing animal suffering 
and improving animal welfare. 
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4.1.7 Aim and Objectives 
The aim of this chapter is to establish an ex vivo model of Acanthamoeba keratitis 
using porcine corneas. The objectives are: 
• To utilise the ex vivo model that has been developed to establish a model of 
Acanthamoeba keratitis. 
• To monitor the progression of infection in the absence of host immune 
response by gross examination and histological sections using light 
microscopy. 
• To observe the spread of infection from initial attachment to corneal epithelial 
cells until the invasion of the corneal stroma by studying histological sections 
under the light microscope. 
• To evaluate the role of macrophages and neutrophils in controlling the 







4.2.1 Acanthamoeba Culture 
Acanthamoeba polyphaga (ATCC 30461) strain was obtained from the American 
Type Culture Collection (LGC Standards, Teddington, UK). Trophozoites were 
maintained in tissue culture flasks using a semi defined axenic medium (Ac#6) as 
previously described in chapter 2 section 2.3. Cysts were produced using Neff's 
encystment medium (NEM) method as previously described in chapter 2 section 
2.6.  
 
4.2.2 Developing Acanthamoeba Passage Cells 
In Ac#6 medium, Acanthamoeba were fed a semi define axenic medium which 
caused a phenotypic shift and became less motile and more rounded in appearance 
because the diet they were fed contained a mixture of amino acids so they could 
feed by just taking in nutrients by phagocytosis or pinocytosis without having to 
move within the medium or secrete enzymes or pathogenic factors. This is different 
from when Acanthamoeba feeds on live or whole cells as it needs to undergo certain 
morphological and functional changes to become highly motile with wider body and 
large abundant acanthapodia (Omaña-Molina et al.,2004) and produces large 
quantities of enzymes to digest cells that are the same size as it. 
To stimulate pathogenicity, Acanthamoeba polyphaga were fed on HEp-2 cell 
monolayers in three-step passage process where it became stretched out instead 
of rounded and upon feeding demonstrated the presence of large feeding vacuoles 
that contained the phagocytosed target cells. 
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4.2.3 Culture of Mammalian Cells 
4.2.3.1 THP-1 Cell Culture 
The cell lineage used was the human monocytic leukaemia cell line (ATCC TIB-
202). The cells were grown as previously described in chapter 2 section 2.11. THP-
1 cells were differentiated into macrophages using PMA as described previously in 
chapter 2 section 2.13. 
 
4.2.3.2 HL-60 Cell Culture  
The cell lineage used was the human acute promyelocytic leukaemia cell line (ATCC 
CCL-240). The cells were grown using the method described in chapter 2 section 
2.11. 
  
4.2.3.3 Human Epithelial Cell Line Culture (HEp-2) Cell Culture 
HEp-2 (HeLa derivative) human cervix carcinoma cell line (ECACC number 
86030501) was obtained from the European Collection of Cell Cultures (Centre for 
Applied Microbiology and Research, Salisbury, UK). The cells were grown in tissue 
culture flask at 37°C. incubator with 5 % CO2 in Dulbecco’s minimum essential 
medium (DMEM) with 10% heat-inactivated foetal bovine serum as previously 




4.2.4 Cornea Culture 
Eye globes were collected, disinfected, then corneas were harvested following the 
same method described in chapter 2 section 2.15. The corneas were cultured using 
a rocking system with 5% CO2 as previously described in section 3.2.2.2. 
 
 
4.2.5 Inducing Infection 
A single gentle superficial scratch to the corneal surface (3mm in length) was 
performed using sterile forceps and scalpel prior to infection with Acanthamoeba. 
The infection was initiated by adding 5µL of 1x 105 /mL Acanthamoeba trophozoites 
to the corneal surface. The same method was used to add 5µL of 1 x 105 
Acanthamoeba cysts to the corneal surface using a different set of corneas. 
Uninfected corneas were maintained as a control along with the infected corneas 
under the same conditions. 
The progression of infection was monitored macroscopically by naked eye for the 
first two days, then from day 3 onwards they were observed every 5 days up to 28 
days by light microscopy.  Before microscopic examination, the specimens were 
fixed in 2% (v/v) buffered paraformaldehyde for 24 hours before sectioning and 
staining with haematoxylin and eosin stain as per the previously described protocol 
in section 2.16 .  After 28 days, no further assessment was performed, and the 




4.2.6 Adding Macrophages and HL-60 
After developing infection following the above-described method, 5µL of 1 x 105 /mL 
macrophages and HL-60 cells were added or injected in the infected corneal surface 
using a 26-gauge needle. 
 
 
4.2.7 Assessment Methodology 
The corneas were assessed at both gross and microscopic levels. On the gross 
level, the effect of infection on the transparency of the cornea was evaluated by 
placing the cornea over the letter ‘X’ and evaluate if the letter was still apparent 
through the cornea in both control and infected ones. If the letter ‘X’ was not clearly 
seen through the cornea it was reported as opaque. 
On the microscopic level, the effect of infection on the integrity of the cornea was 
assessed based on two main features: the damage to the epithelium and the 
development of oedema in stroma. The microscopic examination started on day 3 
and then every 5 days until day 28 based on the results from chapter 3 as this was 
the time when the model started to lose its superficial epithelium. The following 
scoring system was developed to follow the infection: 
• Score 0*: healthy cornea, control. 
• Score 1*: attachment of Acanthamoeba to the corneal epithelium, normal        
                     stroma. 
• Score 2*: superficial loss of the outermost layers of the epithelium, normal                                  
                    stroma. 
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• Score 3*: loss of < 50% of the epithelium, normal stroma. 
• Score 4*: loss of >50% of the epithelium, mild stromal oedema. 
• Score 5*: total loss of the corneal epithelium, invasion of the upper part of the  
                    stroma with mild oedema. 
• Score 6*: total loss of the corneal epithelium, invasion of the upper and middle  





4.3 Results  
In this study, the corneas were cultured using the model established in chapter 3 
(air-liquid interface technique, rocking approach with CO2). Following the 
establishment of the model, the corneas were scratched and Acanthamoeba 
trophozoites and cysts were added to the medium and were followed over a period 
of four weeks when the control cornea started to show histological changes. The 
measured outcomes were corneal transparency and epithelial and stromal changes. 
 
 
4.3.1 Macroscopic Level 
On the macroscopic level, the cornea infected with Acanthamoeba demonstrated 
visible haziness on day 10 compared to control cornea (Figure 4.2). No further 














Figure 4.2: Corneal transparency. a.  Healthy cornea (control): transparent cornea 
with the letter X visible through the cornea.  b. Infected cornea: opaque cornea with 




4.3.2 Microscopic Level 
4.3.2.1 Day 0 (control) 
The control for healthy cornea (Figure 4.3) was examined under the light 
microscope. It showed normal epithelial lining of healthy five to six layers of non-
keratinized, stratified squamous epithelium and normal stroma which contained 
regularly spaced collagen fibres oriented in a uniform parallel direction. 







Figure 4.3: Normal cornea at day 0 showing five to six layers squamous epithelium 
(E) with normal underlying normal stroma (S) and regular parallel collagen fibres, 





4.3.2.2 Day 3 
Control cornea 
The cornea was examined under the light microscope. It showed normal epithelial 
lining with five to six layers of squamous epithelium with normal underlying stroma 
with regular parallel collagen fibres (Figure 4.4a). Score 0*: healthy cornea 
 
Infected cornea 
The infected cornea was examined under the light microscope and there was an 
attachment of the Acanthamoeba trophozoites to the superficial layer of the corneal 
epithelium. The stroma had normal appearance formed of parallel layers of collagen 
fibres (Figure 4.4 b, c). 




















Figure 4.4: Control and infected corneas at day 3. a. Control: healthy control cornea 
with normal five to six layers squamous epithelium (E) with normal underlying 
stroma (S) and regular parallel collagen fibres, score 0*. b. Establishment of 
infection demonstrated by the attachment of Acanthamoeba trophozoites (A) to the 
superficial layers of the corneal epithelium (E) with normal stroma (S) formed of 
parallel layers of collagen fibres, score 1*.  c. Attachment of Acanthamoeba (A) to 
the corneal epithelium. Acanthamoeba is recognised by its characteristic foamy 







4.3.2.3 Day 8 
Control cornea 
The cornea was examined under the light microscope. It showed normal epithelial 
lining with five to six layers of squamous epithelium with underlying normal stroma 
with regular parallel collagen fibres (Figure 4.5a). Score: 0*: Healthy cornea. 
Infected cornea 
The cornea showed attachment of Acanthamoeba trophozoites to corneal 
epithelium with loss of the superficial layers of the epithelium as the number of 
epithelial layers was around 3-4 layers in contrast to the normal 5-6 epithelial layers 
in normal cornea, however the appearance of stroma was normal with parallel layers 
of collagen fibres (Figure.4.5b). 







Figure 4.5: Control and infected corneas at day 8. a. Healthy control cornea showing 
normal squamous epithelium (E) with five to six layers with normal underlying 
stroma (S) and regular parallel collagen fibres, score: 0*. b. Attachment of 
Acanthamoeba trophozoites (A) to the corneal epithelium (E) with loss of the 
superficial layers of epithelium as the number of epithelial layers is around 3-4 layers 




4.3.2.4 Day 13 
Control cornea 
The cornea was examined under the light microscope. It demonstrated normal 
epithelial lining with five to six layers of squamous epithelium with underlying normal 
stroma with regular parallel collagen fibres (Figure 4.6a). Score 0*: healthy cornea.  
Infected cornea 
The cornea was examined under the light microscope. There was further loss of 
epithelial lining as the number of epithelial layers was around 2-3 layers with parallel 
layers of collagen fibres within the normal stroma (Figure 4.6b). 







 Figure 4.6: Control and infected corneas at day 13. a. Healthy cornea showing 
normal five to six layers of squamous epithelium (E) with normal underlying stroma 
(S) with regular parallel collagen fibres, score 0*. b. Infected cornea showing 
attachment of Acanthamoeba trophozoites (A) to the corneal epithelium (E) 
composed of 2-3 cell layers with parallel layers of collagen fibres within the normal 




4.3.2.5 Day 18 
Control cornea 
The cornea was examined under the light microscope. The epithelial lining was 
normal with five to six layers of squamous epithelium with normal underlying stroma 
with regular parallel collagen fibres (Figure 4.7a). Score: 0*: healthy cornea. 
 
Infected cornea 
The cornea was examined under the light microscope. Acanthamoeba trophozoites 
were seen invading the whole epithelium with loss of most epithelial layers 
demonstrated by the loss of >50% of the epithelium, and a mild disruption in the 
arrangement of the collagen fibres was noticed indicating mild degree of stroma 
oedema (Figure 4.7b). 
 












Figure 4.7: Control and infected corneas at day 18. a. Healthy control cornea 
showing normal five to six layers of squamous epithelium (E) with normal underlying 
stroma (S) with regular parallel collagen fibres. b.  Infected cornea showing 
Acanthamoeba trophozoites (A) invading the whole epithelium (E) with loss of most 
epithelial layers, the stroma was also noticed to show mild disruption of the collagen 





4.3.2.6 Day 23 
Control cornea 
The cornea was examined under the light microscope. It showed normal five to six 
layers of squamous epithelium and mild disruption of the collagen fibres 
arrangement indicating mild degree of stroma oedema (Figure 4.8a).  
Infected cornea 
The cornea was examined under the light microscope. There was total loss of the 
corneal epithelium and invasion of the upper part of the stroma with mild disruption 
of the collagen fibres arrangement indicating mild degree of stroma oedema (Figure 
4.8b). 
Score: 5*: Total loss of the corneal epithelium, stromal invasion in the upper part 






Figure 4.8: Control and infected corneas at day 23.a. Normal with five to six layers 
of squamous epithelium (E) with mild disruption of the collagen fibres arrangement 
indicating mild degree of stroma oedema (S). b. Infected cornea demonstrating total 
loss of the corneal epithelium with invasion of the upper part of stroma (S) by 
Acanthamoeba (A) with mild distribution of the collagen fibres arrangement 





4.3.2.7 Day 28 
Control cornea 
The cornea was examined under the light microscope. There was a superficial loss 
of the outermost epithelium layers as the number of epithelial layers is around 3-4 
layers in this cornea with mild disruption of the collagen fibres arrangement 
indicating mild degree of stroma oedema (Figure 4.9a). 
 
Infected cornea 
The cornea was examined under the light microscope. There was total loss of the 
corneal epithelium with stromal invasion in the upper and mid layers and mild 
disruption of the collagen fibres arrangement indicating mild degree of stroma 
oedema (Figure 4.9b). 
Score: 6*: Total loss of the corneal epithelium, invasion of upper and mid layers, 











Figure 4.9: Control and infected corneas at day 28. a. Control cornea showing 3-4 
layers of epithelium indicating lo ss of the outermost epithelial layers (E) with mild 
disruption of the collagen fibres arrangement indicating mild degree of stromal (S) 
oedema. b. Infected cornea demonstrating a total loss of the corneal epithelium and 
stromal (S) invasion in the upper and mid layers by Acanthamoeba trophozoites (A) 
with mild disruption of the collagen fibres arrangement indicating mild degree of 
stromal oedema, score 6*. 
 
4.3.3 Outcome of Adding Acanthamoeba Cysts to Cornea 
Acanthamoeba cysts were added to the medium over the corneal surface, and upon 
microscopic inspection on day 3, many cysts had already hatched into trophozoites 
and continued the same infectious process described above. 
 
4.3.4 Outcome of Adding or Injecting Macrophages and HL-60 Cells to the 
Infected Cornea 
The addition of macrophages and HL-60 (neutrophils) to the already infected cornea 
did not alter or limit the process of infection as the Acanthamoeba phagocytosed 




















Figure 4.10: The addition of macrophages and HL-60 to the infected cornea. a. 
Acanthamoeba trophozoites (A) were attached to the epithelial surface (E) of the 
cornea with macrophages (M) and HL-60 (neutrophils) (N) seen in the slide. b.  
Macrophages demonstrated as rounded cells with abundant clear, vacuolated, 
cytoplasm and HL-60 cells (N) with eosinophilic (pink) cytoplasm. c. Total loss of 
the corneal epithelium and invasion of the upper part of stroma (S) by 
Acanthamoeba trophozoites (A) with mild disruption of the collagen fibres 
arrangement indicating mild degree of stroma oedema with scattered HL-60 cells 





4.4 Discussion  
In this study, we used the previously established air-liquid interface rocking with CO2 
model to induce Acanthamoeba keratitis by scratching the corneal surface and 
introducing Acanthamoeba trophozoites and cysts over a period of four weeks with 
histological examination starting on day 3 and every 5 days afterwards. The main 
outcomes assessed were corneal transparency and damage to epithelium and 
stroma on the microscopic level.  
 
4.4.1 Summary of Results 
On the gross level, the transparency of cornea became obviously opaque on day 
10, and on the microscopic examination, the attachment of trophozoites to the 
epithelium started on day 3 (score 1*), the earliest observed loss of the superficial 
epithelial layers started on day 8 (score 2*) and on day 13, less than 50% of 
epithelial layers were lost (score 3*). On day 18, the stroma started to demonstrate 
mild oedema with loss of more than 50% of epithelium (score 4*), and by day 23 the 
model showed complete loss of epithelial layers and mild stromal oedema with 
trophozoites invading the upper part of the stroma (score 5*) which further invaded 
the middle parts of the stroma by day 28 (score 6*). 
The results demonstrate the usability of the ex vivo model to induce Acanthamoeba 
keratitis and monitor the progression of the infection in the absence of host immune 
response by observing the spread of infection from initial attachment to corneal 
epithelial cells until the invasion of corneal stroma. To our knowledge, this is the first 
ex vivo model developed to study the disease progress of Acanthamoeba keratitis 
for an extended period of 4 weeks. 
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When culturing corneas with Acanthamoeba cysts, most of these cysts hatched into 
trophozoites following the adhesion to the epithelium which served a source of 
nutrition beside the nutrient medium. It is well demonstrated across literature that 
the presence of the carbohydrate mannose in the membrane of the host cell is 
fundamental for pathogenic Acanthamoeba to adhere to cells by the interaction 
between the mannose on the corneal cell with the mannose-binding proteins (MBP) 
in the membrane of the amoebae which is reported to exert one of the strongest 
pathogenic mechanisms of Acanthamoeba (Huth et al.,2017). 
 
4.4.2 Inducing the Infection 
In this current study, we introduced Acanthamoeba to the model after inducing injury 
to the cornea by scratching its surface. The interactions between corneas and 
microbes were extensively studied in previous research (in vivo, in vitro or ex vivo) 
explaining how bacteria and fungi are introduced into corneas and the two main 
methods described were corneal scratching (Blaylock et al.,1990, Kwong et 
al.,2007) and intrastromal injection (Butler et al.,2001, Barequet et al., 2012).  
A study in 2017 supported the results of this current study where researchers 
evaluated infections of single versus mixed species of Staphylococcus 
aureus, Pseudomonas aeruginosa, Candida albicans and Fusarium solani in both 
human and rabbit corneas by both scratching and injection methods and they 
endorsed scratching method to better mimic the mechanism of clinical infection of 
the human eye that is usually initiated by a mechanical abrasion to the corneal 
surface (Pinnock et al.,2017). Different to their study, our work is exclusively focused 
on studying Acanthamoeba which was not part of the microorganisms they used in 
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their research, and our model was developed using pig corneas while they used 
human and rabbit corneas. 
In ‘ Pinnock et al.’ study they scratched the cornea with a scalpel, and a metal ring 
was placed on the centre of the cornea to create a watertight seal then they 
inoculated 1 x 108 of the above-mentioned microorganisms were either added 
or injected in the cornea using a 26-gauge needle. In our study we used a scalpel 
to induce the epithelial injury before adding 5µL of 1x 105 /mL Acanthamoeba 
trophozoites or cysts without using metal rings or using the injection method.  
In ‘Pinnock et al.’ study, the duration of the experiment was short (24 hours – 48 
hours) which is very brief however they were able to demonstrate corneal haziness 
caused by the infection and the histological sections demonstrated infiltration of 
Staphylococcus aureus, Pseudomonas aeruginosa, Candida albicans and 
Fusarium solani within the corneal layers with variable degrees of infiltration. In this 
current study, we were able to follow the progression of infection in the ex vivo model 
for four weeks and were equally able to demonstrate the effect of the infection 
evident by corneal haziness and histological sections showing invasion of the 
microorganism into corneal layers. The long duration upon which this current study 
was performed, hugely facilitates the study of disease pathogenicity, host-pathogen 





4.4.3 Pathogenesis and Previous Studies 
The first step we observed under the light microscope was the attachment of the 
originally cultured trophozoites and the ones stemming from cysts to the corneal 
epithelium. The cyst stage helps Acanthamoeba to survive in extreme conditions 
until excystation process starts in more favourable conditions with the presence of 
glutamic acid and other amino acids (Krishna et al.,1984) which were available to 
the cysts after they were added to the cornea and nutrient medium.  
The attachment process was observed on day 3 of this experiment under the light 
microscope as shown in Figure 4.4 and it is considered a critical step in inducing 
infection (Panjwani,2010) that was extensively studied by many researchers (Jaison 
et al.,1998, Kenett et al.,1992, Yang et al.,1997). The carbohydrate mannose 
proteins in the membrane of the cornea stimulates Acanthamoeba to secrete a 
mannose-induced 133 kDa protease (MIP133), which in turn interacts with 
phospholipids on plasma membrane of the corneal cells and activates the cytosolic 
phospholipase A2  that plays an integral role in apoptosis  by  activating 
proinflammatory cytokines from the corneal cells facilitating the crossing of 
biological barriers   and  destruction of the host cell (Tripathi et al., 2012, Lorenzo-
Morales et al., 2015). 
The second step we observed under the light microscope following the attachment 
was the destruction of the epithelium. The destruction starts from superficial layers 
down to the basal layers and is facilitated by the phagocytosis mechanism that 
engulfs epithelial cells which ultimately leads to further invasion, tissue damage and 
cytolysis by proteolytic enzymes such as metallo and cysteine proteases which 
degrade and digest extracellular targets (Niederkorn et al.,1999).  
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A study from 2004 supported our observations regarding the attachment and tissue 
destruction process where the authors monitored the early steps within the first 12 
hours of the interaction of Acanthamoeba trophozoites with corneas harvested from 
hamsters by using both light and scanning electron microscope (SEM) (Omaña-
Molina et al.,2004). Using light microscopy, they observed adherence of 
trophozoites to the surface of corneal epithelium at hour 1, further advancement 
between the superficial epithelial cell layers at hour 2, extended damage to the 
middle layers at hour 4, and after prolonged periods at 8 and 12 hours the basal cell 
layer was completely disorganised but no Acanthamoeba was seen to extend 
beyond the basal layer into the stroma however in our study we were able to observe 
the invasion of the stroma from day 23 as shown in Figures 4.8 and 4.9. 
In ‘Omaña-Molina et al.’ study, they used SEM to study the morphological changes 
during the infection process and they reported that Acanthamoeba showed 
amebostome-like structures once became in contact with host cells, suggesting that 
phagocytosis of the target cells is vital to the pathogenesis process. They also 
noticed morphological differences between the trophozoites incubated with corneas 
and the trophozoites kept in medium culture only as the former demonstrated wide 
body with large abundant acanthapodia and the latter showed a flattened 
appearance with short acanthapodia. The work presented in this chapter was based 
on light microscopy findings and no SEM was used. 
 
A similar study (Moore et al.,1991) also supported our observations regarding the 
attachment and tissue destruction process in which Acanthamoeba castellanii 
trophozoites were added to the medium and cultured for 12 hours in corneas 
obtained from humans, and it was demonstrated through their work that the 
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attachment of the trophozoites is followed by destruction of the epithelium mainly at 
the periphery of the cornea.  
 
The outcome of our study is consistent with the above discussed studies ‘Omaña-
Molina et al., 2004, Moore et al.,1991’ in the observations regarding the ex vivo 
progression of Acanthamoeba keratitis starting by Acanthamoeba adhesion, 
epithelial destruction and tissue invasion. The main differences between their work 
and this current study are that their observations were limited to the first 12 hours 
while our study continued for 28 days. The corneas they used were from hamster 
and human eyes while this current study used pig corneas. The authors also used 
both light and electron microscopes to evaluate the progression of infection while 
we used light microscopy only . In their studies, the adhesion of the trophozoites to 
the corneal epithelium started within hours in contrast to our study where it took 
days for the Acanthamoeba to succeed in adhesion step. This is likely due to the 
use of the rocking model in our study that mimics the blinking of the eyelid as a 
defensive mechanism against pathogens that perhaps washes Acanthamoeba 
leading to less bonding to the receptors hence less production of MIP133 which 




4.4.4 Previous Studies on Macrophages 
In this current study, we investigated the effect of adding and injecting macrophages 
and HL-60 cells (neutrophils) to the ex vivo infected corneas given the fact that this 
ex vivo model lacks these naturally existing immune cells that normally migrate from 
blood stream to the site of infection. Macrophages are the first line of defence 
against most infectious diseases where monocytes migrate from blood stream to 
the site of infection then differentiate into macrophages (Auffray et al.,2009). 
Macrophages are present in high numbers in corneas with Acanthamoeba keratitis 
highlighting its importance in controlling and resisting Acanthamoeba infection 
(Klink, et al.,1996) beside other phagocytic cells like neutrophils (Ferrante,1991) 
which are chemotactically attracted to Acanthamoeba and can kill trophozoites 
(Marciano-Cabral et al.,1998, G.L. Stewart et al.,1992).  
Our study shows no alteration or limitation to the process of infection as the added 
cells might have been phagocytosed or destroyed by the Acanthamoeba.  A 
previous study conducted on 1998 supports this observation as they cultured 
different Acanthamoeba strains (Acanthamoeba culbertsoni, Acanthamoeba 
castellanii, and Acanthamoeba polyphaga) with macrophages obtained from eight-
week-old mice and stated that the highly pathogenic Acanthamoeba strains 
(Acanthamoeba culbertsoni) resisted the amoebicidal activity of macrophages and  
destroyed them compared to less pathogenic strains (Acanthamoeba castellanii and 
Acanthamoeba polyphaga) (Marciano-Cabral et al., 1998). Considering the above, 
Acanthamoeba strains used in our study were fed on HEp-2 cells in three-step 
passage process as discussed in section 4.2.2 which ultimately boosted the 
pathogenicity of Acanthamoeba, and this potentially explains how Acanthamoeba 
might have been able to destroy the added macrophages and HL-60 cells in the 
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established ex vivo model similar to the above-mentioned study (Marciano-Cabral 
et al., 1998) that demonstrated the destruction of macrophages by highly pathogenic 
Acanthamoeba strains compared to less pathogenic ones. 
 
 
4.5 Conclusion and Future Work 
It is demonstrated through the work in this chapter that we were able to establish an 
ex vivo model for Acanthamoeba keratitis for a period of four weeks that is 
reproducible and mimics the natural human infection.  This model can be further 
used for many applications including: diagnostic approaches, treatment options and 



































Chapter 5: Application of the Porcine Ex Vivo Model: Drugs 
 
5.1 Introduction 
5.1.1 Acanthamoeba Keratitis 
Acanthamoeba is a virtually ubiquitous free-living amoeba with two stages in its life 
cycle; the active trophozoites stage and the dormant cyst stage (Kovacs et al.,2015). 
It infects healthy immunocompetent individuals causing a potentially blinding 
infection of the eye called Acanthamoeba keratitis (AK) mainly among contact lens 
wearers.  
  
5.1.2 Treatment- PHMB 
There is no licensed treatment for AK; however, the current unlicensed therapy is 
available on a named patient-based approach and consists of topical therapy of 
either polyhexamethylene biguanide (PHMB) 0.02% (v/v) or chlorhexidine 
digluconate 0.02% (v/v) alone or in combination with propamidine isethionate 
(Brolene™) 0.1% (w/v) or hexamidine diisethionate (Desomedine®) 0.1% (w/v) 
(Papa et al.,2020). PHMB (Figure 5.1) is a synthetic cationic polymer that is formed 
of repeating basic units of biguanide that are interconnected by hexamethylene 













Figure 5.1: Molecular structure of PHMB (Ansorg et al.,2003) 
 
The duration of treatment ranges between 6 months to 29 months (Lorenzo-Morales 
et al.,2015). Despite this therapy, many patients remain persistently culture positive, 
30% lose some degree of their vision, 11% require repeated corneal transplantation 





5.1.3 Treatment- Doxycycline 
Doxycycline is a drug frequently used for the treatment of ocular surface diseases, 
especially recurrent epithelial cell erosions where spontaneous breakdown of 
corneal epithelium occurs repeatedly due to many factors like minor mechanical 
trauma, diabetes mellitus, ocular rosacea and corneal dystrophies (Durson et 
al.,2001). Doxycycline acquires its therapeutic effect by its effectiveness at inhibiting 
matrix metalloproteinase (MMP) activity of corneal epithelial cells (Golub et 
al.,1995). 
Doxycycline is a broad-spectrum antibiotic well recognised for its effectiveness 
against a multitude of bacterial and parasitic infection including bacterial pneumonia, 
chlamydia, Lyme’s disease, Typhus, Syphilis and Cholera (Navarro-Triviño et 





5.1.4 Rationale  
Many researchers investigated the efficacy of commonly used drugs in treating 
Acanthamoeba keratitis by studying the effect on the viability of the parasite and the 
potential toxicity to the keratocytes. However, up to our knowledge, no previous 
studies were performed on an ex vivo model like the Acanthamoeba keratitis model 
established in this study and so in this chapter we will use the model to study the 
drug effect against Acanthamoeba. 
 
5.1.5 Aim and Objectives 
The model will be utilized to test two pharmacological agents in terms of activity 
against Acanthamoeba and toxicity against the corneal epithelial layer. The 
objectives are: 
• Study ex vivo activity of polyhexamethylene biguanide (PHMB) against 
Acanthamoeba to investigate its efficacy in controlling the progression of 
Acanthamoeba keratitis and to study the toxicity against the epithelial layer of the 
cornea. 
 
•  Study ex vivo activity of doxycycline against Acanthamoeba to investigate its efficacy 
in controlling the progression of Acanthamoeba keratitis and to study the toxicity 





PHMB (Cosmocil CQ 20% (w/v), Lonza, U.K) and doxycycline (Scientific Laboratory 
Supplies Ltd, Nottingham, U.K) were screened to evaluate their efficacy against 
Acanthamoeba castellanii and Acanthamoeba polyphaga using both amoebicidal 
and cysticidal assays and were tested also against HEp-2 cells to detect possible 
toxicity. This step took place before applying the drugs on the ex vivo model. 
 
5.2.1 Test Organism Strains and Culture  
The strains used in this study were A. castellanii (ATCC 50370) and A. 
polyphaga (ATCC 30461) (LGC Standards, Teddington, UK). Trophozoites culture 
and cysts production are described in detail in chapter 2 section 2.3, 2.6 and 2.7.  
 
5.2.2 Drug Sensitivity Testing 
 5.2.2.1 Amoebicidal Assay 
To test potential antimicrobial activity of the test compounds, the plate was prepared 
by adding 200 μl of 1000μg/mL solution of test compound to column 1 row A-H of 
the 96 well microtiter plate, and the other wells were filled with 100μl of ¼ strength 
Ringer’s solution, then serial 2-fold dilution was done through the plate from column 
1-11 to achieve final drug concentrations in the range 500 to 0.49 μg/mL. Column 











Figure 5.2: The layout of the microtiter plate for the sensitivity testing.  
  
Trophozoites were suspended in their growth medium (Ac#6) and cysts were 
suspended in ¼ strength Ringer’s then added to the wells to give a final 
concentration of 1× 104 cells/mL to achieve the requisite concentration.  
The wells were checked after 24 hours for contamination. At 48 hours, the wells 
were checked again under inverted microscope at x 10 objective and x 20 objective 
to compare the test wells to the control to determine the:  
• Minimum trophozoite inhibitory concentration (MTIC) that means 50% inhibition of 
Acanthamoeba trophozoites. 
• Minimum Trophozoite Amoebicidal Concentration (MTAC) which means all 




5.2.2.2 Cysticidal Assay 
For the cyst assay, the plate was kept for 48 hours in the incubator at 32◦C. Following 
that, the liquid was expelled from the 96 wells plate by inverting them sharply leaving 
the cysts attached to the bottom of the wells.  ¼ strength Ringer’s was filled in the 
wells and left for 15 minutes to allow the cysts to reattach and then the liquid was 
removed as before. This process was repeated 3 times to fully remove the drug. E. 
coli was added to each well and the plates were incubated at 32°C and checked 
daily for up to 7 days to see if the alive cyst excysted and the trophozoites replicated, 
and to determine the minimum cysticidal concentration (MCC) which means the 
lowest concentration of test solution that results in no excystation and no 
trophozoites replication. 
 
5.2.3 Toxicology Assay  
This method is used to determine the toxic effect of compounds to human cells. 96 
microtiter plate was seeded with 2×104 cells/mL of the HEp-2 (HeLa derivative) 
human cervix carcinoma cell line (ECACC number 86030501) obtained from the 
European Collection of Cell Cultures (Centre for Applied Microbiology and 
Research, Salisbury, UK). Cells were incubated at 37°C, 5% CO2 for 48 hours to 
allow the cells to achieve 80-90% confluence. After that, the test compound was 
diluted to two-fold serial dilution across the plate achieving a range of concentration 
in the range 500-0.49 µg/mL. 
To determine the toxic effects of the test compounds, a colorimetric method called 
CellTiter 96 AQuous One Solution Cell Proliferation Assay (Promega, 




tetrazolium salt] with PES (Phenazine ethosulfate) which is an electron coupling 
agent. In active cells, the MTS is reduced by NADPH (Nicotinamide adenine 
dinucleotide phosphate hydrogen) producing a coloured formazan product. 5 μl of 
cell titter 96 assay was added to each well in the plate and then incubated for 1-2 
hours at 37°C, 5% (v/v) CO2. The amount of the coloured product was then 
measured in a multiplate reader at 595 nm. 
As a confirmation step to support the CellTiter 96 assay, the toxicity was also 
checked visually using a light microscope (x10 eye piece, x20 objective) to 
determine: 
• Minimum Inhibitory Concentration (MIC) at which inhibition of cell division and 
localised detachment of the cells occurred compared to the control well. 
• Minimum Cytotoxic Concentration (MCT) at which all Hela cells were rounded and 
lysed with general detachment. 
 
5.2.4 Applying the Drugs on The Ex Vivo Model 
PHMB was used in the same concentration used in clinical practice (0.02% v/v), and 
doxycycline was used as recommended in the literature (0.1% w/v).  Acanthamoeba 
trophozoites and cysts were added to the corneas as described in chapter 4 section 
4.2.5 and were left for four days to initiate the infection process. Following this step, 
5µL of each drug were added to the respective corneas directly to the surface using 
a pipette to mimic the application of eye drops to the eyes of patients with 










    Figure 5.3: Adding the drug to the corneal surface. 
 
The process was repeated daily, and every 3-4 days a histological section was taken 
looking for any changes under the light microscope. Histological changes were 
compared to the control corneas that were divided into two control groups: healthy 
corneas with no induced infection or added drugs and healthy corneas with added 






5.3.1 Drug Assays 
PHMB and doxycycline were used to evaluate their efficacy against Acanthamoeba 
castellanii and Acanthamoeba polyphaga using both amoebicidal and cysticidal 
assays. The toxicity of these drugs against HEp-2 cells was also evaluated.  The 
results are shown in the table below. 
 
 A. castellanii (50370) A. polyphaga (30461) HEp-2  
Drug MTIC ⃰ MTAC ⃰ ⃰ ⃰ MCC  ⃰ ⃰ ⃰ ⃰ MTIC ⃰ MTAC ⃰ ⃰ ⃰ MCC  ⃰ ⃰ ⃰ ⃰ MCT 
PHMB 1 3.9 15.6 1 7.8 7.8 31.3 
Doxycycline 625 1250 2500 625 1250 2500 625 
 ⃰ Minimum trophozoite inhibitory concentration, ⃰  ⃰Minimum trophozoite amoebicidal 
concentration, ⃰ ⃰  ⃰ Minimum cysticidal concentration, MCT Minimum cytotoxic 
concentration.            
 
Table 5.1: Activities of tested drugs against the trophozoites and cysts of A. 






Regarding PHMB, the trophozoite assay showed that the MTIC is 1μg/mL for both 
species and the MTAC activity is 3.9 μg/mL for A. castellanii and 7.8 for A. 
polyphaga, while the MCC activity is 15.6 for A. castellanii and 7.8 μg/mL for A. 
polyphaga, with HEp-2 toxicity assay of 31.3 μg/mL. 
Doxycycline does not exert any major antimicrobial effect on the viability 
of Acanthamoeba in comparison with PHMB as it achieved a MTIC of 625 μg/mL 
and MTAC of 1250 μg/mL, respectively. Doxycycline showed very low toxicity 
against human cells in the 625μg/mL range. 
 
5.3.2 Histological Sections - PHMB 
5.3.2.1 Day 3, Control 
The control for healthy cornea (Figure 5.4a) was examined under the light 
microscope. It showed normal epithelial lining of healthy five to six non-keratinized, 
stratified squamous epithelium and normal stroma which contained regularly spaced 
collagen oriented in a uniform parallel direction to maintain transparency. 
 
The control for infected cornea at day 3 (Figure 5.4b) was examined under the light 
microscope and there was an attachment of the Acanthamoeba trophozoites to the 
superficial layer of the corneal epithelium. The stroma was normal and formed of 













Figure 5.4: Histology sections, control versus infected cornea, day 3.  a. Normal 
cornea with five to six layers squamous epithelium (E) with underlying normal 
stroma (S) with regular parallel collagen fibres. b. Establishment of infection 
demonstrated by the attachment of Acanthamoeba trophozoites (A) to the 





5.3.2.2 Day 7 – Control and Test Corneas 
The healthy cornea with added PHMB was examined under the light microscope 
and it showed normal epithelial lining of healthy five to six non-keratinized, stratified 
squamous epithelium and normal stroma with parallel layers of collagen fibres 
(Figure 5.5b).  
In the infected cornea with no added PHMB (Figure 5.5c), the Acanthamoeba 
trophozoites were seen attached to the corneal epithelium to start the invasion 
process, however the stroma was normal. In the Infected cornea with added PHMB 
(Figure 5.5 c), light microscopy examination showed dead trophozoites at the stage 
of attachment to the superficial layers of the epithelium. The cells were reported as 
dead because of the loss of the integrity of its plasma membrane and some of these 
cells showing complete fragmentation into discrete bodies (apoptotic bodies). The 




























Figure 5.5: Histology sections, healthy versus infected cornea, day 7, added PHMB. 
a. Control cornea with healthy five to six non-keratinized, stratified squamous 
epithelium(E) and normal stroma (S) with parallel layers of collagen fibres. b. 
Healthy cornea with added PHMB showing five to six non-keratinized, stratified 
squamous epithelium (E) and normal stroma (S) with parallel layers of collagen 
fibres. c.  Acanthamoeba trophozoites were attached to the corneal epithelium 
starting the invasion process. d. Infected cornea with added PHMB showing dead 
trophozoites (D) at the stage of attachment to the superficial epithelial layers. e. 
Higher magnification of image d. 
 
5.3.2.3 Day 10 – Control and Test Corneas 
The healthy cornea (with added PHMB) was examined under the light microscope. 
It showed loss of the superficial layers of epithelium as the number of epithelial 
layers is around 3-4 layers in this cornea contrast to the normal cornea with healthy 
five to six non-keratinized, stratified squamous epithelium, however the stromal 
layers are normal with parallel layers of collagen fibres (Figure 5.6b). 
Examination of the infected cornea with no added PHMB shows Acanthamoeba 
trophozoites invading the epithelium with loss of the superficial layers of the 
epithelium, however there was normal appearance of the stroma (Figure 5.6c). 
The infected cornea with added PHMB showed dead trophozoites and shedding of 















   
 
 
Figure 5.6: Histology sections, healthy versus infected cornea, day 10, added 
PHMB. a. Control cornea with healthy five to six non-keratinized, stratified 
squamous epithelium(E) and normal stroma (S) with parallel layers of collagen 
fibres. b. Cornea with added PHMB: loss of the superficial layers of epithelium as 
the number of epithelial layers is around 3-4 layers in this cornea and normal 
stromal. c. Infected cornea with no added PHMB showed Acanthamoeba 
trophozoites invading the epithelium with loss of the superficial layers of the 
epithelium. d. Infected cornea with added PHMB day 10: dead trophozoites (D) with 






5.3.2.4 Day 14- Control and Test Corneas 
The healthy cornea with added PHMB was examined under the light microscope. It 
showed further loss of the epithelial layers which was around 2-3 layers with parallel 
layers of collagen fibres within the normal stroma (Figure 5.7b). 
The infected cornea with no added PHMB showed Acanthamoeba trophozoites 
invading the epithelium with loss of many layers of the epithelium; however, the 
stroma was still normal (Figure 5.7c). 
Examination of the infected cornea with added PHMB demonstrated fragmented 
cells with apoptotic bodies and shadows of dead cells where only the outline of the 
















Figure 5.7: Histology sections, healthy versus infected cornea, day 14, added 
PHMB.   a. Control cornea with healthy five to six non-keratinized, stratified 
squamous epithelium (E) and normal stroma (S). b. Cornea with added PHMB: 
further loss of epithelial lining as the number of epithelial layers is around 2-3 layers 
in this cornea with normal stroma. c. Infected cornea with no added PHMB showing 
Acanthamoeba trophozoites (A) invading the epithelium (E) with loss of many layers 
of the epithelium. d. Infected cornea with added PHMB day 14: fragmented cells 







5.3.3 Histological Sections - Doxycycline 
5.3.3.1 Day 3, Controls 
The control cornea was examined under the light microscope, and -as stated earlier- 
it showed normal epithelial lining of healthy five to six non-keratinized, stratified 
squamous epithelium and normal stroma which contained regularly spaced collagen 
fibres oriented in a uniform parallel direction (Figure 5.8a). 
The control for infected cornea was examined under the light microscope and there 
was an attachment of the Acanthamoeba trophozoites to the superficial layer of the 









Figure 5.8: Histology sections, control versus infected cornea, day 3. a. Normal 
cornea with healthy five to six non-keratinized, stratified squamous epithelium (E) 
and normal stroma (S) with parallel layers of collagen fibres. b. Attachment of the 




5.3.3.2 Day 7, Control and Test Corneas 
The healthy Cornea with added doxycycline was examined under the light 
microscope. It showed normal epithelial lining with healthy five to six non-
keratinized, stratified squamous epithelium and normal stroma with parallel layers 
of collagen fibres (Figure 5.9b). 
Examination of the infected cornea with no added doxycycline showed 
Acanthamoeba trophozoites attached to the corneal epithelium to start the invasion 
process and the stroma was normal (Figure 5.9c). The Infected cornea with added 
doxycycline was examined under the light microscope. The Acanthamoeba 
trophozoites were viable and attached to the corneal epithelium to start the invasion 


































Figure 5.9: Histology sections, healthy versus infected cornea, day 7, added 
doxycycline.  a. Control cornea with healthy five to six non-keratinized, stratified 
squamous epithelium (E) and normal stroma (S). b. Cornea with added doxycycline: 
normal cornea with healthy five to six non-keratinized, stratified squamous 
epithelium (E) and normal stroma (S). c. Infected cornea with no added doxycycline: 
attachment of Acanthamoeba trophozoites (A) to the epithelium. d. Infected cornea 
with added doxycycline: Viable Acanthamoeba trophozoites (A) invading the 




5.3.3.3 Day 10, Control and Test Corneas 
The healthy cornea with added doxycycline- was examined under the light 
microscope. It showed normal epithelial lining with healthy five to six non-
keratinized, stratified squamous epithelium and normal stroma with parallel layers 
of collagen fibres (Figure 5.10b). 
Examination of the Infected cornea with no added doxycycline- showed 
Acanthamoeba trophozoites invading the epithelium with loss of the superficial 
layers of the epithelium and the stroma was normal (Figure 5.10c).The Infected 
cornea with added doxycycline was examined under the light microscope. It showed 
viable Acanthamoeba trophozoites invading the epithelium with loss of the 



















Figure 5.10: Histology sections, healthy versus infected cornea, day 10, added 
doxycycline. a. Control cornea with healthy five to six non-keratinized, stratified 
squamous epithelium (E) and normal stroma (S) with parallel layers of collagen 
fibres. b. Cornea with added doxycycline: normal cornea with healthy five to six non-
keratinized, stratified squamous epithelium (E) and normal stroma (S). c. Infected 
cornea with no added doxycycline: attachment of Acanthamoeba trophozoites (A) 
to the epithelium with loss of the superficial layers of the epithelium. d. Infected 
cornea with added doxycycline: Viable Acanthamoeba trophozoites (A) invading the 






5.3.3.4 Day 14, Control and Test Corneas 
The healthy cornea with added doxycycline was examined under the light 
microscope. It showed normal epithelial lining with healthy five to six non-
keratinized, stratified squamous epithelium and normal stroma with parallel layers 
of collagen fibres (Figure 5.11b) 
Examination of the infected cornea with no added doxycycline showed 
Acanthamoeba trophozoites invading the epithelium with loss of many layers of the 
epithelium and the stroma was normal (Figure 5.11c). 
The Infected cornea with added doxycycline was examined under the light 
microscope. It showed viable Acanthamoeba trophozoites invading the epithelium 




















Figure 5.11: Histology sections, healthy versus infected cornea, day 14, added 
doxycycline.  a. Control cornea with healthy five to six non-keratinized, stratified 
squamous epithelium (E) and normal stroma (S) with parallel layers of collagen 
fibres. b. Cornea with added doxycycline: normal cornea with healthy five to six non-
keratinized, stratified squamous epithelium (E) and normal stroma (S). c. Infected 
cornea with no added doxycycline shows Acanthamoeba trophozoites (A) invading 
the epithelium with loss of many layers of the epithelium. d. Infected cornea with 
added doxycycline: viable Acanthamoeba trophozoites (A) invading the epithelium 





5.3.3.5 Day 18, Control and Test Corneas  
The healthy cornea with added doxycycline was examined under the light 
microscope. It showed loss of the superficial layers of epithelium as the number of 
epithelial layers was around 3-4 layers in this cornea and the stroma was normal 
(Figure 5.12 b). 
Examination of the infected cornea with no added doxycycline showed 
Acanthamoeba trophozoites invading the whole epithelium and part of the stroma 
with loss of most epithelial layers (Figure5.12c). The infected cornea with added 
doxycycline was examined under the light microscope. It showed viable 
Acanthamoeba trophozoites invading the whole epithelium and part of the stroma 




























Figure 5.12: Histology sections, healthy versus infected cornea, day 18, added 
doxycycline.  a. Control cornea with healthy five to six non-keratinized, stratified 
squamous epithelium (E) and normal stroma (S) with parallel layers of collagen 
fibres. b. Cornea with added doxycycline: loss of the superficial layers of epithelium 
as the number of epithelial layers is around 3-4 layers in this cornea, normal stroma. 
c. Infected cornea with no added doxycycline shows Acanthamoeba trophozoites 
(A) invading the whole epithelium and part of the stroma with loss of most epithelial 
layers. d. Viable Acanthamoeba trophozoites (A) invading the whole epithelium and 









5.3.3.6 Day 22, Control and Test Corneas 
The healthy cornea with added doxycycline is examined under the light microscope. 
It showed further loss of the epithelial lining as the number of epithelial layers was 
around 2-3 layers and the stroma was normal (Figure 5.13b). 
Examination of the infected cornea -with no added doxycycline- showed 
Acanthamoeba trophozoites invading the stroma and there was total loss of the 
epithelium (Figure 5.13c). The infected cornea with added doxycycline was 
examined under the light microscope. It showed a viable Acanthamoeba invading 


















Figure 5.13: Histology sections, healthy versus infected cornea, day 22, added 
doxycycline.  a. control cornea with healthy five to six non-keratinized, stratified 
squamous epithelium (E) and normal stroma (S) with parallel layers of collagen 
fibres. b. Cornea with added doxycycline: further loss of the epithelial lining as the 
number of epithelial layers was around 2-3 layers in this cornea, normal stroma. c. 
Infected cornea with no added doxycycline shows Acanthamoeba trophozoites (A) 
invading the stroma. There was total loss of the epithelium. d. Infected cornea with 
added doxycycline: viable Acanthamoeba trophozoites (A) invading the stroma with 








5.4 Discussion  
Drug assays were used to investigate the efficacy of PHMB and doxycycline 
against Acanthamoeba trophozoites and cysts and their toxicity against human 
cells. The established ex vivo model was also used to test the therapeutic effect of 
both PHMB and doxycycline against Acanthamoeba keratitis in addition to studying 
any potential toxicity against the corneal epithelium.  
 
5.4.1 PHMB- Assay Results 
The results showed that the inhibitory activity is 1 μg/mL for both A. castellanii and 
A. polyphaga, and the amoebicidal activity was 3.9 μg/mL for A. castellanii and 7.8 
μg/mL for A. polyphaga, and the HEp-2 toxicity assay was 31.3 μg/mL. 
The results of PHMB amoebicidal activity were consistent with previously published 
studies (Kilvington et al.,2002, Heaselgrave et al.,2019) in which they used the same 
amoebicidal assays we used in this study and the same concentration of PHMB 
(0.02% v/v). They reported the MCC mean for different clinical isolates of 
Acanthamoeba to be 3.2 μg/mL in one study (Kilvington et al.,2002), and 15.6 for A. 
castellanii and 7.8 μg/mL for A. polyphaga in the other study (Heaselgrave et 
al.,2019). 
 
5.4.2 PHMB- Light Microscope Results 
The effect of drugs was also investigated using the light microscope to study the 
histology sections of the corneas. On day 7 of adding PHMB to the infected cornea, 
most of the Acanthamoeba trophozoites that were at the stage of attachment with 
the superficial layers of the epithelium were dead. On day 10, further dead 
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trophozoites were noticed and the shedding of the epithelial layers was more 
obvious. On day 14, fragmented dead cells and apoptotic bodies were seen as dead 
cells showed loss of the integrity of the plasma membrane whereas apoptotic cells 
demonstrated complete fragmentation into discrete bodies. These findings were 
compared against healthy corneas with added PHMB. The superficial epithelial 
layers in the corneas without infection started to shed on day 10 with further loss on 
day 14.  
The histological findings were consistent with the drug assay results and confirmed 
the ability of PHMB to inactivate the trophozoites however there was a mild toxic 
effect against corneal epithelial cells, and despite the MCT assay results 
demonstrating PHMB toxicity to human monolayer cells, the actual effect on the 
model was of less amplitude as the model was based on a whole cornea with its 
distinctive layers compared to a monolayer in the MCT assay and also due to the 
extra protection offered by the rocking mechanism. The toxic effect noticed in the ex 
vivo model is of less degree in the human eye which has multiple protective 
mechanisms compared to the ex vivo model. The eye globe is enclosed in the orbit 
socket which is part of the skull bones forming a four-sided pyramid , and the corneal 
surface is protected by the eyelid (Davson and Perkins,2020) all of which further 








5.4.3 PHMB- Previous Studies 
 
Rabbit Eye Model 
The observed limited toxicity of PHMB against corneal epithelial cells in the ex vivo 
model developed in this current study is supported by the outcome of a recent study 
where the authors evaluated the toxic effect of PHMB on the cornea by injecting the 
drug to the corneal stroma of white rabbits. They injected the cornea with (0.01% or 
0.02% v/v) PHMB, then on day 7 post injection the rabbits were euthanized, and the 
corneas were harvested for evaluation. They noticed that the injection of 0.02% 
PHMB led to erosion in the corneal epithelial layer, oedema and neovascularization, 
while 0.01% PHMB did not lead to any obvious corneal toxicity (Lim, 2020).  
There are differences between their study and this current study; they injected the 
drug to the corneas of rabbits in vivo, while in this study we added the drug topically 
to the surface of ex vivo porcine corneas similar to the way patients administer the 
drug to the eye.  
Another difference is that Lim’s study evaluated the toxic effect of PHMB on day 7, 
while this study followed the toxicity from day 4 till day 14 and so we were able to 
run the experiment longer with still limited toxicity shown. Furthermore, they noticed 
mild corneal damage in terms of epithelial erosion, corneal oedema and 
neovascularization while in this study the main observed toxicity was epithelial loss 
given the fact that this study was done in ex vivo conditions that lack the other 
contributors of the body immune system like the attraction of immune and 
inflammatory cells at the site of infection leading to inflammation, angiogenesis and 
further tissue destruction (Chaplin,2010). Both studies are similar in using the 0.02% 
concentration of PHMB and both show mild toxic effect of PHMB on the epithelial 
layers over 7-14 days.  
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PHMB Penetration of Corneal Epithelium Study 
Another study from 2015 was conducted on antiseptic compounds commonly used 
in treating Acanthamoeba keratitis including PHMB to investigate the ability to 
penetrate the corneal epithelium and any effect on the epithelium, and the outcome 
supported our observation in showing the mild toxic effect of PHMB on the corneal 
epithelium (Vontobel et al.,2015). The corneas were harvested from albino rabbits 
and were mounted in artificial anterior chamber. The study showed that PHMB is 
unable to reach the anterior chamber through penetration of the cornea, which may 
explain why treatment of Acanthamoeba keratitis requires several months of 
continuous topical drug treatment.  A small degree of damage to the corneal 
epithelium was also reported. 
The differences between their study and this study includes their use of rabbit 
corneas while in this study porcine corneas were used; the aim of their study was 
focused on the penetration ability of the drug while we aimed to follow the 
therapeutic effect of PHMB and its toxic effects on the corneal cells. They added the 
drug as drops on the surface of the cornea every 30 minutes up to 8 hours while in 
this study we added the drug to the corneal surface once a day for 14 days. The 
therapeutic application of PHMB requires the administration of one application every 
hour day and night for 72 hours then hourly daytime for 48 hours followed by a 6-
month period of administering the drug 6 times daily. In this current study, this is 
unapplicable as PHMB would accumulate in the medium whereas patients’ eyes 
frequently wash out the excess through eye blinking. There are some similarities 
between both studies as both were run in ex vivo environment, both administered 
the drugs as drops on the surface of the cornea and both demonstrated a toxic effect 
of the drug to the epithelial layers. 
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PHMB and Chlorhexidine Study 
Another research supporting our results was conducted to evaluate the effect of 
PHMB and chlorohexidine on Acanthamoeba cysts viability and its toxic effect on 
cultured human corneal cells (Lee et al.,2007). They used PHMB (0.02% v/v) which 
is similar to our study and chlorhexidine (0.02% v/v) and followed the same cysticidal 
assay to determine the MCC. They also administered PHMB (0.02% v/v) and 
chlorohexidine (0.02% v/v) to the cultured corneal cells to observe the survival rate. 
They noticed a strong and similar cysticidal effect for both drugs, however PHMB 
was more toxic to corneal cells compared to chlorohexidine and the level of cell 
death increased with increasing disinfectant concentration and exposure time.  
There are some differences between both studies as they used cultured human 
keratocytes and we used the ex vivo model and although both studies demonstrated 
the PHMB toxicity to cell monolayers, the ex vivo model suffered less damage due 
to the extra protective mechanisms the model possesses. Furthermore, they used 
inverted light microscope and electron microscope to evaluate the morphological 
changes while we used the inverted light microscope only, and they used 
Acanthamoeba castellanii and A. lugdunesis, while we used A. castellanii and A. 
polyphaga. 
 
The outcome of both studies is similar as they reported that the cysticidal activity 
against Acanthamoeba castellanii was 13.21 μg/mL and it was (15.6 μg/mL) in this 
current study. Moreover, both studies demonstrated a toxic effect of PHMB on 
corneal cells.  
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5.4.4 Doxycycline- Assay and Histology Results 
Amoebicidal and cysticidal assays did not show any major antimicrobial effect of 
doxycycline on the viability of Acanthamoeba in comparison with PHMB as it 
achieved a MTIC of 625 μg/mL and MTAC of 1250 μg/mL, respectively. Doxycycline 
showed very low toxicity against human cells in the 625ug/mL range. Under 
histology examination, doxycycline showed no effect on the viability of trophozoites 
as the invasion and spread of Acanthamoeba infection progressed until the total 
loss of corneal epithelium and invasion of stroma. When doxycycline was applied to 
healthy corneas, the toxic effect of the drug against the epithelial layers started at 
day 18 with shedding of the superficial layers of the epithelium and further loss at 
day 22 compared to the control. 
 
5.4.5 Doxycycline- Previous Studies 
A study in 2017 investigated the effect of the coinfection of Acanthamoeba bacterial 
endosymbiont on human corneal cells, and any role of doxycycline and 
azythromycin in treating Acanthamoeba keratitis (Purssell et al.,2017) and the 
outcome of their study supports our observations that doxycycline has no effect on 
the corneal tissue as Acanthamoeba remained viable after administration of the 
drug, however they reported that doxycycline can decrease the virulence effect of 
the bacterial endosymbionts which means that it can be potentially used as an 
adjuvant therapy for Acanthamoeba keratitis beside the standard treatment.  
They infected EpiCorneal cells (a three-dimensional human corneal tissue model) 
with Acanthamoeba-endosymbiont then treated this model with a medium 
containing 4 µg/mL azithromycin and 2 µg/mL doxycycline. The conclusion was that 
both drugs can effectively target the bacterial endosymbionts hence why it can be 
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used as a supportive therapy for Acanthamoeba keratitis. They also noticed that 
neither doxycycline nor azithromycin exert any toxic effect on the EpiCorneal tissue 
and that Acanthamoeba remained viable after the administration of antibiotics. The 
differences between their study and this study are their use of the EpiCorneal cells 
while we used the ex vivo model, they aimed to study the effect of the antibiotic in 
treating Acanthamoeba keratitis by inhibiting the endosymbiont effect while in this 
current study we applied doxycycline on the ex vivo model to study any therapeutic 
effect of the antibiotic on Acanthamoeba keratitis and any toxic effect on corneal 
cells. They noticed no toxic effect on the EpiCorneal cells while in this current study 
slight changes to the epithelial layers were observed on day 18.  In a similar study, 
the researchers also noticed that Acanthamoeba remained viable for at least 7 days 










5.5 Conclusion and Future Work 
The histological findings are consistent with the drug assay results and confirm the 
ability of PHMB to inactivate Acanthamoeba trophozoites with a mild toxic effect of 
the drug on ex vivo corneal epithelial cells despite high level of in vitro toxicity to 
human cells. 
Regarding doxycycline, no major antimicrobial effect was demonstrated on the 
viability of Acanthamoeba by histological findings and drug assays. A minimal toxic 
effect of doxycycline was demonstrated against ex vivo corneal epithelial cells and 
in vitro human cells. 
The above results show that the ex vivo model can be used to investigate drugs 
against Acanthamoeba in terms of the ability of the drug of interest to stop the 
keratitis and any potential toxicity it might exert on corneal cells.  The model can be 
used in the future to study further drugs with various concentrations in terms of 


















Correlation of Ex Vivo and In Vivo 
















Acanthamoeba species are opportunistic human pathogens that cause 
Acanthamoeba keratitis (Carnt et al.,2016) with its early stages resembling other 
forms of infective keratitis making it difficult to initially identify Acanthamoeba as the 
pathogen behind the infection causing delay in diagnosis and management with 
poor visual outcome (Robaei et al., 2016, Carnt et al.,2018).   
 
In the United Kingdom, there is no commercially available method for the diagnosis 
of AK and the diagnosis is based on individual protocols developed locally by 
different hospitals and clinics (Alexander et al.,2015). The diagnosis is often delayed 
because there is currently no rapid diagnostic test available and the most widely 
used laboratory technique to help in the diagnosis of AK is the culture method. 
Corneal samples are commonly obtained by scraping the corneal surface under 
local anaesthesia then inoculating the sample on 2.5% (w/v) non-nutrient agar 
overlaid with a lawn of Escherichia coli, and this corneal culture method requires up 
to 10 days to demonstrate results and has very low sensitivity ranging from 0 to 50% 
which means that many negative cultures are in fact for patients who have the 
infection (Alexander et al.,2015). Polymerase chain reaction (PCR) is another 
method for the detection of DNA of Acanthamoeba in corneal scrapping and tears 
(Mathers et al.,2000). In comparison to corneal culture, it is faster (Pasricha et 
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al.,2003), gives results within hours with sensitivity reported as 66.7% to 75% (Goh 
et al.,2018). 
 
In vivo confocal microscopy (IVCM) is a non-invasive technique used to diagnose 
AK through in vivo examination of corneal cells and can differentiate between 
Acanthamoeba and other pathogens by identifying the unique morphological 
features between pathogens (Matsumoto et al.,2007). Previous studies correlated 
IVCM findings with ex vivo imaging of the organism grown on cultured plates 
obtained from corneal scrape or contact lens solution of same patients (Matsumoto 
et al.2007, Kobayashi 2008, Shiraishi et al.,2010) or from directly examining a 
suspension of cultured Acanthamoeba trophozoites (Yamazaki et al.,2012). IVCM 
has a sensitivity as high as 90.6% to 92.9% and a specificity of 77.3% to 100% (Goh 
et al.,2018) but is largely operator dependant based on their experience. The high 
sensitivity of IVCM helps in detecting Acanthamoeba cysts in deep corneal infiltrates 
that are usually difficult to yield by scraping, and the diagnostic sensitivity varies 
between different methods of diagnosis. In one study, the sensitivity of culture was 
reported as 33.3%, while the sensitivity for PCR and IVCM were reported as 74.1% 




6.2 Aim and Objectives 
This chapter will focus on studying the different morphological appearances of 
Acanthamoeba trophozoites and cysts using confocal microscopy by performing the 
following: 
• Preparation of various forms of Acanthamoeba: live trophozoites, live, dead 
and empty cysts.  
• Inoculation of the model with the different forms of Acanthamoeba.  
After achieving the above, confocal microscope will be used to study the different 
models and correlate the findings of ex vivo confocal microscopy (EVCM) with 
imaging findings from culture positive AK cases on IVCM to investigate any potential 
similarities that can be used to facilitate the interpretation of in vivo findings in light 





6.3.1 Acanthamoeba Strains and Culture 
The strains used in this study were A. castellanii (ATCC 50370). Trophozoites were 
maintained in tissue culture flasks using a semi defined axenic medium (Ac#6) as 
previously described in chapter 2 section 2.3. Cysts were produced using Neff's 
encystment medium (NEM) method described in chapter 2 section 2.6. 
 
6.3.2 Preparation of Dead Acanthamoeba Cysts 
Dead Acanthamoeba cysts were prepared by exposure to 0.02% (v/v) 
polyhexamethylene biguanide (PHMB) for one hour. After incubation, the cells were 
examined by phase contrast microscopy (x100) to confirm the activity of PHMB. 
Cysts and trophozoites were again inoculated into growth media and confirmed to 
be inactivated and non-viable, the cells were then pelleted by centrifugation at 500 
x g for 5 minutes. Dead organisms are defined as follow: 
• Dead trophozoites : smaller and rounded in comparison to live trophozoites 
with reduced cytoplasm due to damage to the plasma membrane. 
• Dead cysts : darker and less refractile compared to live cysts due to 
shrinkage of the plasma membrane of the encysted trophozoite from the 




6.3.3 Preparation of Acanthamoeba Empty Cysts 
Cysts were inoculated into Ac#6 medium for 4 hours to permit maximal excystation 
(>90%) then the resultant trophozoites were exposed to N-lauryl-sarcosine 0.5% 
(w/v) to lyse them. The remaining cyst walls were unaffected by N-lauryl-sarcosine 
and were pelleted by centrifugation at 1000 x g for 5 minutes. Using phase contrast 
microscopy, cysts were examined to confirm >90% empty cyst compared to mature 
un-excysted cysts and cells were then pelleted by centrifugation at 1000 x g for 5 
minutes. Cysts are identified as empty once trophozoites emerge out of them 
through the ostioles. 
 
6.3.4 Preparation of Eye Globes 
Porcine eye globes were collected from freshly slaughtered pigs from a local 
slaughterhouse and excess tissues were removed in Class 2 safety cabinet. The 
globes were processed (previously described in chapter 2, section 2.14) by visually 
inspecting corneas for defects such as pigmentation or gross epithelial defects, and 
corneas with such defects were discarded. Eye globes were sterilized in Povidone-
iodine (PVP-I) 0.5% (w/v) for 2 minutes and then transferred to sodium thiosulphate 
0.1% (w/v) for 1 minute to neutralise the PVP-I followed by transfer to 0.1% (w/v) 
gentamicin-phosphate-buffered saline (PBS) solution for 15 minutes to remove any 
residual bacterial contamination. The globes were finally transferred to sterile 
Dulbecco’s Phosphate Buffered Saline (DPBS) solution and were kept at room 




6.3.5 Inoculation of Acanthamoeba 
 
Infection was induced by inoculating a small volume of Acanthamoeba at a 
concentration of 1 X 105 cells / mL using a sterile 26-gauge needle. The needle was 
inserted tangentially into the middle layers of the cornea without applying pressure 
to the syringe to avoid the formation of pockets of liquid within the stroma. The 
needle was then withdrawn slowly, and samples were inoculated into the needle 
path by capillary action. The following forms of Acanthamoeba were injected into 
different eye globes: live trophozoites, dead, live and empty cysts. 
 
6.3.6 Ex vivo Confocal Microscopy (EVCM) 
EVCM studies were conducted using the Heidelberg Retina Tomograph II with the 
Rostock Corneal Module (HRT II/RCM, Heidelberg Engineering, Dossenheim, 
Germany). A sterile TomoCap (Heidelberg Engineering) was mounted over the lens 
objective of the microscope and a coupling agent ‘GelTears’ (0.2% w/w carbomer 
980, Bausch & Lomb, UK) was used between the disposable cap and the lens 
objective. One drop of 1% Carmellose sodium (Celluvisc 1% w/v, Allergan, UK) was 
added on the corneal surface previously inoculated with Acanthamoeba and the 














Figure 6.1: Eye globe held in place using a three-pronged clamp attached to a retort 




The microscope was then brought into close contact to the area of the cornea where 
the Acanthamoeba were inoculated and then a series of 40 images were acquired 
using multiple volumes over 80µm depth starting from the superficial epithelium 
down to the deep stroma. A total of 10 to 15 volumes scans were recorded for each 
porcine eye. Each en face image has a resolution of 384 x 384 pixels covering an 





6.3.7 EVCM and IVCM Image Comparison  
In this study, Acanthamoeba morphologies which were already identified using 
EVCM were used to validate the various cyst and trophozoite-like features seen on 
IVCM. All available EVCM images were reviewed by experienced observer 
(Moorfields Eye Hospital NHS Foundation Trust). In total, this equated to 
approximately 500 images reviewed for each porcine cornea in an anteroposterior 
approach from the epithelium down to deep stroma. EVCM images from each 
Acanthamoeba form were assessed qualitatively and the observed structures were 
classified according to previous publications on Acanthamoeba morphological 
structures seen on IVCM as per table 6.1 below: 
 
Acanthamoeba Morphology Size 
Round/ovoid hyper-reflective objects without double wall 10-25 µm 
Round/ovoid hyper-reflective objects with double wall 10-25 µm 
Target sign - round/ovoid hyper-reflective central object with surrounding 
halo 
10-25 µm 
Signet ring - round hyper-reflective outer ring with a grey/dark centre 10-25 µm 
Trophozoite-like hyper-reflective objects with spindle shape projection from 
its surface suggestive of acanthopodia 
25-40 µm 
 
Table 6.1: Acanthamoeba morphological structures on IVCM (Kobayashi et 





A single most optimal image corresponding to each Acanthamoeba form was used 
as a reference for validating structures observed on IVCM images. IVCM images 
were taken from an image database of a cohort of Acanthamoeba cultured positive 
cases already categorised into one of the above Acanthamoeba morphological 
features and published in a previous study (Chopra et al.,2020). From this database 
of images, the best images matching EVCM images were identified and compared.  
In addition, phase contrast images of different forms of Acanthamoeba were 
produced and compared to both EVCM and IVCM images.   
 
6.3.8 Phase Contrast Images 
Phase contrast images were generated from the same cell suspensions prepared 
earlier for the inoculation of corneal tissue. Samples of each morphology were 
placed onto microscope slides and were mounted with a glass coverslip. The cells 
were viewed at a magnification of x400 using a Zeiss Primovert inverted microscope 
(Zeiss, Cambridge, UK) and the images were captured on a Canon EOS M50 digital 











In this study, different forms of Acanthamoeba (live trophozoites, live, dead and 
empty cysts,) were injected in different eyes and evaluated using EVCM and the 
images were correlated with imaging of various cyst and trophozoite-like features 
from culture positive Acanthamoeba keratitis cases on IVCM. Phase contrast 
images of each form were also produced and compared with EVCM and IVCM 
images. Control corneas were examined using the same imaging modalities. 
 
6.4.1 Control Cornea 
The cornea of the control porcine eye was evaluated using the HRTII/RCM 
demonstrated intact corneal epithelium (Figure 6.2a) with part of the stroma 
containing a corneal nerve within its layers (Figure 6.2b). After introducing a 
tangential incision to the epithelium and stroma, another image was taken (Figure 
6.2c) demonstrating the incision at the microscopic level with increased refractility 





























Figure 6.2: EVCM images of control cornea. a. Ex vivo image of control cornea with 
intact corneal epithelium b. Ex vivo image demonstrating corneal nerve within the 
stroma. c. Ex vivo image following the stab incision. d. Ex vivo image showing 









6.4.2 Live Acanthamoeba cysts 
Live Acanthamoeba cysts were inoculated in the cornea by introducing the incision 
tangentially into the epithelium and stromal layers and then withdrawing the needle 
to deposit the live cyst preparation into the corneal stroma. Using EVCM, the cyst 
demonstrated a rounded appearance with refractile cyst wall and the trophozoites 
were visible inside the cysts with bright vacuoles present (Figure 6.3a). The same 
cyst preparation was viewed under phase contrast microscopy at x400 (Figure 6.3b) 
and the cyst wall was refractile with a clearly visible double wall. The trophozoites 
were seen inside the cyst wall but the visible vacuoles were non-refractile under 
phase contrast. These images closely resembled those from in vivo confocal images 
acquired from Acanthamoeba keratitis patients using HRT II (Figure 6.3 c,d) as both 




















Figure 6.3: EVCM, IVCM and phase contrast images of live cysts. a. Ex vivo image 
with mixed morphological appearances: rounded, refractile with trophozoites 
present inside cysts. b. In vitro phase contrast image x400, showing refractile cysts 
with double wall. c, d. In vivo image from patients with AK showing similar 










6.4.3 Dead Acanthamoeba cysts 
Inoculation of dead cysts was also evaluated using the same method in which dead 
Acanthamoeba cysts were inoculated in the epithelium and stromal layers. Under 
EVCM, the cyst demonstrated a visible non-refractile outer wall and the remainder 
of the trophozoites within the dead cysts appeared as small refractile dots inside the 
cysts (Figure 6.4a). The dead cyst preparation was studied under phase contrast 
microscopy at x400 and showed the same findings of a visible non-refractile outer 
cell wall and the trophozoites inside the cysts had a ruptured cell membrane leading 
to leakage of the cytoplasm and the shrinking of the cells with a small refractile dots 
inside the cysts demonstrating the remainder of the trophozoites (Figure 6.4b). 
Similar appearance was demonstrated by IVCM for different patients with 





















Figure 6.4: EVCM, IVCM and phase contrast images of dead Acanthamoeba cysts. 
a. Ex vivo image of dead cysts (D) showing non-refractile outer cyst wall with a small 
refractile dots within the cysts representing non-viable trophozoites. b. In vitro phase 
contrast image x400, dead cysts showing non refractile wall. c,d. In vivo image from 












6.4.4 Empty Acanthamoeba cysts 
Empty cysts were inoculated into the cornea using the same method described 
earlier.  Using EVCM, the outer cyst wall was visible, non-refractile with a rounded 
appearance with a small refractile dot inside the cyst representing the remaining 
cellular material of the trophozoite (Figure 6.5a). Phase contrast image showed 
visible non-refractile cyst wall with a small amount of cellular material which was left 
behind inside the cyst by the excysting trophozoite (Figure 6.5b). IVCM images from 






















Figure 6.5: EVCM, IVCM and phase contrast images of empty Acanthamoeba cysts. 
a. Ex vivo image of empty cysts (E)  showing non refractile rounded cysts. b. In vitro 
phase contrast image x400, demonstrating visible non-refractile cyst walls with 
remnants of cellular material of trophozoites post excystation. c,d. In vivo image 











6.4.5 Live Acanthamoeba Trophozoites 
Inoculation of live trophozoites into the ex vivo model was also evaluated. Under 
EVCM, Individual cells were not visualised but an aggregation of trophozoites 
appeared as a coarse speckled area of refractile material, and the plasma 
membrane of individual trophozoites was non-refractile and therefore not visible 
(Figure 6.6a). The phase contrast image demonstrated live trophozoites that were 
amoeboid in shape with intact non-refractile cell membrane and the cytoplasm was 
full of refractile food vacuoles (Figure 6.6b). The appearance was similar to the 






































Figure 6.6: EVCM, IVCM and phase contrast images of live Acanthamoeba 
trophozoites. a.  Ex vivo image demonstrating coarse speckled areas representing 
clusters of trophozoites (T). b. In vitro phase contrast image x400, showing 
amoeboid trophozoites with intact cell membrane and many food vacuoles within 
the cytoplasm. c,d. In vivo image from patients with AK showing similar 












6.5 Discussion  
In this study, various forms of Acanthamoeba morphologies were identified using ex 
vivo confocal microscopy and were correlated with the imaging of various cyst and 
trophozoite-like features from culture positive Acanthamoeba keratitis cases on 
IVCM. Furthermore, phase contrast images of these forms were produced and 
compared with both EVCM and IVCM images. 
 
The evaluation of live cysts inoculation into the ex vivo model under EVCM 
demonstrated a typical rounded appearance with visible cyst wall due to its 
refractility, and the trophozoite was easily seen inside the cyst alongside refractile 
bright vacuoles. This appearance was similar to in vivo confocal images showing 
the refractile cyst wall within. The phase contrast microscopy at x400 also showed 
the refractile double cyst wall with the trophozoite within it. Dead and empty cysts 
where also studied under EVCM and phase contrast microscopy and the findings 
were compared to IVCM images taken from corneas of patients confirmed to have 
Acanthamoeba keratitis and the results were similar in terms of morphology and 
refractility with both dead and empty cyst demonstrating visible non refractile cyst 
wall with a small refractile dot inside the cyst representing the remainder of 
trophozoites. 
 
Researchers studied Acanthamoeba cysts and trophozoites morphologies using 
confocal microscopy on ex vivo and in vivo models, and their findings were in 
consistence with the outcome of this current study.  One study published in 2013 
used IVCM and demonstrated that Acanthamoeba cysts were rounded in shape and 
highly reflective in all examined cases which led to rapid confirmation of the clinical 
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diagnosis of Acanthamoeba keratitis (Kobayashi et al.,2013). They also studied the 
ex vivo cultured samples using EVCM which showed round and stellate reflective 
particles consistent with cyst morphology. In another study, researchers used HRT 
II/RCM to study Acanthamoeba cysts and reported a rounded, double walled 
morphology of Acanthamoeba cysts with various sizes and shapes which is 
consistent with the findings of this current study (Matsumoto et al.,2007). 
 
One research about diagnosis and management of  infectious keratitis used IVCM 
to study cyst morphologies which were found to be hyper-reflective, rounded, 
spherical, ovoid, with occasional double walled appearance (Labbé et al.,2009). 
Another research demonstrated hyper-reflective particles with further morphologies 
including signet ring, coffee bean, rod, stellate, rounded and ovoid shapes that have 
single or double walls (De Craene et al.,2018). Cysts have various morphologies as 
they can be triangular, 5 pointed or 7 pointed depending on the species of 
Acanthamoeba being examined, or due to the uncertainty of the structure under 
evaluation as the cornea may contain other micro-organisms including bacterial and 
fungal spores which are much smaller in size varying between 1-6µm compared to 
the Acanthamoeba cyst size ranging between 25-35µm. 
 
In this study, live Acanthamoeba trophozoites were evaluated using EVCM and 
phase contrast microscopy and the images were compared to IVCM findings from 
confirmed cases of Acanthamoeba keratitis. Individual cells were not visualised 
using EVCM and IVCM which only showed the aggregation of trophozoites as a 
coarse speckled area of refractile material. Phase contrast microscopy images 
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showed amoeboid trophozoites with non-refractile membrane with refractile food 
vacuoles in the cytoplasm.  
 
A paper published in 2012 used EVCM to study Acanthamoeba trophozoites 
cultured from patients with confirmed Acanthamoeba keratitis and they reported the 
trophozoites to be highly reflective, high contrast without cell wall (Yamazaki et 
al.,2012). Another paper used HRT II/RCM to study trophozoites which appeared 
homogenous, highly reflective intense and multiform in shape (Matsumoto et 
al.,2007). Nevertheless, the demonstration of Acanthamoeba trophozoites still 
poses a challenge as a previous study detected Acanthamoeba trophozoites in only 
one in nine cases of patients with confirmed Acanthamoeba keratitis using HRT II-




6.6 Conclusion and Future Work 
Images generated using HRT II- RCM in both EVCM and IVCM showed rounded, 
double walled structures representing Acanthamoeba cysts, however, the 
visualization of trophozoites was difficult to achieve. Up to our knowledge, this is the 
first study to perform this type of ex vivo work to comprehensively demonstrate the 
different morphologies of Acanthamoeba in both EVCM and IVCM and the matching 
in the outcome makes EVCM images a reliable diagnostic aid to validate IVCM 
findings where the study of Acanthamoeba cyst under EVCM facilitates the 
interpretation of in vivo findings in light of ex vivo images. 
 
Further studies can follow for other strains of Acanthamoeba to create a library of 
images for all morphological appearances to be used as a reference to facilitate 




















Phenotypic Similarities between 










Chapter 7: Phenotypic Similarities between Acanthamoeba and 




Macrophages are phagocytes that play a crucial role in innate immunity. They form 
one of the initial defense mechanisms against pathogens and have a major role in 
maintaining immunological homeostasis (Tarique et al.,2015). They are large tissue 
resident myeloid cells characterized by the presence of pseudopodia that give them 
the stellate appearance and they contain many vacuoles and granules which give 
them the foamy appearance (Flannagan et al.,2009). Other names for macrophages 
are based on the tissues within which they reside and include: Kupffer cells in the 
liver, microglia in the brain, Langerhans cells in the skin, osteoclasts in the bone and 
alveolar macrophages in the lungs (Yona et al.,2013). 
 
7.1.2 Function 
The main function of macrophages is phagocytosis which is the ingestion and 
engulfment of microbes and apoptotic cells by initiating a rapid and extensive 
cytoskeletal rearrangement of macrophages to facilitate the engulfment of the 
phagocytosed bodies ‘phagosomes’ (Flannagan et al.,2009). This process is 
followed by exchange of the components of phagosomes with lysosomes forming 
the final stage of phagosome maturation which results in the killing and degradation 
of the lumen content which demarcates one of the most critical steps in 
macrophages function (Flannagan et al.,2009, Silva,2010). 
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Macrophages recognize changes in tissue such as stress, infection, or injury, and 
initiate inflammation which will be followed by tissue remodeling (Italiani and 
Boraschi,2015).  They express many receptors such as Toll-like receptors (TLRs), 
retinoic acid-inducible gene-I-like receptors (RLRs), and cytosolic nucleotide-
binding domain leucine-rich repeat-containing proteins (NLRS) receptors (Price and 
Vance,2014, Takeuchi and Akira,2010), and they are activated when these 
receptors are ligated. 
Macrophages are classified into classically activated macrophages (M1) and 
alternatively activated macrophages (M2) (Figure 7.1) depending on the surface 




Macrophages were first identified by their phagocytic nature in the 19th century by 
Metchinkoff (Cavaillon,2011). In 1884, Metchinkoff demonstrated that macrophages 
help in tissue integrity and immunological homeostasis, and he reported that these 
cells can identify microbes and distinguish between self and non-self cells 
(Cavaillon,2011). This concept formed the basis of innate immunity that awarded 
him the Nobel Prize in 1908. The name macrophages came from the Greek word 





7.1.4 Activation of Macrophages  
The function of macrophages depends on the stimuli they receive from the 
surrounding micro-environment (Mills et al.,2012) (Figure 7.1). The activation of 
macrophages is mediated by ligation of TLRs and cytokine receptors that results in 
the expression of specific genes and proteins (Gordon & Taylor 2005). After the 
discovery of interferon γ (IFN‐γ) in the early 1990s and with better understanding of 
its cellular activity, it is now well established that IFN‐γ produced by type 1 T helper 
cell (TH-1) stimulates macrophages and activates their antimicrobial effect 
(Mosmann et al.,1986, Nathan et al.,1983, Pace et al.,1983).  
M1 macrophages are classically activated as a result of stimulation by IFN‐γ and 
once activated will secrete proinflammatory cytokines like tumour necrosis 
factor (TNF), IL-1β, IL-6, IL-12 (Shao and Lin 2008, Ziegler-Heitbrock et al.,1994). 
A study in 1960s by Mackness and colleagues showed that macrophages can also 
be activated by bacterial products, and they reported an activation and 
enhancement of the anti-microbial activity of macrophages in mice infected with 
Mycobacterium bovis bacillus Calmette-Guerin (BCG) and Listeria monocytogens 
(Mackaness ,1964). M1 macrophages play an important role in host defenses 
against microorganisms and in tumor suppression and regression (Italiani and 
Boraschi,2015). 
Macrophages that are activated by IL-4, IL-10, IL-13 are referred to as alternatively 
activated macrophages or M2 macrophages (Nishizuka 1992, McCarthy et al.,2012, 
Qin 2012).  They are involved in tissue repair, wound healing (Wynn 2004, Bouhlel 
et al.,2007, Sica et al.,2008), resolution of parasite infection, tissue remodeling, 




Many researchers reported that the concept of macrophage activation (polarization) 
into M1, M2 states is probably over-simplistic and that these states represent two 
extreme ends of the polarization journey, with many macrophage phenotypes falling 
in between (Mosser and Edwards,2008). For example, M2-like macrophages called 
regulatory macrophages have some of the characteristics of both M1 and M2 states. 
Regulatory macrophages express CD206, CD163 while also producing high levels 
of IL-10 and low levels of TNF-α and IL -12  similar to M2 macrophages (Biswas and 
Mantovani,2010). 
Macrophages can be differentiated from the human leukemic cell line (THP-1), 
which was established by Tsuchiya et al.in 1980 from the peripheral blood of a one-
year-old male human with acute monocytic leukemia (Takashiba et al.,1999). After 
exposure to phorbol-12-myristate-13-acetate (PMA), THP-1 cells in the monocytic 
state start to attach to the culture flask and take on a macrophage-like morphology 
by becoming amoeboid in shape and acquiring a well-developed Golgi apparatus, 
rough endoplasmic reticulum and large numbers of ribosomes in the cytoplasm 
(Auwerx,1991). Vitamin D3 (1 alpha, 25-dihydroxyvitamin D3) is another reagent 
used to differentiate monocytic cells into a macrophage state. PMA works by 
recruiting protein kinase C leading to a more mature phenotype with higher level of 
adherence and phagocytic ability and high levels of cell surface CD11b and CD14 
(Gordon and Taylor,2005) in comparison to vitamin D3, which recruits MAPK 
phosphatase -1 (MKP-1) pathways that facilitate monocytic differentiation (Gocek et 





Figure 7.1: Schematic diagram showing different stimuli and signaling pathways in 
activation and polarization of macrophages from M0 to M1 or M2 and the various 
roles of the activated macrophages with their surface receptors (CD) and 
inflammatory mediators. TGF: transforming growth factor; MR: mannose receptor; 
TNF: tumour necrosis factor; MCP: monocyte chemoattractant protein; IFNg: 




7.1.5 Acanthamoeba and Macrophages 
Acanthamoeba and macrophages share many phenotypic and functional properties 
related to their structure (Figure 7.2), movement, physiology, phagocytic processes 
and interaction with microorganisms (Greub et al.,2003, Wynn et al.,2013).   Both 
Acanthamoeba and macrophages engulf microbes by an actin-dependent process 
that leads to pseudopod formation (Siddiqui and Khan,2012). Both hosts exhibit 
features that allow bacteria to survive within them as for example, Legionella 
pneumophila grows inside them by expressing genes such as ICMT, ICMR, ICMQ, 
ICMB which play a role in intracellular growth and multiplication in both hosts, (Segal 
and Shuman 1999), with a similar life cycle in both hosts (Escoll et al.,2013). In 
addition, Pseudomonas aeruginosa, Yersinia spp., Bacillus anthracis (Price and 
Vance,2014), Parachlamydia intracellular and Listeria monocytogens had been 
reported to survive in both hosts (Greub et al.,2003). It was established that bacteria 
which can survive in amoeba can adapt to replicate in macrophages and become 
human pathogens (Price and Vance,2014). 
Both Acanthamoeba and macrophages have interchangeable states of cytoplasm, 
namely endoplasm and ectoplasm. The endoplasm is liquid and can be found in the 
cell centre while the ectoplasm is gelatinous and is usually located beneath the cell 
membrane (Siddiqui and Khan,2012), and they both demonstrate an increase in the 
number of mitochondria in their active stage (Cohn and Benson 1966; Cohn et 
al.,1965). Another similarity is that both Acanthamoeba and macrophages use 
NADPH oxidase to kill bacteria (Anderson et al.,2005). NADPH is essential for the 
function of phagocytic cells that form the innate immune system such as neutrophils, 
eosinophils, monocytes and macrophages (Cross et al.,2004). 
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Tissue resident macrophages recognize microbes by receptors such as Toll-like 
receptors which are transmembrane proteins that recognise pathogen-associated 
molecular patterns (PAMPs) derived from various microbes and subsequently 
synthesise pro-inflammatory cytokines and chemokines (Vaure and Liu,2014). 
Similarly, Acanthamoeba carries specific molecules on its surface that are 
recognized by TLR4 inducing innate immunological response (Cano et al.,2017). A 
previous study reported that the plasma membrane of Acanthamoeba castellanii 
has 31% of its mass composed of lipophosphoglycans (LPG) (Korn et al.,1974) 
which are considered Acanthamoeba-associated molecular patterns (Karaś et 
al.,2013) that stimulate TLR expression on macrophages and induce IL12 and IL16 
(Cano et al.,2017). 
There are some differences between Acanthamoeba and macrophages, mainly the 
ability of Acanthamoeba to live independently in the environment and its ability to 


















Figure 7.2: Transmission electron microscope images showing similar appearance 






The similarities between Acanthamoeba and macrophages have been investigated 
throughout literature. Nevertheless, there is a paucity of research performed on 
studying amoebic cell surface in comparison to that of macrophages. Assessing the 
expression of various membrane-bound antigens on amoebic cell surface in 
comparison to macrophages and finding any similarities between Acanthamoeba 
and macrophages will improve the understanding of how Acanthamoeba interacts 
with human immune system during infection which will help to identify novel 
therapeutic approaches in any future work. 
 
7.1.7 Aim and Objectives 
The work of this chapter aims to investigate the similarities between Acanthamoeba 
and human macrophages. The objectives are: 
• Investigate structural similarities between Acanthamoeba and macrophages 
that may reflect functional similarities by using the flow cytometry panel to 
assess the expression of different membrane-bound antigens to screen 
amoebic cell surface. 
•  Evaluate the possibility of using anti-human leukocytes antibodies to screen 
amoebic cells surface to investigate further structural similarities between 






7.2.1 Organisms  
The following table shows cell lines and organisms used in this study. 
Human cell line  Strain  
THP-1 ATCC – TIB-202 
Microorganism Strain  
Acanthamoeba polyphaga  ATCC 30461  
Acanthamoeba castellanii  ATCC 50370 
Naegleria gruberi ATCC 30133 
Acanthamoeba –clinical isolate* ---------- 
Acanthamoeba culbertsoni ATCC 30171 
*Obtained from Moorfields Eye Hospital NHS Foundation Trust 





7.2.2.1 THP-1 Cells  
Cells were maintained at 37 Co and 5% CO2 in RPMI 1640 growth medium and were 




Acanthamoeba castellanii (ATCC 30011), Acanthamoeba polyphaga (ATCC 30461) 
and Acanthamoeba culbertsoni (ATCC 30171) were maintained in tissue culture 
flasks using a semi defined axenic medium (AC#6) as previously described in 
chapter 2 section 2.3, and the same culture method was followed for both Naegleria 
gruberi (ATCC 30133) and Acanthamoeba – clinical isolate. 
 
7.2.3 Flow Cytometry 
Organisms and macrophages were processed using the following steps: the culture 
medium was removed from tissue culture flasks, and adherent cells were washed 
twice with staining buffer consisting of phosphate buffered saline (PBS), then 2% 
paraformaldehyde in PBS was added to the cells that were subsequently kept at 
room temperature for 10 minutes. The cells were then removed by gentle scraping 
with cell scraper and transferred to a 50 mL tube and centrifuged to form a cell pellet. 
The supernatant was removed, and cell pellets were re-suspended in 10 mL fresh 
buffer of PBS. The cells were centrifuged again under the same conditions. The cell 
pellets were again suspended in 1.5 mL buffer and transferred to 12 mm x 75 mm 
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tubes for counting. The cells were counted and then the count was adjusted to 1x 
106 cells/mL. 
 
The monoclonal antibodies (mAb) used in this study were CD11b, CD36, CD14, 
CD45, and MHC-II, all of which are anti-human. The antibodies used for flow 
cytometry analysis were obtained from Thermo Fisher Scientific, UK (table7.2). The 
negative controls consisted of IgG were derived from normal mouse serum 
conjugated with either PE or FITC fluorophores. Sample tubes with 100 µL of 
adjusted cell suspension received 5µL of anti-CD45, CD11b, CD36, CD 14, MHC-
II, or isotype control antibody according to manufacturer instructions of the 
antibodies. Cell control tubes received 5 µL of buffer to be used for assessing 
endogenous auto fluorescence. The tubes were incubated in the dark for 10 minutes 
at room temperature. All tubes received 3 mL of buffer of BPS, then were centrifuged  
at 4◦C for 10 minutes at 250 x g, and the supernatant was removed. 
 
Cell pellets were re-suspended in 3 mL of buffer and centrifuged under the same 
conditions. The supernatant was then removed, and the cell pellets were further re-
suspended in 1 mL buffer. The tubes were kept for 10 minutes in dark area at room 
temperature before analysis. All samples and corresponding controls were analysed 








Antibody Clone(s) Isotype Label Supplier 
CD14 61D3 IgG 1κ PE Thermo Fisher 
 Scientific 
CD36 eBioNL07 (NL07) IgM FITC Thermo Fisher 
 Scientific 
CD11b ICRF44 IgG 1κ PE Thermo Fisher 
 Scientific 
CD45 HI30 IgG 1κ PE Thermo Fisher 
 Scientific 
MHC Class II M5/114.15.2 IgG2b κ APC Thermo Fisher 
 Scientific 
 
Table 7.2: Anti‐human leukocyte monoclonal antibodies used in flow cytometry 






Flow cytometry (FCM) analysis showed a strong reactivity in macrophages with 
CD11b, CD36, CD14, MHC-II, CD45 antibodies. Results showed negative staining 
in all tested amoeba strains except for a positive staining of Naegleria gruberi with 
CD45 compared to its respective isotype control, and potential weak positivity with 









Flow cytometry analysis showed a positive reactivity in macrophages with the 
following antibodies: MHC-II (Figure 7.3a), CD 14(Figure 7.3b), CD36 (Figure 7.3c), 












Figure 7.3: Flow cytometry results for macrophages stained with anti-human mAbs. 
The X-axis represents fluorescent signal intensity, the Y-axis represents the number 
of detected events. All screened antibodies (mAb) showed positive staining in 
macrophages compared to the negative control (isotype). a. mAb: MHC-II, isotype: 
IgG2b κ; b. mAb: CD14, isotype: IgG 1κ; c. mAb: CD36, isotype: IgM; d. mAb: CD45, 







7.3.2 Acanthamoeba castellanii 
Flow cytometry analysis showed a negative reactivity in Acanthamoeba castellanii 
with MHC-II (Figure 7.4a) and CD14 (Figure 7.4b) and weak positivity with CD36 











Figure 7.4: Flow cytometry result for Acanthamoeba castellanii stained with anti-
human mAbs. The X-axis represents fluorescent signal intensity, the Y-axis 
represents the number of detected events. All controls isotypes were negative. a. 
mAb: MHC-II, negative, isotype: IgG2b κ; b. mAb: CD14, negative, isotype:  
IgG 1κ; c. mAb: CD36, weakly positive, isotype: IgM; d. mAb: CD45, weakly positive, 




7.3.3 Naegleria gruberi  
Flow cytometry analysis showed a negative reactivity in Naegleria gruberi with the 
following antibodies: MHC-II (Figure 7.5a), CD 14(Figure 7.5b), CD36 (Figure 7.5c), 
and CD11b (Figure 7.5e). However, a positive staining of Naegleria gruberi with 












Figure 7.5: Flow cytometry result for Naegleria gruberi stained with anti-human 
mAbs. The X-axis represents fluorescent signal intensity, the Y-axis represents the 
number of detected events. All controls isotypes were negative. a. mAb: MHC-II, 
negative, isotype: IgG2b κ; b. mAb: CD14, negative, isotype: IgG 1κ; c. mAb: CD36, 
negative, isotype: IgM; d. mAb: CD45, positive, isotype: IgG 1κ; e. mAb: CD11b, 
negative, isotype: IgG 1κ.  
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7.3.4 Acanthamoeba (clinical isolate) 
Flow cytometry analysis showed a negative reactivity in Acanthamoeba (clinical 
isolate) with the following antibodies: MHC-II (Figure 7.6a), CD14 (Figure 7.6b), 











Figure 7.6: Flow cytometry result for Acanthamoeba (clinical isolate) stained with 
anti-human mAbs. The X-axis represents fluorescent signal intensity, the Y-axis 
represents the number of detected events. All screened antibodies (mAb) showed 
negative staining in Acanthamoeba (clinical isolate) similar to the negative control 
(isotype).   
a. mAb: MHC-II, isotype: IgG2b κ; b. mAb: CD14, isotype: IgG 1κ; c. mAb: CD36, 







7.3.5 Acanthamoeba polyphaga 
Flow cytometry analysis showed a negative reactivity in Acanthamoeba polyphaga 
with the following antibodies: MHC-II (Figure 7.7a), CD14 (Figure 7.7b), CD36 (fig 












Figure 7.7: Flow cytometry result for Acanthamoeba polyphaga stained with anti-
human mAbs. The X-axis represents fluorescent signal intensity, the Y-axis 
represents the number of detected events. All screened antibodies (mAb) showed 
negative staining in Acanthamoeba polyphaga similar to the negative control 
(isotype). 
a. mAb: MHC-II, isotype: IgG2b κ; b. mAb: CD14, isotype: IgG 1κ; c. mAb: CD36, 







7.3.6 Acanthamoeba culbertsoni 
Flow cytometry analysis showed a negative reactivity in Acanthamoeba culbertsoni 
with the following antibodies: MHC-II (Figure 7.8a), CD 14(Figure 7.8b), CD36 











Figure 7.8: Flow cytometry result for Acanthamoeba culbertsoni stained with anti-
human mAbs. The X-axis represents fluorescent signal intensity whereas the Y-axis 
represents the number of detected events. All screened antibodies (mAb) showed 
negative staining in Acanthamoeba culbertsoni similar to the negative control 
(isotype).   
a. mAb: MHC-II, isotype: IgG2b κ; b. mAb: CD14, isotype: IgG 1κ; c. mAb: CD36, 








In this study, four species of Acanthamoeba alongside Naegleria gruberi were 
incubated with different anti-human leukocyte monoclonal antibodies (mAb) to find 
any similarities between macrophages and amoebic proteins and to investigate the 
utility of these anti-human leukocyte antibodies to screen amoebic cell surfaces. 
Similar to Acanthamoeba, Naegleria gruberi is a widespread free-living 
freshwater amoeba which is classified as a free-living protist and its reproductive 
form is a 15-µm amoeba which feeds on bacteria (Jonckheere,2002). The 
monoclonal antibodies (mAb) used in this study are well-recognised macrophage 
markers and they have different established functions: major histocompatibility 
complex (MHC-II), phagocyte activation (CD14, CD45), surface adhesion (CD11b), 
and metabolism-mediated receptor (CD36).  
The results obtained by the flow cytometry analysis showed a strong reactivity in 
macrophages with CD11b, CD36, CD14, MHC-II, CD45 antibodies. Results showed 
negative staining in all tested amoeba strains except for the detection of positive 
staining of Naegleria gruberi with CD45 compared to its respective isotype control, 
and potential weak positivity with CD36, CD45 and CD11b in Acanthamoeba 
castellanii. The positive staining suggests similarities in protein surfaces and their 
functions mainly with the positive reactivity of Naegleria to CD45 which might 
indicate the ability of Naegleria to synthesize similar proteins on its surface to 
perform similar functions to CD45 on the surface of macrophages.  
There are limited studies on the roles of CD45, however it was recently shown to be 
involved in several aspects of macrophages activation mainly C5a activated 
monocytes and epithelium-lining macrophages (Werfel et al.,1991). The evidence 
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suggests a role of CD45 in monocyte adherence (Lorenz et al.,1993) and respiratory 
burst (Liles et al.1995, Jean et al.,2000). CD45 is also referred to as protein tyrosine 
phosphatase receptor type C (PTPRC) which plays an important role in regulating 
human leukocyte activity making it a panleukocytic marker highly expressed in all 
hemopoietic cell lines (Dahlke et al.,2004).  
There are possible similarities between surface proteins and their functions between 
Acanthamoeba castellanii and macrophages given the potential weak positivity with 
CD11b, CD36 and CD45. Regarding CD11b, it is also referred to as macrophage-1 
antigen or complement receptor 3 and is expressed on the surface of a number of 
leukocytes that play a role in innate immunity as macrophages, neutrophils and 
monocytes (Solovjov et al.,2005).  CD11b facilitates inflammation by its role in the 
regulation of adhesion and migration of leukocytes and is also involved in vital 
immune processes including phagocytosis and attraction of the immune cell to the 
site of inflammation or injury by a process called chemotaxis (Solovjov et al., 2005). 
CD36, also known as fatty acid translocase, is found on many cell surfaces and aids 
in importing fatty acids inside cells and has many ligands as collagen (Tandon et 





7.4.1 Previous Studies 
A similar research was conducted in 2010 to investigate whether anti-human 
leukocytes antibodies can be used to screen amoebic cell surface to find similar 
proteins (Ravine et al.,2010) and the results of which supported the outcome of this 
current study. In their research, they incubated Naegleria and Acanthamoeba with 
anti-human antibodies such as CD14, CD45, CD206 and CD59, and they found that 
both Naegleria fowleri and Naegleria gruberi demonstrated strong reactivity for 
CD45 antibody and a dimmed positive staining of N. fowleri with CD59 antibody, 
while N. gruberi revealed a negative result for CD59 antibody. Negative staining 
results were obtained in all other tested Acanthamoeba species. The differences 
between their study and this study is that they used Acanthamoeba castellanii, 
Acanthamoeba culbertsoni, Naegleria fowleri and Naegleria gruberi where this 
study did not include Naegleria fowleri but included further species of  
Acanthamoeba such as A. polyphaga and Acanthamoeba (clinical isolates).Their 
selection of CD markers (CD14, CD45, CD206, CD59) was based on their role in 
phagocyte activation while the CD markers used in this study have different roles 
like adhesion (CD11b), metabolism (CD36), phagocytosis (CD14,CD45) and major 
histocompatibility complex  (MHC-II). Both studies showed positive reactivity of 
Naegleria to CD45 antibody and negative staining for the rest of the antibodies 
however in our study we also observed potential weak positivity with CD36, CD45 
and CD11b in Acanthamoeba castellanii. 
Another research supported this current study by demonstrating the potential to use 
anti-human leukocytes antibodies to screen amoebic cells surface (Fritzinger et 
al.,2006). They reported that Naegleria fowleri expresses CD59 like molecule on its 
surface, but this molecule was not detected on the surface of non-pathogenic 
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Naegleria gruberi amebae. They used Southern blot, Western immunoblot, and 
immunofluorescence analysis to identify any reactivity of Naegleria fowleri 
membrane with anti-human CD59 antibody. Southern blot analysis showed one 
gene in Naegleria fowleri that encodes CD59, while Western immunoblot revealed 
a protein that is reactive with human CD59 monoclonal antibodies in the membrane 
of Naegleria fowleri. Furthermore, immunofluorescence analysis demonstrated the 
presence of CD59 on the membrane of Naegleria fowleri. They concluded that the 
expression of this protein may be associated with a protective role for amoeba 
(Fritzinger et al.,2006).  
CD59 (protectin) is a membrane inhibitor of reactive lysis that attaches to host cells 
by a glycophosphatidylinositol anchor and can prevent the formation of the 
complement membrane attack complex (Huang et al.,2006). Some viruses such as 
human immunodeficiency virus and human cytomegalovirus incorporate CD59 of 
the host cell into their envelope to prevent being lysed by the complement system 
(Bohana-Kashtan et al.,2004). 
The differences between their study and this current study are that they mainly 
studied N.fowleri and N .gruberi, while in this current work N. fowleri was not 
included but four species of Acanthamoeba were studied in addition to N. gruberi, 
they used CD59 only while this work investigated different CD markers antibodies, 
and another difference is that for this study we only used flow cytometry technique 







7.5 Conclusion and Future Work 
The results obtained demonstrate various degrees of positive reactivity of amoebic 
cell surface to a limited number of anti-human monoclonal antibodies. This positivity 
suggests some similarities in protein surfaces and their functions between amoeba 
and macrophages and while this limited reactivity can potentially offer a tool for 
screening, it is still difficult to use it to screen amoebic cell surface using anti-human 
monoclonal antibodies.  
Future work may include further studies on positive results using immuno-
histochemical analysis, electron microscope and Immunofluorescence in 
conjunction with our method in addition to using comparative genomic analysis 
techniques. 
The surface receptors shown to have positive reactivity in this study can be further 
investigated with regards to the ligands that bind to them in aim of finding potential 
similarities between these ligands and the ones that bind to Acanthamoeba 
receptors. Finally, more antibodies can be investigated to detect further similarities 
between macrophages and amoeba which can potentially carry diagnostic and 
































Chapter 8: General Conclusions 
 
Acanthamoeba is a virtually ubiquitous, small free-living amoeba found in the 
environment and has a life cycle of an active trophozoite and a dormant highly 
resistant cyst stage. Acanthamoeba species are opportunistic pathogens of humans 
that can cause different diseases including a blinding keratitis.  
 
This chapter summarises the work in this thesis starting by the developing an ex 
vivo corneal model of Acanthamoeba keratitis (AK) and using this model for different 
applications including reaching a better understanding of the pathophysiological 
processes that occur throughout the disease, investigating the role of cells of innate 
immunity in fighting the infection, testing the efficacy of different pharmaceutical 
compounds in treating AK, correlating morphological findings of Acanthamoeba 
between in vivo samples of confirmed cases of AK and the ex vivo model using 
confocal microscopy, and finally evaluating the phenotypic similarities between 
Acanthamoeba and cells of the innate immune system mainly macrophages using 
flow cytometric analysis. 
 
Several approaches were used to develop and maintain the ex vivo model, and the 
outcome was evaluated at both gross and microscopic levels. We developed a 
grading system to quantify the integrity of the model starting from grade 0 for healthy 
cornea up to grade 4 where there is a total loss of corneal epithelium and the 
presence of stromal oedema. The models were evaluated using the grading system 




Using the immersion system, we were able to maintain the corneal transparency 
and epithelium for one week after which the cornea became opaque and lost all of 
its epithelium (grade 4). Using the air liquid interface, the static model with CO2 
maintained corneal transparency for two weeks with loss of more than 50% 
epithelium (grade 3), and a total loss of epithelium at week four (grade 4).                 
The air- liquid interface was also evaluated using a rocking system with and without 
CO2 which showed superior results with the addition of CO2 as we were able to 
maintain the epithelium up to four weeks with only superficial loss of the outermost 
epithelium layers (grade1) and no stromal oedema. Both rocking models (with and 
without CO2) lost corneal transparency after 2 weeks. These results signify the 
superiority of using the air-liquid interface using a rocking system with better 
outcome with the supplement of CO2 where the rocking system mimics the natural 
blinking of the eye lid and CO2 serves as a vital nutrient to cells and maintains the 
pH close to neutral which is more resembling to an in vivo environment. 
 
Acanthamoeba keratitis model was developed using the air- liquid interface rocking 
system with CO2 for the reasons described above. A scoring system was developed 
to describe the infection process starting from the attachment of Acanthamoeba 
trophozoites to corneal epithelium (score 1*) and the progression of the disease was 
followed up till the invasion of trophozoites to the stroma with total loss of epithelium 
(score 6*). The infection was induced by adding the trophozoites to the corneal 
surface after inducing epithelial injury by scratching the surface of cornea and the 
model was subsequently examined microscopically on day 3 and every 5 days 
afterwards for a total of four weeks. The attachment of trophozoites started on day 
3 (score 1*), and the earliest changes to the epithelium were noted on day 8 with 
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superficial loss of epithelial layers (score 2*). The progression of the disease was 
studied, and the findings were documented until there was a complete loss of all 
epithelial layers with invasion of the trophozoites to the middle parts of the stroma 
on day 28 (score 6*). These observations demonstrated the usability of the ex vivo 
model to induce infection and monitor the progression of the disease in the absence 
of host immune response. To our knowledge, this is the first ex vivo model 
successfully developed to study Acanthamoeba keratitis for an extended period of 
four weeks. 
 
The established ex vivo model was utilized to test the therapeutic effect of 
doxycycline and PHMB against Acanthamoeba keratitis and to study any potential 
toxicity against the corneal epithelium. Furthermore, drug assay was performed to 
Investigate the efficacy of PHMB and doxycycline against Acanthamoeba 
trophozoites and cysts and any toxic effect against human cells.  
 
Both histological findings and drug assay results confirmed the ability of PHMB to 
inactivate Acanthamoeba trophozoites, however despite the AK model 
demonstrating mild toxic effect of PHMB against corneal epithelial cells, drug assay 
results show high level of in vitro toxicity to human cells which is explained by the 
extra protection mechanisms the ex vivo model acquires compared to the in vitro 
setting used in the drug assay. Doxycycline showed no major antimicrobial effect on 
Acanthamoeba with minimal toxic effect on human cells. The findings demonstrate 
the usability of the ex vivo model to test the efficacy of different drugs against 
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Acanthamoeba and detect any potential toxic effects drugs might exert of corneal 
epithelial cells. 
 
The model was also used in confocal microscopy and phase contrast studies to 
correlate morphologies of various forms of Acanthamoeba in both ex vivo and in 
vivo settings. We inoculated the model with different forms of Acanthamoeba (live 
trophozoites, live, dead and empty cysts) and compared confocal microscopy and 
phase contrast images to those from in vivo images from patients diagnosed with 
AK. The morphology of Acanthamoeba cysts using ex vivo confocal microscopy 
(EVCM) was consistent with phase contrast and in vivo contrast microscopy (IVCM) 
images showing rounded, double walled structures. The visualization of individual 
trophozoites was difficult to achieve in both EVCM and IVCM as the aggregation of 
trophozoites was only demonstrated as a coarse speckled area of refractile material. 
Phase contrast microscopy images showed amoeboid trophozoites with non-
refractile membrane and refractile food vacuoles within the cytoplasm. This is the 
first study to perform this type of ex vivo work which will help in early diagnosis of 
Acanthamoeba keratitis by facilitating the interpretation of IVCM findings in light of 
ex vivo images. 
 
To better understand how Acanthamoeba interacts with human immune system 
during infection, a flow cytometric analysis was conducted to detect any similarities 
between amoeba and macrophages by investigating the expression of various 
membrane-bound antigens on amoebic cell surface in comparison to macrophages 
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using several anti-human monoclonal antibodies, namely CD11b, CD36, CD14, 
MHC-II and CD45.  
 
The results of the analysis demonstrated a strong reactivity in macrophages with 
MHC-II, CD14, CD36, CD45 and CD11b antibodies and negative staining in all 
tested amoeba strains except for a positive staining of Naegleria gruberi with CD45 
compared to its respective isotype control, and a potential weak positivity with CD36, 
CD45 and CD11b in Acanthamoeba castellanii. 
The positive reactivity suggested some structural and functional similarities in 
protein surfaces between amoeba and macrophages. Despite having the potential 
to offer a tool for screening, it is still difficult to screen for amoebic cell surface 
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